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One research interest of Dr. Zhao’s group is to develop efficient methodologies
for the enantioselective C－ C bond formation for constructing potentially useful
building blocks. The catalytic allylation and vinylation have been developed into one
of the powerful tools for C－ C bond forming reaction. This thesis describes my
efforts during my Ph.D. research aimed towards the development of Lewis
base/cobalt-catalyzed enantioselective allylation and vinylation reactions that result in
the formation of many biologically and pharmaceutically important intermediates.
Chapter 1 provides a comprehensive review of catalytic asymmetric vinylation of
carbonyls, imines and alkenes by the use of organometallic reagents.
Chapter 2 describes Lewis base-catalyzed practical, enantioselective allylation and
crotylation of aldehydes (and imines). It has been demonstrated that bidentate Lewis
base catalysts can be constructed based on the Cinchona alkaloild structure, which
promote highly stereoselective reaction of allyl- and crotyltrichlorosilane with
aromatic as well as aliphatic aldehydes. Gram-scale reactions with catalyst recovery
and reuse showcased the practicality of the catalytic system.
Chapter 3 presents cobalt-catalyzed allylation of heterobicyclic alkenes. By using
inexpensive cobalt salt as the catalyst and easy-to-handle potassium
allyltrifluoroborate as the reagent, an unprecedented formal hydroallylation of the
bicyclic alkenes is realized in high efficiency. When a chiral cobalt-bisphosphine
complex is used instead, the alternative ring opening products can be obtained in high
yield and excellent enantioselectivity.
IX
Chapter 4 introduces an efficient method of cobalt-catalyzed enantioselective
vinylation of alkenes, carbonyls and imines. The method utilizes commercially
available vinyl boronic acid and readily available starting material, and employs a
direct Co(II)-catalyzed addition procedure. The efficiency, selectivity and operational
simplicity of the transformations and the broad range of electrophiles are expected to
render this methodology important for the synthesis of chiral allylic alcohols and
amines which are useful in chemistry, biology and medicine in the future.
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Chapter 1 Review onAsymmetric Vinylation of Carbonyls,
Imines and Alkenes Using Organometallic Reagents
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1.1 Importance of asymmetric vinylation
Stereocontrolled C-C bond formation has played a significant role in organic
synthesis. The asymmetric vinylation of carbonyls, imines and activated alkenes has
attracted much attention and has been considered as a powerful tool for
stereocontrolled C-C bond formation.[1] The past twenty years witnessed the explosive
development of asymmetric vinylation of potentially useful electrophiles (such as
carbonyls, imines and alkenes) using various vinyl organometallic reagents. This
method provided a straightforward access to enantioriched allyl alcohols and amines
that are valuable targets in their own right (Figure 1.1) and also serve as versatile
intermediate to afford a range of other enantiomerically enriched molecules with
various substitutions patterns (Scheme 1.1).
Scheme 1.1Asymmetric vinylation of carbonyls, imines and alkenes
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Figure 1.1. Selected examples of molecules (naturally occurring and artificial)
bearing allylic alcohols, amines and 1, 4-chiral dienes
1.2 Synthetic utility of asymmetric vinylation
The asymmetric vinylation has proved to be a useful strategy to couple to
complex cross partners to yield synthetically versatile allylic alcohols/amines. Vinyl
zinc reagents were the most commonly utilized, which were prepared through
functionalization of alkyne precursors. One classical application of asymmetric
vinylation of aldehyde is the total synthesis of macrocyclic natural product
(R)-Muscone 1.4 (Scheme 1.2), which was reported by Oppolzer and coworkers.[2]
Monohydroboration of terminal alkyne 1.1 followed by transmetalation of the
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resulting (E)-(1-alkenyl) dicyclohexylboranes with diethylzinc provided (1-alkeny1)
ethylzinc reagents. In the presence of chiral ligand (+)-DAIB 1.3, the in situ generated
vinyl zinc reagent added to the aldehyde enantioselectively to form the key
intermediate of (R)-Muscone: macrocyclic (E)-allyl alcohol 1.2.
Scheme 1.2 (R)-Muscone synthesis via asymmetric vinylation
One representative application of the asymmetric vinylation of ketone is to set up
chiral tertiary alcohol moiety 1.7 for the total synthesis of anti-tumor agent Fostriecin
1.8 reported by Jacobsen and coworkers (Scheme 1.3).[3] Enantioriched terminal
alkyne 1.5 underwent hydrozirconation /transmetalation to form the vinyl zinc reagent,
which reacted with chiral ketone 1.6 to afford tertiary allylic alcohols 1.7 with
excellent diastereoselectivity. The α-stereogenic center in 1.6 determined the d.r. of
the newly formed tertiary alcohol stereoselectivity.
Scheme 1.3Asymmetric vinylation of ketone for total synthesis
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In addition, asymmetric vinylation of imines provides a direct way to construct
chiral allylic amines for the total synthesis of bioprotective reagent JP4-039 1.13
(Scheme 1.4).[4] A similar sequence of hydrozirconation of 1.9 with Cp2ZrHCl,
transmetalation with trimethylaluminum and vinylation of chiral sulfinimine 1.10,
provided a diastereomerically pure allylic amine 1.11. After deprotection of
t-butysulfinyl group and -TBDPS groups, common intermediate 1.12 was obtained for
the synthesis of JP4-039 1.13.
Scheme 1.4 Asymmetric vinylation of imine to construct chiral allylic amine moiety
for total synthesis
1.3 Catalytic asymmetric vinylation of aldehydes
Catalytic asymmetric vinylation of aldehydes has been extensively explored due
to its utility. In the past few years, great progress has been made in this research area
by the use of vinyl metallic reagent such as vinylzinc, vinylsilane, vinylboronates, et
al.
1.3.1 Vinylzinc addition
In the early stage, vinylzinc reagent was one of the most widely used reagent in
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asymmetric vinylation of aldehydes. It is readily accessible by either hydroboration or
hydrozirconation of terminal alkynes followed by transmetalation with dialkylzinc
reagent. Impotantly, alkenylzinc reagents possess relatively low background reactivity.
Their activity, however, can be greatly enhanced by the use of Lewis basic ligand. In
particular, chiral amino alcohols and related compounds have been successfully used
as the chiral catalyst. Early work on this topic came from the Oppolzer group in 1993
(Scheme 1.5) . They developed vinylzinc reagent through transmetalation of the
hydroboration product alkenyldicyclohexylboranes with diethyl zinc and found that
10 mol% Noyori’s 3-exo-dimethylaminoisoborneol (DAIB) 1.14 was an optimal
catalyst for excellent enantioselectivity (79-98%) and chemical yield (67-94%) for the
vinylation of a range of aryl and alkyl aldehydes.[3] In 2002, Walsh’s group disclosed
an efficient and highly enantioselective method for the synthesis of protected D- and
L-α-amino acids from terminal alkynes. A catalytic asymmetric vinylation of
aldehydes followed by an Overman imidate rearrangement to install an amino group
was the key steps in their synthesis.[5] In their system, the chiral allylic alcohols were
obtained by the use of vinylzinc reagent in the presence of 2 mol% catalyst 1.15.
Later in 2005, Seto developed ligand 1.16 mediated enantioselective addition of
vinylzinc reagents to benzaldehyde in 89-93% ee and in up to 80% yield in a solid
phase synthesis manner.[6] Alternatively, Wipf and his coworkers developed vinyl zinc
reagent from zirconocene-zinc transmetalation and in situ catalytic asymmetric
addition to aromatic and aliphatic aldehydes in the presence of 10 mol% chiral amino
thiol catalyst 1.17, which provided an efficient protocol for the preparation of
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enantioriched (E)-allylic alcohols.[7]
Scheme 1.5 Vinylation of aldehyde using vinyl zinc reagents
The Wash group also disclosed an efficient synthesis of enantioriched
(Z)-trisubstituted allylic alcohols 1.21 by choosing 1-bromo-1-alkynes 1.18 rather
than terminal alkynes (Scheme 1.6) as the starting material[8]. (Z)-Trisubstituted
vinylzinc reagents 1.19 are formed in situ by initial hydroboration of
1-bromo-1-alkynes followed by reaction with Et2Zn. (R)-Ethyl and (R)-cyclohexyl
(Z)-trisubstituted allylic alcohols 1.22, 1.23, 1.24 can be synthesized with excellent
levels of enantioselectivity in the presence of catalyst 1.20 (-)-MIB. It is noteworthy
that 1 equivalent of TMEDA played an important role in inhibiting the byproduct
formation. Also zinc bromide that is formed as a by-product is sufficiently Lewis
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acidic to promote the background reaction and generate the racemate.
Scheme 1.6 Synthesis of enantioenriched (Z)-trisubstituted allylic alcohols via
(Z)-vinylzinc reagents
1.3.2 Vinylsilane reagents
As a useful synthetic method for chiral allylic alcohol synthesis, catalytic
enantioselective alkenylation using alkenylzinc species reliably achieved both high
yield and enantioselectivity. However, it is necessary to use a stiochiometric amount
of zinc reagents such as ZnR2 in addition to prior hydroboration or hydrozirconation
of terminal alkynes. All the dialkylzinc reagents are extremely pyrophoric, which
limits its utility in large scale production. On the other hand, easily synthesized,
storable, air- and moisture-stable vinylsilanes have strong potential for direct
synthesis of versatile chiral allylic alcohols. However, vinylsilanes are much less
reactive than vinylzinc reagents. Therefore, this transformation needs an external
transition metal as the catalyst and a transmetalation process to generate the vinyl
metal as the actual vinylating reagent.
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In 2005, Shibasaki’s group disclosed chiral copper complex-catalyzed
enantioselective vinylation of aldehydes by the use of air and moisture-stable and
commercially available vinylsilane as the nucleophile (Scheme 1.7).[9] In their
reaction, various aldehydes such as aromatic, heterocyclic, alkenyl, and aliphatic
aldehydes were well tolerated and the desired products 1.25-1.28 were obtained in
excellent yield and enantioselectivity. Desired product 1.29 could be obtained in a
moderate yields and enantioselectivity by the use of substituted vinylsilane. More
importantly, this catalyst system could be applied to activated α-keto ester to yield
chiral allylic tertiary alcohols 1.30 in 76% yield and 84% ee.
Scheme 1.7 Copper catalyzed asymmetric vinylation of aldehydes using vinylsilane
reagents
R 1 C H O + SiY(OM e)2
R 2
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The preliminary working hypothesis of the catalytic cycle was proposed by
Shibasaki’s group (Figure 1.2). Through ligand exchange between CuF and
vinyltrimethoxysilane 1.31, vinylcopper 1.32 can be generated while liberating
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(MeO)3SiF. The formation of a strong Si-F bond serves as the driving force of this
step. Appropriate diphosphines can stabilize the vinylcopper species. The vinylation
of carbonyl compounds should proceed rapidly from vinylcopper as an active
nucleophile. After the addition, copper sec-alkoxide 1.33 can be generated.
Regeneration of an active vinylcopper from the copper alkoxide was proposed to be
the rate-determining step. The bulky diphosphine ligands should accelerate the
rate-determining step to reliese the steric bulk of the [Cu-OR] intermediate.
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In 2009, Mikami’s group described asymmetric vinylation of glyoxylates by the
use of vinylsilanes catalyzed by a chiral dicationic Pd complex (Scheme 1.8)[10]. The
palladium catalyst facilitated the alkenylation of glyoxylates with vinylsilanes bearing
an electron-donating methoxy substituent on the aromatic ring and yielded the
corresponding product 1.34 in excellent yield and enantioselecvity. An
electron-withdrawing CF3 substituent led to the vinylation product 1.35 in excellent
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enantioselectivity but relatively lower yield. More importantly, sterically more
demanding disubstituted and trisubstitued vinylsilanes underwent very smoothly,
resulting in the corresponding product 1.36, 1.37 in excellent yields and
enantioselectivity. The same approach could extend to asymmetric dienylation and
trienylation to produce the corresponding products 1.38 and 1.39 in high yield and
excellent enantioselectivity. The mechanism of this catalytic system turned out to be
very intriguing and counter-intuitive. Crossover experiment for vinyl reagents bearing
different silyl substituents 1.40, 1.41 was carried out to elucidate whether transfer
proceeds via intra- or intermolecular process (Scheme 1.8b). Only the intramolecular
silicon transfer was observed, suggesting that no vinylpalladium intermediate was
formed in this case, even though Pd is well-known to engage in transmetalation.
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In 2006, Shibasaki’s group applied their CuIF–DTBM-segphos catalyst system
to alkenylation of aldehydes by the use of vinylboronates as the nucleophile[11]. The
TBAT or TBAT–BF3·OEt2 combination was effective in reactions with aromatic or
aliphatic aldehydes, respectively (Scheme 1.9). These additives possibly modulated
the catalyst turnover step from copper alkoxide intermediates to the vinylcopper
reagent
Scheme 1.9 Enantioselective alkenylation of aldehydes by the use of vinylboronic
acid pinacol ester.
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In 2010, Harada and coworkers developed catalytic enantioselective synthesis of
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allylic alcohols from terminal alkynes and aldehydes via 1-alkenylboron intermediate
(Scheme 1.10).[12] This practical one-pot method was realized through hydroboration
of terminal alkynes with dicyclohexyborane and subsequent reaction of the resulting
alkenylboron reagents 1.42 with aldehydes. In the presence of a catalytic amount of
BINOL derivative 1.48 and excess titanium tetraisopropoxide, the corresponding
allylic alcohols were formed in high enantioselectivities up to 94% ee. More
importantly, the chiral allylic alcohols bearing a variety of functionalized groups,
including a chlorine atom (1.44), a protected alcohol (1.45), a nitrile (1.46) and an
amide (1.47) were obtained in good yields and excellent enantioselectivity. The author
speculated that alkenylboron reagent 1.42 undergoes boron/titanium transmetalation
with titanium tetraisopropoxide selectively on the alkenyl group to produce
alkenyltitanium species as an active intermediate.
Scheme 1.10 Titanium mediated enantioselective vinylation of aldehydes
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1.4 Asymmetric vinylation of ketones
While catalytic enantioselective addition of performed vinylmetallics to aldehydes
have been well established, the vinylation of the corresponding ketones are much
more challenging, due to the low reactivity and difficult differentiation of two
enantiotopic faces. Indeed, only a few successful catalyst asymmetric variants were
reported in the past few decades.
1.4.1 Vinylzirconocene reagents
In 2003, Wipf’s group reported the first protocol of diastereoselective vinylation
of α-keto esters.[13] In their reaction, a similar hydrozirconation of alkynes 1.49
followed by in situ transmetalation with dimethylzinc and yielded vinylzinc reagent.
And 8-phenylmenthol mioety served as the chiral auxiliary. Chiral tertiary allylic
alcohols 1.51 were obtained in high overall yield and excellent diastereoselectivitity
(Scheme 1.11). The chiral auxiliary could be recovered and recycled in high yield.
Scheme 1.11 Dimethylzinc-mediated addition of alkenylzirconocenes to α-keto esters
Later on, Walsh’s group developed a protocol for the highly enantioselective
catalytic addition of functionalized vinyl groups to ketones (Scheme 1.12).[14] This
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reaction followed a similar hydrozirconation/transmetalation to zinc and addition
sequence. By using 1.2 equivalent Ti(OiPr)4 and a catalytic amount of chiral
bis-sulfonamide/diol 1.52, tertiary allylic alcohols were accessed in excellent yields
and enantioselectivity. Both aryl and aliphatic ketones could be vinylated smoothly
and yielded products 1.53 and 1.56 with satisfactory results. This reaction was
compatible with functionalized substrates to yield the vinylation products 1.54 and
1.55 in good yield and good ee. More importantly, α,β-unsaturated ketones were
examined in the asymmetric vinylation, and the resulting dienols 1.57, 1.58 were
produced with excellent enantioselectivities (92%, 94%) and high yields. No
conjugate addition products were isolated. Later on, Wash’s group applied this
catalytic system to dienylation of ketones successfully.[15]
Scheme 1.12 Catalytic asymmetric vinylation of ketones
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1.4.2 Vinylaluminum reagents
In 2009, Gau reported asymmetric vinylation of ketones catalyzed by titanium
and (S)-BINOL by the use of vinylaluminum reagents that can be formed in situ
from the reaction of DIBAL-H and alkynes (Scheme 1.13)[16]. Varieties of aromatic
ketones and α,β-unsaturated ketones were examined to afford products with excellent
enantioselectivity of up to 98% ee in high yield. Moreover, reaction with
vinylaluminum reagents derived from a variety of alkynes also produced allylic
alcohols in excellent enatioselectivities (up to 96% ee).
Scheme 1.13 Asymmetric vinyl addition of vinylaluminum to ketones
1.4.3 Vinylboron reagents
Hayashi group developed a rhodium-catalyzed asymmetric addition of
arylboronic acids to isatins to produce biologically relevant
3-aryl-3-hydroxy-2-oxindoles in high yield. High enantioselectivity was achieved by
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the use of (R)-MeO-mop 1.60 as a ligand. These conditions were also successfully
extended to the addition of alkenyl boronic acid 1.62 to isatin 1.61 to form allylic
tertiary alcohols 1.16 in high enantioseletivity (Scheme 1.14).[17]
Scheme 1.14 Rh/(R)-MeO-MOP complex catalyzed asymmetric vinylation of isatin.
1.5 Asymmetric vinylation of imines
The nucleophilic additions to imines with vinyl organometallic species
represents the most straightforward and versatile strategy to prepare chiral allylic
amines with various substitution patterns. In this area of the research, vinylation has
been explored in the form of Petasis-type reaction catalyzed by either organocatalysts
or transition metal catalysts.
1.5.1 Organocatalytic asymmetric vinylation of imines
As a modern variation of the Mannich reaction using organoboronic acids, the
Petasis reaction is of great importance in synthetic chemistry. In 2007, Takemoto and
coworkers reported the first catalytic enantioselective variant of the Petasis
transformation of quinolines.[18] A newly designed thiourea catalyst 1.66 provided
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sufficient activation of the alkenyl boronic acid to react with quinolines even at -65 oC.
Up to 78% yield, 98% ee of vinylation products 1.65 were achieved in the reaction of
various quinolines 1.64 and vinyl boronic acids by using a combination of H2O and
NaHCO3 as additives (Scheme 1.15a). In their concept, the thiourea moiety could
activate N-acylated quinolinium salts as a BrØnsted acid, and the 1,2-amino alcohol
functionality could activate the boronic acid to increase its nulceophilicity (Scheme
1.15b).
Scheme 1.15 Catalytic enantioselective Petasis-type reaction of quinolines
In 2007, Schaus disclosed the first enantioselective Petasis reaction of alkenyl
boronates, secondary amines, and ethyl glyoxylate catalyzed by chiral biphenols.[19]
The reaction required the use of 15 mol % of (S)-VAPOL 1.67 as the catalyst, alkenyl
boronates as the nucleophiles, ethyl glyoxylate as the aldehyde component, and 3 Å
molecular sieves as an additive. The chiral α-amino ester products were obtained in
good yields (71−92%) and high enantiomeric ratios (89:11−98:2) (Scheme 1.16).
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Scheme 1.16 Asymmetric Petasis reactions catalyzed by chiral biphenols
Later on, Schaus’s group also applied the chiral bis-phenols system to
enantioselective addition of boronates to acyl imines (Scheme 1.17).[20] A range of
alkenylboronates, aryl and aliphatic imines, as well as acyl imine substituents were
found to be effective in the BINOL-catalyzed addition reaction, each affording the
corresponding amide in good yields (74-91% yield) and excellent enantioselectivities
(95:5-99:1 er). Other than vinylboronate nucleophile, aryl and alkynylboronates were
also add to imines smoothly under the standard reaction condition. The transition state
for asymmetric boronate addition to acyl imines was proposed in Figure 1.3. The
observed enantiofacial selectivity is the result of catalyst coordination to the Z
conformer of the acyl imine. The more reactive Z conformer in reactions involving
imines because of the steric interactions that arise from the metal reagent and the
substituents of the imine. The hydrogen-bonding character of the bis-phenol activates
the acyl imine towards nucleophilic attack and orients the boronate complex towards
Re enantiofacial selectivity in the addition reaction.
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Figure 1.3 Proposed tranistion state for asymmetric boronate addtion to acyl imines
Subsequently, Schaus’s group reported the use of tartaric acid 1.69 as the catalyst
to perform highly enantioselective additions of vinylboronates to N-acyl quinoliniums
1.70 to form chiral dihydroquinolines 1.71 in good yield and enantioselectivity
(Scheme 1.18)[21]. The catalyst served to activate the boronate through a
ligand-exchange reaction, and the N-acyl quinolinium was generated in situ from the
stable quinoline-derived N,O-acetal. Their proposed catalytic cycle relied on the
tetracoordinated boron “ate” 1.72 as the resting state of the catalyst (Scheme 1.19).
The dimeric borate 1.72 underwent a disproportionation with boronate 1.73 to form
the activatied alkenyl dioxaborolane 1.74. Next, 1.74 reacted with N,O-acetal 1.75 to
form N-acyl quinolinium and boron “ ate” intermediate 1.76. Nucleophilic addition of
the alkenyl group to the iminium proceeded enantioselectively to afford
dihydroquinoline 1.77 and regenerate complex 1.72.
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Scheme 1.18 Enantioselective boronate additions to N-acyl quinoliniums
Scheme 1.19 Proposed catalytic cycle
Very recently, Liu’s group described the first orgaocatalytic enantioselective
oxidative C－H functionaliziation of N-acyl tetrahydroisoquinolines with vinyl and
aryl boronates promoted by a chiral BrØnsted acid 1.78 (Scheme 1.20).[22] This
metal-free process tolerated a wide range of electronically varied N-acyl
tetrahydroisoquinolines and structurally diverse boronates with good to excellent
enantioselectivities. The proposed catalytic cycle is shown in Scheme 1.21. Firstly,
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DDQ promotes the C−H oxidation of N-Boc tetrahydroisoquinolines 1.79 to generate
acyliminium 1.80, which is then captured by the solvent to give N-acyl hemiaminal
1.81. Catalyst 1.78 reacts with vinyl boronates, affording a reactive dioxaborolane
complex 1.82. The carboxylic acid moiety in 1.82 promotes the collapse of 1.81 to
give acyliminium boron “ate” intermediate 1.83. The“ate”complex is then activated
by the CF3CH2O anion to promote the addition of the vinyl group to the acyliminium
affording 1.84 together with the regeneration of catalyst 1.78 .
Scheme 1.20 Organocatalytic asymmetric C－H vinylation and arylation of N-acyl
tetrahydroisoquinolines
Scheme 1.21 Proposed catalytic cycle
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Later on, Liu’s group applied the same catalytic system to asymmetric vinylation
and arylation of tetrahydro-β-carbolines (THCs) 1.85 and N-carbamoyl
tetrahydropyridines 1.89 with excellent enantiocontrol using a wide range of
boronates (Scheme 1.22)[23]. CF3CH2OH additive has been demonstrated to play a
significant role in the C－H oxidation and nucleophilic addition processes.
Scheme 1.22 Organocatalytic enantioselective oxidative C－H alkenylation
46
1.5.2 Asymmetric vinylation of imines mediated by transition metals
Organocatalytic asymmetric Petasis reaction has been developed as a powerful
transformation for installing an vinyl unit on the imines to produce chiral allylic
amines with a alkene group transferred from the corresponding alkenyl boron reagent.
In addition to organocatalytic asymmetric Petasis reaction, the asymmetric vinylation
of imines can be also catalyzed by transition metal catalysts Vinylboron and various
vinylmetallic reagents based on Zr, Zn etc have been used.
1.5.2.1 Hydrozirconation/transmetallation with zinc
Wipf’s group is the pioneer in the development of the hydrozirconation/
transmetalation/imine addtion protocol for asymmetric synthesis of (E)-allylic amines,
A chiral auxiliary was used to achieve high d.r.(Scheme 1.23)[24].
In 2006, Seto’s group reported a small chiral molecule-catalyzed enantioselective
addition of vinylzinc reagents to 3,4-dihydroisoquinoline N-oxide 1.94 (Scheme
1.24)[25]. With 0.1 equiv. of the ligand 1.95, the product was obtained in up to 84% ee,
whereas with 1.2 equiv. of the ligand 1.95, the ee was increased to the 90 - 95% range
with a variety of aliphatic, cyclic, and aromatic vinylzinc reagents. This method was
used to synthesize the protected unnatural amino acid, N-Cbz-D-1,2,3,4-
tetrahydroisoquinoline-1-carboxylic acid 1.95 in three steps from the allylic
hydroxylamine 1.96.
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Scheme 1.23 Alkyne hydrometalation/imine addition method
Scheme 1.24 Enantioselective vinylation of 3,4-dihydroisoquinoline N-oxide
In 2015, Trost’s group applied their new non-C2-symmetric triol ligand 1.98 to
the first catalytic asymmetric vinylation of N-Boc imines via hydrozirconation, giving
rise to valubale allylic amines in excellent yields and enantioselectivities (Scheme
1.25)[26].
Scheme 1.25Asymmetric catalytic vinylation of N-Boc imines
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1.5.2.2 Transition metal catalyzed diastereoselective 1,2-addition of alkenylboron
reagents to imines
In 2009, chiral sulfinyl imines were utilized by Ellman and coworkers to form di-,
tri-, or tetrasubstituted chiral allylic amines (Scheme 1.26)[27]. The sulfinyl imine 1.99
was coupled with potassium trifluoroborates 1.100 via Rh(I)-catalysis. Air-stable
[Rh(OH)(cod)]2 along with dppbenz gave the best yield and diastereoselectivity of the
allylic sulfinylimines 1.101-103.
Scheme 1.26 Rh(I)-catalyzed addition of alkenylation of N-tert- butylsulfinylimines
Later on, highly diastereoselective Petasis borono-Mannich reaction was
developed by Xu’s group (Scheme 1.27)[28]. This transformation provides an efficient
and straightforward method for the preparation of highly enantioriched
β,ɤ-unsaturated α-amino acid derivatives by InBr3-catalyzed Petasis reaction of
vinylboronic acid 1.105, N-tert-butanesulfinamide 1.106, and glyoxylic acid 1.107.
Various chiral allylic amines 1.109-1.112 were obtained by the use of 10 mol% InBr3.
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Scheme 1.27 InBr3-catalyzed highly diastereoselective Petasis borono-Mannich
reaction
1.5.2.3 Transition metal-catalyzed enantioselective 1,2-addition of alkenylboron
reagents to imines
In 2012, cyclic imines 1.113 in which the C=N is contained in the Z geometry
was discovered as an effective substrates for enantioselective rhodiu-catalyzed
addition of potassium alkenyltrifluoroborates 1.114 (Scheme 1.28)[29]. By using the
chiral diene ligand, chiral allylic amines 1.115 were obtained in good yields and
excellent enantioselectivity. Cyclic N-sulfonyl ketimine was also a viable substrate,
providing sultam 1.116 in 68% yield and 90% ee. The derivatization of the vinylation
product 1.115 was demonstrated to yield useful intermediates 1.117 and 1.118 in
several steps.
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Scheme 1.28 Rh(I)-catalyzed addition of potassium alkenyltrifluroborate to cyclic
imines
In 2013, Wu’s group demonstrated for the first time, acyclic N-tosyl aryl
aldimines 1.120 could be used as substrates in the rhodium catalyzed 1, 2-addition
reaction using alkenylboron nucleophiles (Scheme 1.29)[30]. In the presence of 1.5
mol % of [RhCl(C2H4)2]2, and 3.6 mol% chiral diene ligand 1.121, enantioselective
addition of various potassium alkenyltrifluoroborates 1.122 to aryl aldimines
furnished the corresponding chiral allylic amines 1.123 in 73−96% yield and 72
−>99.5% ee. Notably, this method efficiently provided the di-, tri-, and
tetrasubstituted allylic N-tosyl amines 1.124-1.126 with high asymmetric induction.
In 2014, Lin’s group also reported a similar transformation. They demonstrated
that N-nosylaldimines 1.127 could be a suitable substrate for Rh-catalyzed
asymmetric addition reaction of potassium alkenyltrifluoroborates (Scheme 1.30a)[31].
Under optimal conditions, the reactions proceeded with good to excellent yields and
excellent enantioselectivities (97 - 99.5% ee). Furthermore, the protecting group of
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chiral allylic amine 1.129 could be easily removed by treatment with 2-thioglycolic
acid (TGA) and LiOH·H2O at room temperature to produce free allylic amine 1.130
in 93% yield (Scheme 1.30b). The utility of this method was demonstrated by the
formal synthesis of (−)-aurantioclavine 1.135 (Scheme 1.30c). The key step,
rhodium-catalyzed asymmetric addition of trifluoroborate 1.132 to imine 1.131,
produced the desired adduct 1.133 in 98% yield with 99% ee. Suzuki coupling of
1.133 with vinyltrifluoroborate introduced a vinyl group at the 3-position of indole,
generating a properly decorated indole 1.134, which is a key intermediate in the
formal synthesis of (−)-aurantioclavine 1.135.
Scheme 1.29 Highly enantioselective Rh-catalyzed alkenylation of N-tosylimines
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1.6 Asymmetric vinylation of alkenes
Chiral transition metal complex catalyzed asymmetric alkylation of alkenes by use of
various organometallic reagents has been a topic of long-standing interest in the last
two decades. Asymmetric vinylation of alkenes has been explored in the forms of
enantioselective 1,4-conjugate addition and enantioselective allylic substitution
reaction.
1.6.1 Transition metal-catalyzed enantioselective 1,4-conjugate vinylation
The enantioselective 1,4-conjugate addition of organometallic reagents to enones
is a well-established process for carbon－ carbon bond formation affording chiral
β-substituted carbonyl compounds. The last two decades have witnessed the
enormous development of asymmetric 1,4-conjugate arylation by the the use of
phenyl boronic acid catalyzed by late transtion metal complexes[32]. However, the
investigation of asymmetric 1,4-conjugate vinylation is still less studied. This
transformation can give β-vinylic carbonyl compounds, which are versatile synthons
for further organic transformations.
53
1.6.1.1 Vinylic zirconium reagent
At the early stage, the vinylic zirconium reagent has been most widely used to
install vinyl units on the alkenes. Alkenylzirconocene chlorides could be prepared
easily through the hydrozirconation of alkynes with Schwartz reagent (Cp2ZrHCl),
which were considered as convenient and reliable organometallic reagents for
constructing the alkenyl groups in transition metal-catalyzed C–C bond formation
reactions. In addition to asymmetric vinylation of carbonyls and imines, vinylic
zirconium reagent could also be employed in asymmetric vinylation of alkenes.[1]
In 2004, Oi and Inoue employed alkenylzirconium reagents for the asymmetric
vinylation of α,β-unsaturated ketones in the presence of chiral rhodium complex
generated from [Rh(cod)(MeCN)2]BF4 and 1.136 (S)-BINAP (Scheme 1.31)[33]. Either
cyclic or acyclic enones 1.137-1.140 were obtained in excellent yields and
enantioselectivity. The key intermediate, alkenyl Rh species could be generated by the
transmetalation between the rhodium complex and alkenyl zircononcene chloride
1.135. This catalytic system also worked well with alkenylation of enones by the use
of alkenylsilane reagents.[34]
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Based on the pioneering work of Oi and Inoue, Nicolaou and coworkers
developed an asymmetric multicomponent reaction that combined α,β-unsaturated
enones, aldehydes and alkenyl zirconium species for enantioselective access to
2,3-disubstituted cycloalkanones in the presence of a chiral rhodium catalyst (Scheme
1.32)[35].
Scheme 1.32 Catalytic asymmetric three-component 1,4-addition/aldol reaction
Their proposed mechanism is shown in scheme 1.33. Firstly, the transmetalation
of the alkenyzirconium species 1.143 might generate the rhodium alkenyl complex
1.144, which could react with cyclic enone 1.145 to form the π-coordination complex
1.146. Rearrangement of 1.146, upon transfer of the alkenyl group onto the 4-position
of the enone, should lead to the rhodium enolate 1.147. This chiral enolate might then
react with the aldehyde 1.148 in an aldol reaction, generating rhodium complex 1.149
through a six-membered ring transition state. Transmetalation of 1.150 with another
alkenyl zirconium species 1.143 lead to zirconium alkoxide 1.151 and regeneration of
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rhodium alkenyl complex 1.144. Hydrolysis of 1.151 provides aldol product 1.152.
Scheme 1.33 Proposed mechanism
1.6.1.2 Vinylic aluminum reagent
Very recently, Woodward and Alexakis reported Cu-chiral phosphoramidite
catalyzed asymmetric 1,4-addition to cyclic enones (Scheme1.34).[36] In their reaction,
chloromethyl vinyl alanes 1.154 was prepared directly from terninal alkynes 1.153.
Both cyclohexenone and 3-methylcyclohexenone proceeded very smoothly and
yielded the products 1.156-1.159 in good level enantioselectivity in the presence of
readily available copper(I) sources and chiral ligand 1.155. However, acyclic enones
failed to engage in this transformation efficiently and the product 1.160 was only
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obtained in <10% yield.
Scheme 1.34 Cu-catalyzed alkenylation of cyclohexenones
1.6.1.3 Vinylsilane reagents
Organosilane has played a great role in C－C bond forming reaction in organic
synthesis. Most of them are readily available and less moisture- and oxygen-sensitive
compared to alkylmetal reagent such as Grignard and zinc. More specifically, vinyl
silanes have been considered as a good nucleophile to be transmetalated by transition
metal catalyst. In 2007, Hoveyda’s group reported chiral non-C2-symmeric
Cu-N-heterocyclic carbene 1.161 complex catalyzed asymmetric conjugate vinyl
addition reaction by use of alkenyl silyl fluoride reagents and afforded the
vinylcycloalkanones 1.162 in up to 92% ee. (Scheme 1.35).[37]
tris(dimethylamino)sulfonium difluorotrimethylsilicate (TASF) was used for in situ
formation of the hypervalent tetrafluoroalkenyl silicate, which can subsequently give
rise to the derived active NHC-Cu-alkenyl complex.
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Scheme 1.35 NHC-Cu-complex catalyzed vinylation of enones
1.6.1.4 Vinylic organoboron reagent
In recent years, organoboron reagents have proven to be the most popular and
user-friendly organometallic reagents used in various trasformations because of their
suitable reactivity, easy accessibility, low toxicity, and high stability toward air and
water.
In 1998, Hayashi and Miyaura reported the first example of asymmetric 1,4-
conjugate arylation and alkenylation of enones using aryl- and alkenyl boronic acid in
the Rh-(S)-BINAP catalyst system (Scheme 1.36a).[38] Only two substrates have been
carried out in the alkenylation reaction. Cyclopentanone and cyclohexanone could be
vinylated smoothly to produce the vinylating product in high yield and
enantioselectivity (64%, 96% ee; 88%, 94% ee). Extensions of this reaction included
the 1,4-addition of aryl- and alkenylboronic acids or boroxines to enones, α,
β-unsaturated esters, amides, phosphonates and nitroalkenes.[39] Later on, asymmetric
conjugate arylation and alkenylation by the use of potassium trifluoroborates has been
reported by Darses and Geneˆt (Scheme 1.36b)[40] and the Feringa group (Scheme
1.36c)[41], respectively. (R)-BINAP 1.166 and chiral phosphimidite 1.167 gave a good
performance on enantioselective control. Moreover, potassium organotrifluoroborates
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could be readily prepared in high yields and purities and could be stored indefinitely
without any precaution.[42]
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In 2012, Lin’s group described rhodium-catalyzed asymmetric conjugate
addition of potassium alkenyltrifluoroborates and α,β-unsaturated carbonyl
compounds by using a rhodium–chiral diene 1.168 complex as a catalyst (Scheme
1.37)[43]. Under optimized reaction conditions, the reactions gave products with
moderate to excellent yields and high levels of enantioselectivity. Application of this
methodology was demonstrated by a concise synthesis of 1.169 (S)-pregabalin and
1.170 (-)-α-kainic acid.
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1.6.2 Organocatalytic conjugate addition
1.6.2.1 Vinylboronate reagents
In conjugate additions to enones using alkenyl boronates and chiral rhodium
catalysts, transmetalation to a chiral alkenylrhodium species is believed to be the
common intermediate. However, Chong’s group has described an alternative
activation method in which they used readily accessible chiral binaphthol 1.171 as the
catalyst to activate the alkenylboronates to facilitate the asymmetric alkenylation
reaction[44]. Enantioselectivities of the products were uniformly high for a wide range
of enones and alkenyl groups (Scheme 1.38). They have also proposed the
mechanism (Scheme 1.39a) and transition state of this transformation (Scheme1.39b).
Catalysis of the reaction arised from transesterification of boronate with chiral
binapthols to produce more Lewis acidic, and more reactive, boronates 1.172. .
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Scheme 1.38Asymmetric conjugate alkenylation of enones catalyzed by chiral diols
Scheme 1.39 Proposed mechanism and transition state
1.6.3 Enantioselective asymmetric allylic vinylation.
Compared to the allylic alkylation process with arylmetal and alkylmetal,
processes with the corresponding vinylic reagents are of higher synthetic utility,
which provided a straightforward method to install 1,4-chiral diene, the potentially
versatile building blocks in natural product synthesis.
1.6.3.1 Vinyl aluminum reagent
In 2008, Hoveyda’s group reported the first example of asymmetric allylic
alkylation reaction involving vinylmetal reagents[45]. In their reaction, vinylaluminum
reagents could be prepared from commercially available DIBAL-H with readily
61
accessible terminal alkynes efficiently and used in situ. Vinylation reactions were
catalyzed by 0.5-2.5 mol% chiral Cu N-heterocyclic carbene (NHC) complexes that
was generated in situ from chiral silver NHC complexes 1.173 and copper dichloride
monohydrate. Various allylic phosphates could undergo vinylation smoothly as shown
in Scheme 1.40. More specifically, products 1.175 of trisubstituted olefins bearing an
aryl group with different electronic properties were obtained in 84-94% yields and 87-
98% ee. Alkenylation of disubstituted olefins bearing an alkyl group and a silyl group
proceeded to obtain desired products 1.176 and 1.177 in high yield and
enantioselectivity. More importantly, Product 1.178 bearing the alkyl halide
substituent was obtained in 86% yield and 92% ee. Chiral bicyclic diene 1.179 and
homoallylic ether 1.180 could be synthesized in 93% ee and 89% ee, respectively, and
exclusively as E alkene isomers.
Scheme 1.40 NHC-Cu-catalyzed allylic substitution with alkenylaluminium reagents
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Later on, the same group employed the chiral N-hetercyclic carbene copper
catalyst system for a transformation involving silyl-substituted alkenylaluminum
compounds 1.181, which can be obtained through a silyl-alkyne and its site-selective
hydroalumination (Scheme 1.41)[46]. The catalytic allylic substitution reactions
proceeded in high yield, and the desired 1,4-dienes 1.184 were formed in 82-98%
yield and 88-98% ee. Nonetheless, silylated alkynes had to be prepared initially, and
the desired Z alkenes 1.185 were revealed after desilylation.
Scheme 1.41 NHC-Cu-catalyzed allylic substitution with silyl-substituted
alkenylaluminium reagents
1.6.2.2 Vinylboronate reagents
Although the vinyl aluminum reagent has been successfully applied to
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enantioselective allylic vinylation reaction, it also has a significant disadvantage that
the vinylalumnium reagents with a heteroatom substituent at their allyic position
cannot be prepared by hydrometalation. In contrast, the corresponding vinylboron
reagents can be readily prepared via the same approach. Hoveyda’s group has made
great efforts on the research area of asymmetric allylic vinylation to improve the
general utility of this important transformation. His group developed a method for
catalytic enantioselective asymmetric substitution with vinylboron reagents, including
those containing a carboxylic ester and an acetal unit (Scheme 1.42)[47]. The desired
products 1.187-1.190, including those with an ester, an aldehyde, and an alkyl halide
group, were formed in up to 95% yield and more than 98% ee in the presence of
sulfonate-bridged bidentate N-heterocyclic carbene 1.186 complexes of copper. More
importantly, to further showcase the utility of this transformation, concise
enantioselective synthesis of Pummerer ketone 1.191 has been disclosed through the
transformations of enantioriched 1,4-chiral dienes product 1.190.
Scheme 1.42 Copper-catalyzed enantioselective allylic aubstitution with vinylboron
reagents
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Very recently, Carreira described that a variety of secondary allylic alcohols
could react with potassium alkenyl(trifluoro)boronates to generate products in the
presence of a chiral phosphoramidite 1.192-Ir complex (Scheme 1.43)[48]. Highly
efficient transformations proceeded in 75:25 to >98:2 of branch to linear ratios and up
to 98% ee. The advantage of the catalyst system is that unsaturated alcohols served as
starting materials instead of more activated derivatives such as allylic carbonates.
Moreover, this method provided a rapid access to various chiral 1,4-diene or trienes
by the use of corresponding potassium trifluoro alkenylboronates. nBu4NHSO4 could
play dual roles: first, as the phase transfer catalyst for potassium
alkenyltrifluoroborates; and second, as the BrØnsted acid activator for the allylic
alcohols. HF played a role as the activator for potassium trifluoroborates salt.
Scheme 1.43 Iridium-catalyzed enantioselective allylic vinylation
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The value of this transformation has been demonstrated through the concise
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synthesis of biologically active (−)-nyasol (1.93) and (−)-hinokiresinol (1.194) in
excellent yields and enantioselectivity (Scheme 1.44).
Scheme 1.44Application for synthesis of (−)-nyasol and (−)-hinokiresinol
O H
M eO
BF 3K O M e
















(-)-h inokires ino l 86%  y ie ld , 94%  ee
1.193
1.194
1.7 Conclusions and future perspectives
As evidenced in the preceding sections, many discrete variants of catalytic
enantioselective vinylation of carbonyls, imines and alkenes by the use of
organometallic reagents have been established. The utilities of these catalyst systems
have been demonstrated by the enantioselective synthesis of complex molecules.
Recently, efforts have been focused on extending the vinylation to more generalized
and useful substrates such as epoxides, azirines, and polarized alkenes and alkynes. In
the future, in order to develop more sustainable and economic asymmetric
transformation, there will be a strong push for the use of the abundant and less
expensive transition metals, such as Co, Fe and Ni as the catalysts, instead of noble
metals. The methodology developed aloong those lines will be highly desired.
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Chapter 2 Practical, Highly Stereroselective Allyl- and




2.1.1 Importance of allylation
Asymmetric allylation and crotylation have played a great role in C－C bond
formation for organic synthesis. Asymmetric allylation of aldehydes (including related
crotylation) provides a straightforward access to enantioriched homoallylic alcohols
with various substitution patterns, which are important structural features in many
natural products and medicinal agents (Scheme 2.1).[49] The high level of
stereselectivity (diastereoselectivity and enantioselectivity) coupled with the latent
functionality in the products makes this reaction a useful and popular tactic in total
synthesis of natural product.[50]
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2.1.2 Types of allylation
The allylation can be divided into three types according to the classification
system proposed by Denmark (Scheme 2.2).[51]
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Type I allylation involves a closed six-membered chair transition state
characterized by internal activation of carbonyl by the metal center of the allylating
reagent. A predictable diastereospecificity for the corresponding crotylation reactions
is the significant advantage for this type of reactions. Most chiral allyllating reagents
such as Brown, Roush and recently developed Leighton’s reagents as well as Lewis
base-catalyzed allyltrichlorosilane addition to aldehydes and imines belong to this
category.
In type II allylation, the electrophile is activated by external Lewis acids and the
reaction goes through an open transition state. It would provide a mixture of
diastereomers with syn-isomer as the major product. Allyltrialkylsilanes and
allyltrialkylstannanes belong to this category.
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Type III allylation, exemplified by allylchromium and allyltitanium species, also
react through a six-membered chair transition state. Z to E isomerization of the
allylating reagent through a π-allyl intermediate, however, takes place faster than the
carbonyl addition. So it would provide the anti-diastereomers as the major product
regardless of the geometry of the allylating reagent.
2.1.3 Cinchona alkaloid derivatives in asymmetric catalysis
In 1820, ierre-Joseph Pelletier and Joseph Bienaimé Caventou discovered the
antimalarial property of cinchona bark and subsequently isolated its active compound,
quinine. Since then, cinchona alkaloids (Figure 2.1) have played an indispensable
role in medicinal chemistry for over 200 years. More specifically, quinine and
quinidine have been identified as important muscle relaxant drug and antiarrhythmic
agent.[52] In addition to medicine, Cinchona alkaloids can also be used as a bitter
additive in the food and beverage industry.
Figure 2.1 Quinine and other Cinchona alkaloids
During the last two decades, Cinchona alkaloids and their derivatives have
played a significant role as a privileged scaffold in asymmetric catalysis.[53] A wide
70
range of useful transformations has been developed by using Cinchona alkaloid
derivatives as a ligand or catalyst. The strongly basic quinuclidine nitrogen
functionality can effectively serve as a ligand for metal-catalyzed process. The most
representative example is the osmium-catalyzed asymmetric dihydroxylation of
olefins (Scheme 2.3).[54]
Scheme 2.3 Sharpless asymmetric dihydroxylation
R 1 R 3
R 2 R 4 organ ic solvent/ w ater
K 2O sO 2(O H )2
K 3Fe(C N )6
(D H Q )2PH A L
H O O H
R 2 R 4













(D H Q )2 PH A L
Cinchona alkaloids have also been developed into bifunctional catalysts. In 2005,
Tibor SoÓs reported the first example of Cinchona alkaloid-derived bifunctional
thiourea organocatalyst and this catalyst was applied in the Michael addition of
nitromethane to chalcones with excellent enantioselectivity and chemical yield
(Scheme 2.4).[55] The incorporation of H-bonding donor such as urea or thiourea
moiety on the catalyst definitely increased the efficiency and selectivity of catalytic
reaction.
In 2011, Dixon disclosed the highly enantio- and diastereoselective aldol reaction
of isocyanoacetates catalyzed by a combination of Ag2O and Cinchona alkaloid-
derived phosphine ligand (Scheme 2.5)[56]. The cinchona alkaloid-derived pre-catalyst
installed a phosphine moiety that acted as a metal binding site, while the quinuclidine
nitrogen acted as a BrØnsted base in the formation of an enolate. This catalytic system
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has been successfully applied to other electrophiles such as activated imines and
ketones. [57]
Scheme 2.4 Bifunctional cinchona organocatalyst catalyzed conjugate addition of
nitromethane to chalcones
Scheme 2.5 Highly enantioselective silver-catalyzed isocyanoacetate Aldol reaction
In summary, structures such as 2.1, 2.2 and 2.3 (Scheme 2.6) have proven to be
powerful bifunctional catalysts for various organic transformations. Surprisingly, the
construction of a simple bidentate ligand or catalyst, employing the quinuclidine
nitrogen and another Lewis basic donor moiety (2.4 in Scheme 2.7), has remained
unexplored in asymmetric catalysis.
Scheme 2.6 Known catalyst design based on Cinchona alkaloids
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Scheme 2.7 Proposed new bidentate Lewis base catalyst
Towards the development of such a catalyst scaffold that will certainly benefit
from the readily available, inexpensive Cinchona alkaloids, we chose the addition of
allyl- and crotyltrichlorosilanes 2.6 to aldehydes 2.5 as our model reaction, not only
because it is a well-established reaction that can be catalyzed by a bidentate Lewis
base,[49][58] but more importantly, it represented the first catalytic approach to realize
predictable, diastereospecific crotylation (Type I allylation,[51] where the use of E- or
Z-crotylsilane provides anti- or syn-products with >98% fidelity through the six-
membered closed chair transition state), which is a key requirement in the formation
of propionate units that are ubiquitous in polyketide natural products such as 2.7
(Scheme 2.8).[59]
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Scheme 2.8 Lewis base-catalyzed diastereospecific crotylation
Many catalytic systems have been developed for this reaction, which are
dominantly chiral phosphoramides 2.8 from the group of Denmark,[60] and N-oxide
catalysts 2.9 - 2.13 from the groups of Nakajima,[61] Hayashi,[62] Kočovskў,[63]
Snapper and Hoveyda[64] and Zhu[65]. All these systems have been reported to promote
allylation of aromatic aldehydes with high diastereo- and enantioselectivities (Scheme
2.9).
While the great potential of these methods in chemical synthesis has been
demonstrated, there is still much room for improvement with these catalytic Type I
allylations. Firstly, one common limitation is the lack of reactivity for aliphatic
aldehydes as the substrate, with the only exception being highly stereoselective allyl-
and crotylation of aliphatic aldehdyes 2.14 catalyzed by chiral formamide 2.15 from
the Iseki group that required an impractically long reaction time (2-4 weeks) (Scheme
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2.9).[66] Secondly, these catalysts are not readily accessible. A multi-step synthesis has
to be carried out to obtain them commonly with a low overall isolated yield. Moreover,
since some of them are not from the chiral pool, a classical resolution step is required.
Lastly, essentially all these reactions were carried out at extremely low temperature,
which limits scalability and practicability. Even though this is not uncommon in
asymmetric organocatalysis, a procedure that utilizes ambient temperature and readily
available catalysts would provide us with an indispensable practical advantage.
Scheme 2.9 Chiral Lewis bases for asymmetric allylation of aldehydes
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In fact, due to the limitation of the catalyst systems, chiral Type I reagents
(mainly allylborations such as Brown allylation reagent 2.16,[67] Roush allylation
reagent 2.17[68] and the recent developed silane-based reagent 2.18 from the Leighton
group[69]) are still commonly used in asymmetric synthesis (Scheme 2.10).
Scheme 2.10 Chiral reagent for crotylation of alddehydes
A catalytic Type I allylation that can address the limitations of previous systems
is therefore still desired.[70] we have developed a Cinchona alkaloid amide as a highly
efficient and stereoselective catalyst for the allylation and crotylation of a wide range
of aldehydes, and in particular, aliphatic aldehydes (95–99% ee). This system also
provides significant practical advantages that enable large scale production: the
catalyst can be prepared in a one-pot procedure from inexpensive starting materials,
can be easily recovered and reused, and promotes the allylation reactions at ambient
temperature (instead of low temperatures of -40 to -78 oC for most previous systems)
2.2 Results and discussion
We initiated our studies by examining the catalytic activity of a variety of
quinine-derived compounds for the addition of allyltrichlorosilane to 2-1a, the
product of which is highly synthetically useful but was not previously available using
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Lewis base catalysis (Table 1). Quinine 2.19 and quinine ester 2.20 that were
previously widely used as nucleophilic catalysts[71] proved inefficient for our purpose,
presumably due to limited Lewis base activation from the monodentate quinuclidine
nitrogen (Table 2.1, entries 1-2). The well-established bifunctional catalysts[72]
(Brønsted base coupled with H-bond donor) urea 2.21 and thiourea 2.22 were also
poor catalysts (Table 2.1, entries 3-4). Sulfonamide 2.23 and phosphoric amide 2.24
that were previously used as bifunctional catalysts may also serve as bidendate Lewis
base, and we did observe an interesting shift for the enantiomeric product (40% ee vs.
-20 or -40% by using 2.21 or 2.22), however the level of efficiency and selectivity
obtained were far from satisfactory (Table 2.1, entries 5-6). To our delight, simple
quinine amide[73],[74] 2.25 that was introduced by the Brunner group for
enantioselective decarboxylation but rarely proved successful elsewhere provided the
desired product with high efficiency and excellent enantioselectivity (Table 2.1, entry
7). Evaluation of the electronics of the aryl group (Table 2.1, entries 7-9) clearly
showed that the amide moiety serves as a Lewis base (instead of H-bond donor in
which case the catalyst would be more effective with electron-withdrawing
substituent installed such as 2.26), with the catalyst 2.27 possessing a strongly
electron-donating dimethylamino group being the optimal catalyst.
Cinchonidine-derived 2.28 (only lacking the methoxy substituent on quinoline)
provided essentially the same result as 2.27, suggesting that the quinoline moiety in
the catalyst structure is not directly involved in activation of the silylating reagent.
Compound 2.29 possessing the analogous chiral amide moiety but lacking
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quinuclidine was much less efficient and selective, which further supported our
hypothesis of bidentate Lewis base activation of allyltrichlorosilane. Finally, as
cinchona alkaloids exist as pseudo-enantiomers, quinidine-derived 2.30 was also
tested that provided the enantiomeric product 2-2a with the same excellent
enantioselectivity.
Table 2.1 Optimization of asymmetric allylation of aliphatic aldehyde.
Entry Catalyst T(h) Conv.(%)[a] e.e.[%][b]
1 2.19 48 15 -8
2 2.20 48 10 -5
3 2.21 24 30 -41
4 2.22 24 40 -20
5 2.23 24 36 40
6 2.24 24 45 40
7 2.25 24 83 95
8 2.26 24 35 81
9 2.27 24 88 96
10 2.28 24 83 96
11 2.29 24 35 9
12 2.30 24 88 -96
[a] The Conv. were determined by 1H NMR of the crude reaction mixture. [b] The e.e. values were
determined by high-performance liquid chromatography (HPLC); e.e., enantiomeric excess.
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The optimal reaction conditions can be employed to produce a wide range of
homoallylic alcohols in excellent enantioselectivity (Table 2.2). The reactions were
carried out with 2.27 or 2.30 that yielded both antipodes of the products in
comparable excellent enantioselectivity. The enantioselectivities for allylation of
aliphatic aldehydes are uniformly high (95-99%). It is noteworthy that various
functional groups such as ethers and silyl ethers 2-2a - 2-2c (Table 2.2, entries 1-3),
esters 2-2d (Table 2.2, entry 4) as well as N-heterocycles 2-2e (Table 2.2, entry 5) are
all well-tolerated, in addition to simple alkyl and alkenyl aldehydes 2-2f - 2-2j (Table
2.2, entries 6-10). This unprecedented scope bodes well for application in complex
natural product synthesis. Aromatic aldehydes 2-2k - 2-2n also work under same
conditions to yield the products in slightly lower selectivity (90-94% ee).







1 2-2a 83; 96 86; -97
2 2-2b 89; 99 82; -98
3 2-2c 70; 95 73; -96
4 2-2d 90; 98 88; -98
5 2-2e 75; 95 80; -96
6 2-2f 80; 96 74; -96
7 2-2g 76; 96 71; -95
8 2-2h 76; 97 70; -98
9 2-2i 78; 97 85; -96
10 2-2j 83; 96 80; -96
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11 2-2k 77; 90 75; -91
12 2-2l 83; 92 90; -92
13 2-2m 77; 94 80; -93
14 2-2n 80; 93 89; -92
[a] The e.e. values were determined by high-performance liquid chromatography (HPLC). [b] The
yields are isolated yields based on average of two runs.
The ability of a catalytic system to override inherent control in chiral substrates
is a key parameter for its synthetic utility in a more complicated setting. As the first
step, we examined the allylation of α-chiral aldehyde 2-1o using DMF as well as 2.27
or 2.30 as the catalyst (Scheme 2.11). The reaction with DMF as the achiral catalyst
provided 2-2o and epi-2-2o in a ratio of 55:45. For the reactions catalyzed by our
chiral catalysts, in the matched case, allylation of 2-1o (98:2 enantiomeric ratio)
catalyzed by 2.27 provided 2-2o with 98:2 diastereomeric ratio, suggesting perfect
installation of the new stereogenic center. Impressively, in the mismatched case, the
other diastereomer epi-2-2o was also obtained with a high diastereomeric ratio of
97:3.
More importantly, we demonstrated that our catalytic system can be applied to
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crotylation of aliphatic aldehydes with high enantioselectivity as well as reliable
diastereospecificity, characteristic of Type I allylation. As shown in Table 2.3, by the
use of either E- or Z-crotyltrichlorosilane 2.31 (each prepared in one step from
commercially available starting materials)75, the alcohol products 2-3a, b, c, d of the
two ether containing substrates were obtained with excellent e.e. as well as high dr
(>99% transfer of the geometry of crotylsilane to the product diastereomeric ratio).
In contrast, the classical chiral Lewis acid-catalyzed addition of allylic organometallic
reagents (Si, Sn, B) to aldehydes (Type II allylation; open transition state) provides a
mixture of diastereomers, predominantly syn-isomer, independent of starting allylic
geometry, while the addition of allylic organometallic reagents (Cr, Zn, In) generated
in situ from the corresponding allylic halides catalyzed by chelating ligands (Type III
allylation) yields predominantly the anti-isomer regardless of starting allylic
geometry.[49a]
Scheme 2.11 Asymmetric sllylation of β-chiral aldehyde
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Table 2.3. Diastereospecific crotylation of aliphatic aldehydes
[a] The e.e. values were determined by high-performance liquid chromatography (HPLC). [b] The
yields are isolated yields based on average of two runs.
It is noteworthy that the current catalytic system is simple to perform at ambient
temperature using a readily available catalyst and commercial reagents
(allyltrichlorosilane, DIPEA, etc.) as received from popular vendors without further
purification. As stated earlier, the catalyst can be easily prepared from inexpensive








































Mitsunobu reaction of quinine with diphenylphosphoryl azide followed by Staudinger
reaction to yield 9-amino-9-deoxy-quinine[55], and finally acylation using
commercially available 4-(dimethylamino)benzoyl chloride to yield the amide catalyst
(Scheme 2.12a). The yield for the one-pot procedure, after a single purification by
silica gel chromatography, was over 70%. To further showcase the utility of the
system, gram-scale allylation of 2-1a was carried out that yielded 2-2a with
comparable chemical yield and enantioselectivity to the small scale reactions
(Scheme 2.9b vs. Tables 2.2 and 2.3). The selectivity of this system is not sensitive
towards concentration or heat transfer (as it is carried out at ambient temperature) so
scaling up was very straightforward. In addition, the catalyst could be easily
recovered nearly quantitatively. When the recovered catalyst was used for another
gram-scale crotylation of 2-1a, alcohol 2-3b was again obtained in high diastereo- as
well as enantioselectivity.
Scheme 2.12 Practical allylation of aldehydes
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It has been showcased by the Denmark group that a Lewis base can liberate a
chloride ion from SiCl4 or allyltrichlorosilane 2.34 to form a silicate intermediate 2.35
in (Scheme 2.13).[76] In the case of aliphatic aldehydes 2.36, however, this chloride
adds to the aldehyde to form the corresponding α-chloro silyl ether 2.37 that is
presumably responsible for the lack of allylation reactivity for such substrates. In our
case, it was also observed that catalyst 2.27 binds to SiCl4 to liberate a chloride that
quickly adds to aliphatic aldehydes to generate the a-chloro silyl ethers (>60% conv.
in 10 min). On the other hand, the related product was not clearly observed when we
mixed 2.27 with allyltrichlorosilane and aliphatic aldehyde (Scheme 2.13). This is in
large contrast to the control experiment using HMPA, which promotes this undesired
reaction with both SiCl4 and allyltrichlorosilane. This may be due to the relatively
lower Lewis basicity of our catalyst compared to HMPA, which is a fortunate
character for the success of aliphatic aldehyde allylation.
It is noteworthy that the secondary amide moiety in our catalyst may react with
allyltrichlorosilane in the presence of DIPEA to generate the corresponding O-silyl
imidate, in which process the chloride ion that is liberated from the silane will be
sequestered as part of the DIPEA·HCl salt (and thus avoid the undesired α-chloro silyl
ether formation). As stated earlier, DIPEA was found to be essential for the allylation
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reaction to proceed to high conversion. Preliminary NMR studies by mixing the
catalyst, silane, and DIPEA in a 1 : 1 : 1 ratio were inconclusive as a complex mixture
was formed; however, the resulting mixture was shown to be catalytically active.
Scheme 2.13 Exploration of chloride ion liberation
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We have further tested the activity of catalyst 2.38 with a methylated amide
moiety, which, under otherwise identical conditions, led to only <10% conv. to the
allylation product with <5% ee (Scheme 2.14). While the steric hindrance of this
catalyst may certainly contribute to this low activity and selectivity, it provides
support for the O-silyl imidate formation from catalyst 2.27 and 2.30. More extensive
mechanistic studies as well as calculations will be carried out to further elucidate the
nature of the active catalytic species as well as the turnover of the“anionic”catalyst.
Scheme 2.14Mechanistic studies via catalyst modification
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The conformational analysis of related cinchona alkaloid amides both in solution
and in solid state has been performed by the Brunner group using NMR, X-ray as well
as molecular orbital calculations.[73] These studies showed that these molecules prefer
the open conformation,[77] where the quinuclidine nitrogen points away from the
quinoline unit, and in turn, towards the 9-amide moiety. In particular, the calculated
minimum energy conformation of the protonated cinchonine amide 2.39 (Scheme
2.15a) possesses a H-bond interaction between the amide oxygen and the ammonium
hydrogen.[73b] These data pointed to the possibility of 9-amide and quinuclidine
serving as bidentate catalyst. Preliminary kinetic studies of our catalytic system
suggested that the allylation reaction is first-order dependent on the catalyst (Table 4
and Figure 1). Based on the above rationales, we propose the transition state model
(with 2.27) in (Scheme 2.15a).
On the basis of the principles and mechanistic studies presented by the Denmark
group[78], the aldehyde was placed trans to chloride to increase its electrophilicity; the
allyl group, on the other hand, would coordinate trans to the strongly Lewis basic
quinuclidine nitrogen, rendering it more nucleophilic. While the quinoline moiety
points away to the back, the quinuclidine moiety effectively blocks the top of the
complex so that the aldehyde is placed underneath. Allylation/crotylation through the
chair like Zimmerman-Traxler transition state then provides the desired product in
excellent enantioselectivity and predictable, perfect diastereoselectivity.[79]
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Table 2.4 Effect of initial catalyst concentration [2.27] on the rate of allylation
reaction.




In conclusion, we have demonstrated, for the first time, the utility of bidentate
Lewis base catalysts constructed from Cinchona alkaloids in the highly stereoselective
allyl- and crotylsilylation of aldehydes. The catalytic procedure provides a practical,
scalable preparation of various homoallylic alcohols that are useful building blocks in
organic synthesis. Current efforts in these laboratories are focused on detailed
mechanistic studies to further elucidate the origin of the asymmetric induction,
further extending the synthetic utility of the system to allyl/crotylation of chiral




Melting point (MP) was obtained on Buchi B-540. Thin layer chromatography
(TLC) was performed on Merck precoated TLC plates (Merck 60 F254), and
compounds were visualized with a UV light at 254nm. Further visualization was
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achieved by staining with iodine, or potassium permanganate solution followed by
heating using a heat gun. Flash chromatography separations were performed on
Merck 60 (0.040-0.063 mm) mesh silica gel.1H and 13C NMR spectra were recorded
on a Bruker ACF300 (300 MHz) or AMX500 (500 MHz) spectrometer.
Chemical shifts were reported in parts per million (ppm), and the residual solvent
peak was used as an internal reference: proton (chloroformδ7.26), carbon
(chloroformδ77.0) or tetramethylsilane (TMSδ0.00) was used as a reference. Data
are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet,
q = quartet, m = multiplet, br = broad), coupling constants (Hz) and integration. High
resolution mass spectra (HRMS) were obtained on a Finnigan/MAT 95XL-T
spectrometer. Optical rotations were recorded on an mrc AP81 automatic polarimeter.
Enantiomeric excesses (ee) were determined by HPLC analysis on Agilent HPLC
units, including the following instruments: pump, LC-20AD; detector, SPD-20A;
column, Chiralcel OD-H, Chiralpak AS-H, AD-H or IC. All reactions were carried
out under nitrogen atmosphere. Liquid reagents were handled with a micropipette.
THF was dried on alumina columns using a solvent dispensing system.
All commercially available aldehydes, allyltrichlorosilane and N,N-
diisopropylethylamine were purchased for Aldrich and used as received for the
reactions without any purification. (E)-and (Z)-crotyltrichlorosilanes were synthesized
according to literature procedure.[75]
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2.4.2 General procedure for enantioselective allylation of aldehydes
To a 4 mL vial equipped with a stir bar was added the catalyst 2.27 or 2.30 (0.03
mmol, 10 mol%). The vial was taken into glovebox, where anhydrous THF (1 mL),
DIPEA (0.45 mmol, 1.5 equiv.) and allyltrichlorosilane (0.75 mmol, 2.5 equiv.) were
added. The reaction mixture was taken outside the glovebox and the aldehyde 2-1 (0.3
mmol) was added using a micropipette (open to air). The vial was then sealed and the
reaction mixture was allowed to stir at ambient temperature for 24 h. The crude
reaction mixture was quenched by pouring into a mixture of dichloromethane (5 mL)
and saturated NaHCO3 solution (5 mL). The resulting mixture was vigorously stirred
for 1 h, and then extracted with dichloromethane (3 x 20 mL). The combined organic
layer was washed with brine (1 x 20 mL), dried over anhydrous Na2SO4 and
concentrated. Purification by silica gel chromatography yielded the desired product
2-2 that was analyzed for purity by NMR and for enantioenrichment by chiral HPLC
(Chiralcel OD-H, Chiralpark IC, AS-H or AD-H)
Colorless oil, 83% yield with catalyst 2.27, 86% yield with catalyst 2.30. 1H NMR
(300 MHz, CDCl3) δ 7.44 – 7.32 (m, 5H), 5.87 (ddt, J = 17.2, 10.2, 7.1 Hz, 1H), 5.22
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– 5.05 (m, 2H), 4.60 (s, 2H), 3.99 – 3.85 (m, 1H), 3.56 (dd, J = 9.5, 3.4 Hz, 1H), 3.42
(dd, J = 9.5, 7.4 Hz, 1H), 2.42 (d, J = 3.6 Hz, 1H), 2.36 – 2.24 (m, 2H). 13C NMR (75
MHz, CDCl3) δ 137.89, 134.15, 128.39, 127.72, 127.66, 117.62, 73.82, 73.31, 69.65,
37.83. Optical Rotation: catalyst 2.27: [α]25D = -6.5 (0.24, CHCl3). The absolute
configuration of 2-2a was assigned by comparing its specific rotation with that of the
same compound reported in the literature[69b]. 96% ee. (HPLC condition: Chiralcel
OD-H column, n-hexane/i-PrOH = 99:1, flow rate = 1.0 ml/min, wavelength = 254nm,
tR= 24.09min for major isomer, tR= 26.57min for minor isomer).
Colorless oil, 89% yield with catalyst 2.27, 82% yield with catalyst 2.30. 1H NMR
(500 MHz, CDCl3) δ7.45–7.26 (m, 5H), 5.95–5.79 (m, 1H), 5.24–5.08 (m, 2H), 4.55
(s, 2H), 3.97–3.84 (m, 1H), 3.83–3.64 (m, 2H), 2.93 (s, 1H), 2.28 (t, J = 6.5 Hz, 2H),
1.97–1.76 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 137.99, 134.89, 128.47, 127.76,
127.69, 117.58, 73.32, 70.32, 68.91, 41.94, 35.90. Optical Rotation: catalyst 2.27:
[α]25D = -11 (0.20, CHCl3). 99% ee. (The absolute configuration of 2-2b was assigned
by the analogue 2-2a. HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH =
99:1, flow rate = 0.5ml/min, wavelength = 254nm, tR = 32.93min for minor isomer, tR
= 33.76min for major isomer).
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Colorless oil, 90% yield with catalyst 2.27, 88% yield with catalyst 2.30. 1H NMR
(300 MHz, CHCl3) δ 8.17 – 8.01 (m, 2H), 7.70 – 7.44 (m, 3H), 6.01 – 5.78 (m, 1H),
5.32 – 5.11 (m, 2H), 4.62 (ddd, J = 11.2, 8.5, 5.3 Hz, 1H), 4.47 (dt, J = 11.2, 5.7 Hz,
1H), 3.89 (s, 1H), 2.50 – 2.19 (m, 3H), 2.13 – 1.74 (m, 2H). 13C NMR (75 MHz,
CDCl3) δ 166.71, 134.27, 132.93, 129.51, 128.31, 118.31, 67.51, 62.01, 41.89, 35.81.
HRMS (ESI) m/z Calcd for [C13H16O3, M+H]+ : 220.1123 Found: 220.1118 Optical
Rotation: catalyst 11: [α]25D = -8 (0.60, CHCl3). 98% ee. (The absolute configuration
of 2-2c was assigned by comparing its specific rotation with analogue 2-2a. HPLC
condition: Chiralpak IC column, n-hexane/i-PrOH = 97:3, flow rate = 1.0ml/min,
wavelength = 254nm, tR = 32.81min for major isomer, tR = 41.08min for minor
isomer).
Colorless oil, 70% yield with catalyst 2.27, 73% yield with catalyst 2.30. 1H NMR
(500 MHz, CDCl3) δ 5.90 – 5.77 (m, 1H), 5.14 – 5.04 (m, 2H), 3.89 (dt, J = 9.9, 4.9
Hz, 2H), 3.84 – 3.76 (m, 2H), 3.37 (d, J = 2.0 Hz, 1H), 2.33 – 2.14 (m, 2H), 0.90 (d, J
= 6.8 Hz, 9H), 0.08 (d, J = 8.5 Hz, 6H). 13C NMR (125 MHz, CDCl3) δ 135.01,
117.29, 71.25, 62.58, 41.95, 37.76, 29.68, 25.85, 25.64, -3.60, -5.58. Optical
Rotation: catalyst 2.27: [α]25D = -7 (0.30, CHCl3). 95% ee. (The absolute
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configuration of 2-2d was assigned by the analogue 2-2a. HPLC condition: Chiralcel
OD-H column, n-hexane/i-PrOH = 99.5:0.5, flow rate = 0.5ml/min, wavelength =
254nm, tR = 32.81min for major isomer, tR = 41.08min for minor isomer).
Colorless oil, 75% yield with catalyst 2.27. 80% yield with catalyst 2.30. 1H NMR
(300 MHz, CDCl3 ) δ 8.01 (s, 1H), 7.67 (d, J = 7.8 Hz, 1H), 7.48 – 7.35 (m, 1H), 7.33
– 7.12 (m, 2H), 7.07 – 6.98 (m, 1H), 5.88 (dddd, J = 11.1, 9.3, 7.8, 6.5 Hz, 1H), 5.32 –
5.12 (m, 2H), 3.80 (ddd, J = 12.1, 7.7, 4.6 Hz, 1H), 3.10 – 2.82 (m, 2H), 2.50 – 2.33
(m, 1H), 2.33 – 2.16 (m, 1H), 2.00 – 1.88 (m, 2H). 13C NMR (75 MHz, CDCl3) δ
136.40, 134.79, 127.49, 121.98, 121.20, 119.21, 118.94, 118.21, 116.21, 111.10, 70.31,
42.05, 37.10, 21.35. HRMS (ESI) m/z Calcd for [C14H16NO, M+H]+: 215.1254 Found:
215.1237 Optical Rotation: catalyst 2.27: [α]25D = -3.083(0.6, CH2Cl2). 96% ee. (The
absolute configuration of 2-2e was assigned by the analogue 2-2a. HPLC condition:
Chiralpak IC column, n-hexane/i-PrOH = 95:5 flow rate = 1ml/min, wavelength =
254nm, tR = 33.56min for major isomer, tR = 37.40min for minor isomer).
Colorless oil, 80% yield with catalyst 2.27, 74% yield with catalyst 2.30. 1H NMR
(500 MHz, CDCl3) δ 5.85 (dddd, J = 11.6, 9.4, 7.8, 6.5 Hz, 1H), 5.19 – 5.12 (m, 2H),
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3.67 (s, 1H), 2.39 – 2.28 (m, 1H), 2.22 – 2.14 (m, 1H), 1.68 (s, 2H), 1.38 – 1.26 (m,
10H), 0.90 (t, J = 6.9 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 134.94, 118.03, 70.71,
41.94, 36.83, 31.82, 29.70, 29.62, 29.27, 25.67, 22.65, 14.08. Optical Rotation:
catalyst 2.27: [α]25D = -18.00 (0.5, CH2Cl2). 96% ee. (The absolute configuration of
2-2f was assigned by the analogue 2-2a. The enantiomeric ratio of the compound was
determined by formation of 3,5-dinitrobenzate. HPLC condition: Chiralpak AD-H
column, n-hexane/i-PrOH = 99:1, flow rate = 0.5ml/min, wavelength = 254nm, tR =
14.34min for major isomer, tR = 17.27min for minor isomer).
Colorless oil, 78% yield with catalyst 2.27. 71% yield with catalyst 2.30. 1H NMR
(300 MHz, CDCl3) δ 5.83 (dddd, J = 14.5, 9.5, 7.8, 6.6 Hz, 1H), 5.18 – 5.05 (m, 2H),
3.63 (s, 1H), 2.38 – 2.22 (m, 1H), 2.23 – 2.07 (m, 1H), 1.51 – 1.38 (m, 3H), 1.21 (d, J
= 31.6 Hz, 14H), 0.88 (q, J = 6.5 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 134.85,
117.95, 70.62, 41.84, 36.74, 31.81, 29.61, 29.57, 29.48, 29.23, 25.58, 22.59, 14.02.
Optical Rotation: catalyst 2.27: [α]25D = -20 (0.6, CH2Cl2). 96% ee. (The absolute
configuration of 2-2h was assigned by the analogue 2-2a. The enantiomeric ratio of
the compound was determined by formation of para-dimethylaminobenzate. HPLC
condition: Chiralpark AD-H column, n-hexane/i-PrOH = 99:1, flow rate = 0.5ml/min,
wavelength = 254nm, tR = 14.34 min for minor isomer, tR = 17.27min for major
isomer).
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Colorless oil, 76% yield with catalyst 2.27. 71% yield with catalyst 2.30. 1H NMR
(300 MHz, CDCl3) δ 7.47 – 7.18 (m, 5H), 5.87 (dddd, J = 16.2, 9.5, 7.8, 6.6 Hz, 1H),
5.26 – 5.14 (m, 2H), 3.79 – 3.66 (m, 1H), 3.02 – 2.61 (m, 2H), 2.49 – 2.28 (m, 1H),
2.30 – 2.17 (m, 1H), 1.84 (ddd, J = 8.9, 7.2, 3.5 Hz, 2H). 13C NMR (75 MHz, CDCl3)
δ 141.99, 134.54, 128.36, 128.33, 125.75, 118.22, 69.88, 41.98, 38.37, 31.97. Optical
Rotation: catalyst 2.27: [α]25D = -3.2 (0.7, CH2Cl2). 97% ee. (The absolute
configuration of 2-2i was assigned by the analogue 2-2a. HPLC condition: Chiralcel
OD-H column, n-hexane/i-PrOH = 95:5 flow rate = 0.5ml/min, wavelength = 254nm,
tR= 14.31min for major isomer, tR = 20.65min for minor isomer).
Colorless oil, 78% yield with catalyst 2.27. 85% yield with catalyst 2.30. 1H NMR
(500 MHz, CDCl3) δ 6.15 – 5.59 (m, 2H), 5.14 (dd, J = 10.2, 6.5 Hz, 2H), 5.05 – 4.82
(m, 2H), 3.63 (s, 1H), 2.37 – 2.23 (m, 1H), 2.19 – 2.08 (m, 1H), 2.03 (dd, J = 14.4,
6.9 Hz, 2H), 1.69 – 1.54 (m, 1H), 1.40 – 1.20 (m, 14H). 13C NMR (125 MHz, CDCl3)
δ 139.22, 134.93, 118.03, 114.11, 70.70, 41.94, 36.82, 33.80, 29.63, 29.54, 29.42,
29.11, 28.92, 25.65. HRMS (ESI) m/z Calcd for [C14H26O, M+H]+ : 211.2043
Found:211.2010 Optical Rotation: catalyst 2.27: [α]25D = -14.2 (0.58, CH2Cl2). 97%
ee. (The absolute configuration of 2-2j was assigned by comparing its specific
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rotation with the analogue 2-2a . The enantiomeric ratio of the compound was
determined by formation of 3,5-dinitrobenzate. HPLC condition: Chiralpak AS-H
column, n-hexane/i-PrOH = 99:1 flow rate = 0.4ml/min, wavelength = 254nm, tR =
14.38min for minor isomer, tR = 15.16min for major isomer).
Colorless oil, 83% yield with catalyst 2.27. 80% yield with catalyst 2.30. 1H NMR
(300 MHz, CDCl3) δ 6.06 – 5.64 (m, 1H), 5.42 – 5.26 (m, 2H), 5.18 – 5.05 (m, 2H),
3.63 (s, 1H), 2.39 – 2.22 (m, 1H), 2.19 – 2.07 (m, 1H), 2.01 (dd, J = 13.5, 7.1 Hz, 3H),
1.32 (dd, J = 33.5, 27.4 Hz, 12H), 0.95 (t, J = 7.5 Hz, 3H). 13C NMR (75 MHz,
CDCl3) δ 134.91, 1341.59, 129.24, 118.08, 70.69, 41.94, 36.82, 33.80, 29.63, 29.54,
29.42,27.06, 25.65, 20.51, 14.39. HRMS (ESI) m/z Calcd for [C14H26O, M+H]+:
211.2021 Found:211.2036 Optical Rotation: catalyst 2.27: [α]25D = -11 (0.60,
CH2Cl2). 96% ee. (The absolute configuration of 2-2k was assigned by comparing its
specific rotation with analogue. The enantiomeric ratio of the compound was
determined by formation of 3,5-dinitrobenzate. HPLC condition: Chiralpak AD-H
column, n-hexane/i-PrOH = 99:1 flow rate = 0.5ml/min, wavelength = 254nm, tR =
14.38min for minor isomer, tR = 15.16min for major isomer).
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Pale yellow oil, 77% yield with catalyst 2.27. 75% yield with catalyst 2.30. 1H NMR
(500 MHz, CDCl3): δ 7.38-7.27 (5H, m), 5.82 (1H, ddt, J = 17.2, 10.0, 7.2 Hz), 5.17
(1H, dd, J = 17.2, 1.2 Hz), 5.15 (1H, dd, J = 10.4, 1.2 Hz), 4.74 (1H, dt, J = 6.4, 2.4
Hz), 2.58-2.6 (2H, m), 2.06 (1H, d, J = 2.8 Hz). 13C NMR (500 MHz, CDCl3): 143.9,
134.5, 128.5, 127.6, 125.9, 118.5, 73.5, 44.1. Optical Rotation: catalyst 2.27: [α]25D
= +34.90 (c 0.7, CHCl3). ee 90%. (The absolute configuration of 2-2l was assigned by
comparing its specific rotation with that of the same compound reported in the
literature[64]. HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 95:5 flow
rate = 0.5ml/min, wavelength = 254nm, tR = 16.557min for major isomer, tR =
18.612min for minor isomer).
Yellow oil, 83% yield with catalyst 2.27. 90% yield with catalyst 2.30. 1H NMR (300
MHz, CDCl3) δ 8.23 (d, J = 8.7 Hz, 2H), 7.56 (d, J = 8.5 Hz, 2H), 6.00 – 5.72 (m,
1H), 5.31 – 5.12 (m, 2H), 5.02 – 4.83 (m, 1H), 2.71 – 2.34 (m, 3H). 13C NMR (75
MHz, CDCl3) δ 151.05, 133.13, 126.49, 123.54, 119.52, 72.10, 43.80. Optical
Rotation: catalyst 2.27: [α]25D = +56 (c 0.7, CHCl3). ee 92%. (The absolute
configuration of 2-2m was assigned by comparing its specific rotation with analogue
2-2l. HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 99:1 flow rate =
0.5ml/min, wavelength = 254nm, tR = 92.22min for major isomer, tR = 96.58min for
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minor isomer).
Yellow oil, 77% yield with catalyst 2.27. 80% yield with catalyst 2.30. 1H NMR
(500 MHz, CDCl3) δ 7.46 (d, J = 8.3 Hz, 2H), 7.21 (d, J = 8.3 Hz, 2H), 5.85 –
5.65 (m, 1H), 5.22 – 5.09 (m, 2H), 4.76 – 4.61 (m, 1H), 2.57 – 2.36 (m, 2H),
2.30 (d, J = 2.7 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 142.85, 133.96, 131.48,
127.59, 121.26, 118.82, 72.62, 43.78. Optical Rotation: catalyst 2.27: [α]25D =
+50.25 (c 0.5, CHCl3). ee 94%. (The absolute configuration of 2-2n was
assigned by the analogue 2-2l. HPLC condition: Chiralpak AS-H column,
n-hexane/i-PrOH = 99:1 flow rate = 0.4ml/min, wavelength = 254nm, tR =
92.22min for major isomer, tR= 96.58min for minor isomer).
White solid, 80% yield with catalyst 2.27. 89% yield with catalyst 2.30. 1H NMR
(300 MHz, CDCl3) δ 7.87 (dd, J = 7.1, 5.6 Hz, 4H), 7.52 (dd, J = 6.1, 1.9 Hz, 3H),
5.88 (ddt, J = 17.1, 10.1, 7.1 Hz, 1H), 5.29 – 5.16 (m, 2H), 5.03 – 4.87 (m, 1H), 2.65
(dd, J = 9.0, 6.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 141.21, 134.31, 133.21,
132.89, 128.14, 127.89, 127.61, 126.06, 125.74, 124.44, 123.95, 118.44, 73.33, 43.67.
Optical Rotation: catalyst 2.27: [α]25D = +11.33 (c = 0.3, CHCl3). ee 94%. (The
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absolute configuration of 2-2o was assigned by the analogue. HPLC condition:
Chiralcel OD-H column, n-hexane/i-PrOH = 95:5 flow rate = 0.5ml/min, wavelength
= 254nm, tR = 32.85min for minor isomer, tR =35.98min for major isomer).
Colorless oil, 88% yield with catalyst 2.27. 80% yield with catalyst 2.30. 1H NMR
(300 MHz, CDCl3) δ 5.92 – 5.72 (ddt, J = 16.5, 10.7, 7.4 Hz, 1H), 5.13 (bd, J = 16.5
Hz, 1H), 5.06 (bd, J = 10.7 Hz, 1H), 5.02 (bt, J= 6.5 Hz, 1H), 3.75-3.70 (m, 1H),
2.30-1.94(m, 4H), 1.66 (s, 3H), 1.58 (s, 3H), 1.50-1.17 (m, 5H), 0.88 (d, J = 6.2 Hz,
3H,), 0.84 (d, J = 6.2 Hz, 3H,); 13C NMR (75 MHz, CDCl3) δ 134.77, 131.17, 124.67,
118.10, 68.64, 44.23, 42.06, 36.63, 29.20, 25.63, 25.26, 20.14, 17.57. HRMS (ESI)
m/z Calcd for [C13H24O, M+H]+:197.1237 Found:197.1232 Optical Rotation:
catalyst 2.30: [α]25D = -24.1 (c=0.4, CHCl3). ee 94%. (The absolute configuration of
2-2n was assigned by comparing its specific rotation with analogue 2-2a. The
enantiomeric ratio of the compound was determined by formation of
para-dimethylaminobenzate. HPLC condition: Chiralpak AD-H column,
n-hexane/i-PrOH = 99:1 flow rate = 1ml/min, wavelength = 254nm, tR = 16.66min for
minor isomer, tR= 19.043min for major isomer).
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Colorless oil, 78% yield with catalyst 2.27. 75% yield with catalyst 2.30.1H NMR (500 MHz,
CDCl3) δ 7.59 – 7.31 (m, 5H), 6.05 – 5.70 (m, 1H), 5.15 – 5.05 (m, 2H), 4.58 (s, 2H),
3.75 – 3.64 (m, 1H), 3.58 (dd, J = 9.8, 3.1 Hz, 2H), 3.45 (dd, J = 9.5, 7.6 Hz, 1H),
2.50 - 2.38 (m, 2H), 1.07 (d, J = 6.8 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 140.08,
138.4, 128.63, 128.46, 128.06, 115.59, 73.2,72.8, 40.83, 16.19. Optical Rotation:
catalyst 2.27: [α]25D = -2.5 (c=0.3, CH2Cl2). ee 97%. (The absolute configuration of
2.33a was assigned by comparing its specific rotation with that of the same compound
reported in the literature[70]. HPLC condition: Chiralcel OD-H column,
n-hexane/i-PrOH = 99:1 flow rate = 1ml/min, wavelength = 254nm, tR = 17.51min for
minor isomer, tR= 25.082min for major isomer).
Colorless oil, 78% yield with catalyst 2.27. 75% yield with catalyst 2.30. 1H NMR
(300 MHz, CDCl3) δ 7.44 – 7.32 (m, 5H), 5.79 (ddd, J = 17.4, 10.3, 7.9 Hz, 1H), 5.09
(ddd, J = 9.4, 5.2, 1.3 Hz, 2H), 4.59 (s, 2H), 3.69 (dt, J = 10.7, 3.6 Hz, 1H), 3.61 (dd,
J = 9.5, 3.1 Hz, 1H), 3.44 (dd, J = 9.5, 7.7 Hz, 1H), 2.51- 2.38 (m, 2H), 1.13 (d, J =
6.8 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 140.30, 137.95, 128.38, 127.69, 127.64,
115.01, 73.29, 72.70, 41.03, 15.59. Optical Rotation: catalyst 2.27: [α]25D = -4.666
(c = 0.3, CH2Cl2). ee 96%. (The absolute configuration of 2.33b was assigned by
comparing its specific rotation with that of the same compound reported in the
literature[70]. HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 99:1 flow
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rate = 1ml/min, wavelength = 254nm, tR = 15.99min for minor isomer, tR = 17.897min
for major isomer).
Colorless oil, 74% yield with catalyst 2.27. 70% yield with catalyst 2.30. 1H NMR
(300 MHz, CDCl3) δ 7.36 (dd, J = 5.8, 2.1 Hz, 5H), 5.97 – 5.72 (m, 1H), 5.21 – 5.04
(m, 2H), 4.57 (d, J = 2.3 Hz, 2H), 3.73 (dt, J = 12.6, 5.7 Hz, 2H), 2.74 (td, J = 6.1, 1.8
Hz, 1H), 2.31 – 2.18 (m, 1H), 2.06 (s, 1H), 1.78 (dt, J = 7.6, 3.8 Hz, 2H), 1.12 – 1.03
(m, 3H). 13C NMR (75 MHz, CDCl3) δ 140.39, 137.94, 128.35, 127.60, 127.40
115.42, 74.09, 73.25, 69.10, 43.94, 33.54, 15.75. Optical Rotation: catalyst 2.27:
[α]25D = -7.125 (c=0.4, CH2Cl2). ee 96%. (The absolute configuration of 2.33c was
assigned by the analogue 2.33a. HPLC condition: Chiralpak AS-H column,
n-hexane/i-PrOH = 99:1 flow rate = 0.5ml/min, wavelength = 254nm, tR = 17.896min
for minor isomer, tR= 21.426min for major isomer).
Colorless oil, 72% yield with catalyst 2.27. 73% yield with catalyst 2.30. 1H NMR
(500 MHz, CDCl3) δ 7.39 – 7.27 (m, 5H), 5.86 – 5.71 (m, 1H), 5.12 – 4.99 (m, 2H),
4.53 (d, J = 6.3 Hz, 2H), 3.77 – 3.69 (m, 1H), 3.69 – 3.62 (m, 2H), 2.86 (d, J = 3.2 Hz,
1H), 2.26 (dd, J = 13.6, 6.8 Hz,1H), 1.87 – 1.76 (m, 1H), 1.75 – 1.65 (m, 1H), 1.05 (d,
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J = 6.8 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 141.00, 137.94, 128.46, 127.75,
127.70, 114.99, 74.52, 73.37, 69.48, 43.87, 33.53, 15.03. Optical Rotation: catalyst
2.27: [α]25D = -9.05 (c0.3, CH2Cl2). ee 95%. (The absolute configuration of 2.33d was
assigned by the analogue 2.33a. HPLC condition: Chiralpak AS-H column,
n-hexane/i-PrOH = 99:1 flow rate = 0.5ml/min, wavelength = 254nm, tR = 17.896min
for minor isomer, tR=21.426min for major isomer).
2.4.3 General procedure one pot catalyst synthesis
Quinine 2.19 (5 mmol) and triphenylphosphine (1.6g, 6 mmol) were dissolved in
anhydrous THF (25 ml), and the solution was cooled to 0 °C. Diethyl
azodicarboxylate (1.0 g, 6 mmol) was subsequently added. To the resulting solution
was added dropwise the solution of diphenyl phosphoryl azide (1.3 ml, 6 mmol) in
anhydrous THF (10 ml) at 0 °C. The mixture was allowed to warm to ambient
temperature. After being stirred for 24 h, it was heated to 50°C and stirred.
Triphenylphosphine (1.7 g, 6.5 mmol) was added again, and the mixture was stirred at
50 °C for additional 3 h. After the solution was cooled to ambient temperature, H2O
(0.5 ml) was added, and the solution was stirred for 10 h. Followed by addition of
4-(Dimethylamino) acid chloride (1.098g, 6mmol), then the reaction mixture was kept
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stirred at room temperature for 1h. Solvents were removed in vacuo, and the residue
was dissolved in CH2Cl2/10% aqueous HCl (25 ml/ 25 ml). The aqueous phase was
separated and washed with CH2Cl2 (25 ml × 4). It was subsequently made alkaline
with excess aqueous NH3, and the aqueous phase was extracted with CH2Cl2 (25ml
×4). The combined organic layers were dried over Na2SO4, and concentrated in vacuo.
Purification by flash silica gel column chromatography using EtOAc/Hexane (v/v =
1/1) then EtOAc/CH3OH (v/v = 10/1) as an eluent gave the corresponding amide
containing product 2.27. White solid 70% yield. [α]D23 = –50.3 (c1.0, CH2Cl2). 1H
NMR (500 MHz, CDCl3) δ 8.72 (dd, J = 9.6, 4.6 Hz, 1H), 8.02 (t, J = 8.7 Hz, 1H),
7.78 (d, J = 7.2 Hz, 1H), 7.73 (t, J = 7.8 Hz, 1H), 7.60 (s, 1H), 7.45 (dd, J = 8.8, 4.6
Hz, 1H), 7.42 – 7.32 (m, 1H), 6.65 (t, J = 9.3 Hz, 2H), 5.74 (td, J = 17.3, 9.0 Hz, 1H),
5.11 – 4.87 (m, 2H), 3.99 (d, J = 8.0 Hz, 3H), 3.37 – 3.26 (m, 1H), 3.19 (d, J = 8.5 Hz,
2H), 3.00 (d, J = 10.2 Hz, 6H), 2.84 – 2.66 (m, 2H), 2.33 (s, 2H), 2.21 (s, 1H), 1.79 –
1.57 (m, 3H), 1.47 (d, J = 8.0 Hz, 1H), 1.12 – 0.92 (m, 1H). 13C NMR (125 MHz,
CDCl3) δ 167.37, 157.70, 152.60, 147.57, 144.78, 141.29, 131.70, 128.69, 121.53,
120.72, 114.61, 111.01, 102.05, 56.06, 55.64, 40.93, 40.09, 39.60, 27.94, 27.41, 26.19.
HRMS (ESI) m/z Calcd for [C29H34N4O2, M+H]+: 471.2776 Found: 471.2755
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The same procedure with 2.27. The compound 2.28 characterization results are
as below. White solid. 68% Yield. [α]D25 = –52.5 (c1.0, CH2Cl2). 1H NMR (500 MHz,
CDCl3) δ 8.89 (d, J = 4.5 Hz, 1H), 8.53 (d, J = 8.5 Hz, 1H), 8.15 (d, J = 8.5 Hz, 1H),
7.73 (t, J = 7.9 Hz, 4H), 7.63 (t, J = 7.5 Hz, 1H), 7.54 (d, J = 4.6 Hz, 1H), 6.67 (d, J =
8.8 Hz, 2H), 5.73 (ddd, J = 17.4, 10.2, 7.6 Hz, 1H), 5.45 (s, 1H), 4.98 (dd, J = 19.7,
13.7 Hz, 2H), 3.31 (dd, J = 13.8, 10.2 Hz, 1H), 3.23 – 3.10 (m, 2H), 3.03 (d, J = 13.2
Hz, 6H), 2.86 – 2.63 (m, 2H), 2.33 (s, 1H), 2.05 (d, J = 16.0 Hz, 2H), 1.76 – 1.55 (m,
3H), 1.40 (dd, J = 13.2, 10.1 Hz, 1H), 1.07 (dd, J = 13.7, 6.3 Hz, 1H).13C NMR (125
MHz, CDCl3) δ 167.52, 152.60, 150.08, 148.62, 141.29, 130.43, 128.97, 128.71,
126.57, 123.46, 120.78, 114.60, 111.02, 56.01, 40.84, 40.11, 39.65, 27.85, 27.38,
25.92.HRMS (ESI) m/z Calcd for [C28H32N3O, M+Na]+: 441.2649 Found: 441.2637
The compound 2.28 characterization results are as below. [α]D23 = -10 (c1.0,
CH2Cl2).1H NMR (300 MHz, CDCl3) δ 8.43 – 8.18 (m, 1H), 8.03 – 7.80 (m, 2H),
7.78 – 7.45 (m, 6H), 6.64 (t, J = 10.6 Hz, 2H), 6.39 (d, J = 7.5 Hz, 1H), 6.16 (dd, J =
13.6, 6.8 Hz, 1H), 3.11 – 2.97 (m, 6H), 1.81 (dd, J = 13.2, 6.5 Hz, 3H). 13C NMR (75
MHz, CDCl3) δ 152.37, 138.75, 133.90, 131.27, 128.62, 128.39, 128.19, 126.47,
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125.74, 125.15, 123.66, 122.60, 110.95, 44.87, 40.01, 20.78. HRMS (ESI) m/z Calcd
for [C21H22N2O, M+Na]+: 341.1625 Found: 341.1635
The same procedure with 2.27. The compound 2.30 characterization results are
as below. White solid. 63% Yield. [α]D23 =+53.5 (c 1.0, CH2Cl2). 1H NMR (300 MHz,
CDCl3) δ 8.76 (d, J = 4.6 Hz, 1H), 8.04 (d, J = 9.2 Hz, 2H), 7.93 – 7.66 (m, 3H), 7.54
(d, J = 4.6 Hz, 1H), 7.40 (dd, J = 9.2, 2.7 Hz, 1H), 6.72 – 6.52 (m, 2H), 6.08 – 5.90
(m, 1H), 5.37 – 5.16 (m, 2H), 4.04 (s, 3H), 3.43 (d, J = 8.9 Hz, 1H), 3.14 (d, J = 15.7
Hz, 3H), 3.08 – 2.96 (m, 6H), 2.44 (s, 1H), 2.05 (d, J = 16.0 Hz, 2H), 1.84 – 1.60 (m,
3H), 1.54 – 1.41 (m, 1H), 1.19 (d, J = 8.2 Hz, 1H). 13C NMR (75MHz, CDCl3) δ
167.37, 157.70, 152.60, 147.57, 144.78, 141.29, 131.70, 128.68, 121.53, 120.72,
114.61, 111.06, 102.05, 56.09, 55.68, 40.93, 40.09, 39.64, 27.94, 27.41, 26.18.
HRMS (ESI) m/z Calcd for [C29H35N4O2, M+H]+ : 471.2749 Found: 471.2771
2.5 Misellaneous
Asymmetric allylation of imines is recognized as a highly valuable method for
preparation of chiral homoallylic amines. Lewis base catalyzed, enantioselective
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allylation would be even more attractive for its nature of diastereosepecificity in the
addition of ɤ–substituted allyl species. However, up to date, only Lewis basic
promoters used in superstoichimetric amount have been reported for this purpose.
Quinine amide catalyst system has successfully applied to disclose allyl- and
crotylation reaction of aromatic aldehydes as well as aliphatic aldehydes with
excellent enationselectivities and good chemical yield. Therefore, we wonder if
quinine based lewis basic catalyst system could be applied to the imines allyl- and
crotylation to construct homoallylic amines.
After a variety of tries, all imine substrates were failed to engage in allylation
reaction except phenolic imines 2.40. This particular imine could be proceeded
allylation reaction ang the product was obtained in 26% yield and 30% ee in the
presence of quinine derived N-oxide catalyst 2.41 (Scheme 2.16).
Scheme 2.16 Initial hit of Lewis basic catalyst catalyzed imine allylation
Further optimization, however prove fruitless. No significant catalytic turnover
could be realized. Even though higher loading 100 mol% of 2.41 was beneficial for
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the selectivity, the highest enantioselectivity under optimized conditions was only
46%. Interestingly, this result suggested picolinic acid N-oxide amide was an
important tuner for the reactivity and selectivity, but quinine backbone was not
suitable chiral porket for enantioselective control. Therefore we pay more attention to
other commercial available chiral scanfold such as chiral diamine which has been
successfully applied to asymmetric synthesis. Initially, we used commercial available
diphenyl chiral diamine to couple with picolinic acid N-oxide to form the catalyst
with 75% yield. And then we tested the new catalyst’s performace on the allylation of
phenolic imine. Surprisingly, both yield and enantioselectivity were improved
obviously (yield 50%, ee 75%). The most importantly, the reaction could proceed
smoothly with catalytical loading of 2.42 (Scheme 2.17).
Scheme 2.17 Enantioselective allylation of imine by the use of chiral diamine derived
bis N-oxide catalyst.
With the promising result in hand, we decided to modify catalyst structure based
on different commercially available chiral diamine scaffolds. However, these catalysts
proved useless for improving enantioselectivity (Scheme 2.18). Catalyst 2.41 still
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showed the optimal performance on the reactivity and enantioselectivity.
Scheme 2.18 Catalyst screening
Then after systematic reaction condition optimization by using the catalyst 2.41,
it was found that the reaction carried out in the nitroethane at 24oC was the optimal
parameters in term of reactivity and enantioselectivity (75% conv., 77% ee). Current
efforts are focused on improving the enantioselectivity of imines allylation.
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3.1.1 The stereoselective allylation
The stereoselective allylation of carbonyl and imines has been developed as one
of the most powerful carbon-carbon bond forming reactions.[49] The allylation of other
π-systems such as activated alkenes has also been explored in the form of conjugate
allylation of α,β-unsaturated carbonyls and allyl-allyl cross coupling reactions.
3.1.1.1 Conjugate allylation of α,β-unsaturated carbonyls
Recent work from the Morken’s lab led to the first catalytic, enantioselective
conjugate allylboration of dialkylidene ketones 3.1 (Scheme 3.1).[80] Ni(cod)2 and
TADDOL-derived phosphorite 3.3 complexes provided the allylation of the
benzylidene site in nonsymmetric substrates in high regioselectivity and
enantioselectivity. This reaction is proposed to proceed by conversion of the
diakylidene ketone substrate to an unsaturated π-allyl complex 3.4, followed by
3,3’-reductive elimination, to produce the allylation product 3.2 with regeneration of
the catalyst.
Scheme 3.1Asymmetric Ni-catalyzed conjugate allylation of activated enones
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Later on, Snapper and Shizuka developed the first catalytic, enantioselective
Hosomi-Sakurai conjugate allylation of the activated enones 3.5 using
allyltrimethylsilane 3.6 (Scheme 3.2).[81] The allylation catalyzed by the readily
available ligand 3.7 and Cu(OTf)2 proceeded with complete 1,4-regioselectivity to
provide the allylation products 3.8 with up to > 98% ee.
Scheme 3.2 Enantioselective Hosomi-Sakurai conjugate allylation of the activated
enones
3.1.1.2 Allyl-allyl cross coupling reactions
Transition metal-catalyzed enantioselective cross coupling of allyl metal with
allyl electrophile has proved to be a valuable transformation. It enables the
construction of two continuous chiral centers with concomitant formation of an
sp3-sp3 carbon-carbon bond. An important feature of the reaction is that it provides
enantiomerically enriched vicinal π-π systems that are not accessible by the Cope
rearrangement. In 2010, Morken’s group reported the first example of Pd-catalyzed
highly regio- and enantioselective allyl-allyl cross-coupling in the presence of
appropriate chiral ligand 3.12 or 3.13 (Scheme 3.3).[82] Either linear 3.9 or branch
allyl carbonate 3.10 could proceed smoothly and obtained the product at the same
level of enatioselectivity and chemical yield, which suggesting that the oxidative
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addition of the allyl carbonate to Pd(0) provided a common intermediate 3.14.
Subsequent reaction with allyl B(pin) might occur by transmetalation from boron to
Pd to form 3.15. An inner-sphere 3,3’-reductive elimination of 3.15, then produces
1,5- chiral diene 3.16.
Scheme 3.3 Pd-catalyzed highly regio- and enantioselective allyl-allyl cross-coupling
In 2013, Feringa’s group described the first Cu(I)-phosphoramidite complex
catalyzed asymmetric allyl−allyl cross-coupling reaction by employing the
commercial available allyl Grinard reagent 3.18 as the nucleophile.[83] In this reaction,
easily accessible allyl bromides reacted with allyl copper species generated by
transmetalation between copper (I) salt and allyl magnesium bromide to generate the
intermediate 3.22, which could probably equilibrate to 3.23. This CuIII σ−π
intermediate would lead directly to the desired branch product 3.19 with high regio-
and enantioselectivity.
In 2014, Carreira’s group reported the development of the enantioselective
cross-coupling reaction between racemic branched allylic alcohols 3.24 and
allylsilanes, catalyzed by a chiral Ir-(P,olefin) complex (Scheme 3.5).[84] The salient
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feature of the method was that desired products can be obtained with excellent regio-
and enantioselectivity (up to 99% ee) by the use of bench stable allylsilane 3.25. More
importantly, Crotysilane can successfully engage in this transformation to generate
two continuing stereogenic centers.
Scheme 3.4 Copper-catalyzed enantioselective allyl−allyl cross-coupling
Scheme 3.5 Iridium-catalyzed enantioselective allyl–allylsilane cross-coupling
3.1.2 Asymmetric cobalt catalysis
In the past few decades, there has been a strong push for the replacement of
precious-metal catalysts with the more economical and abundant base catalysts in an
effort to promote more economical and sustainable chemical synthesis.[85] More
specifically, cobalt based catalysts have been actively pursued for alkene
functionalization, which is an extremely important transformation in organic synthesis.
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Great progress has been made recently in Co-catalyzed hyrogenation (Scheme 3.6 a,
b),[86] hydroboration (Scheme 3.7),[87] hyroacylation (Scheme 3.8) and related
transformation of alkenes.[88] which generally involves hydrocobaltation of alkenes as
a key step.
Scheme 3.6 Chirik’s cobalt-catalyzed asymmetric hydrogenation
Scheme 3.7 Huang’s cobalt-catalyzed asymmetric hydroboration
Scheme 3.8 Cobalt-catalyzed enantioselective hydroacylation of ketones and olefins
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Zhang group developed a different types of cobalt catalysis. They disclosed a
highly asymmetric and highly diastereoselective method of cyclopropanation of
alkenes (Scheme 3.9).[89] High yields and high selectivities were obtained for a wide
range of alkenes. The product can be converted to β-amino acids. The authors
proposed hydrogen bonding interactions between the amide moieties on the exterior
of the porphyrin and the carbene complex intermediate.
Scheme 3.9 Zhang’s Cobalt(II)-catalyzed steroselective cyclopropanation of alkenes
In our own efforts in this field of research,[90] we became interested in exploring
allylation of new types of electrophiles and were attracted to the strained
meso-bicyclic alkenes. The desymmetrization of these compounds has been
developed into highly useful transformations by Lautens’s group and many others.[91]
The scope of carbon-based nucleophiles used in these studies, however, are largely
limited to simple non-functionalized arylboronic acid,[92] air-sensitive alkyl zinc or
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Grignard reagents.[93],[94] Moreover, most of these catalytic systems required the use of
precious metals such as Rh, Pd and Pt. These limitations certainly hamper the
scalability and practical utility of these systems. As these desymmetrization products
are useful building blocks in chemical synthesis and medicinal chemistry,[95]
development of more economical and sustainable catalyst system to introduce new,
synthetically versatile nucleophiles such allyl group will greatly expand the utility of
this transformation. We have developed the first catalytic stereoselective allylation of
bicyclic alkenes using easy-to-handle potassium allyltrifluoroborate as the allylating
reagent catalyzed by cobalt(II) salt (Scheme 3.9).[96] In addition, intriguing divergent
reactivities have also been achieved; either the hydroallylation of these alkenes or the
ring opening allylation products could be accessed in high efficiency by a simple
switch of catalytic reaction conditions. This transformation involves a key
carbocobaltation step and thus greatly expands the scope of cobalt-catalyzed
functionalization of alkenes.
Scheme 3.9 Unprecedented Co-catalyzed allylation of heterobicyclic alkenes
3.2 Result and discussion
The representative optimization studies for the allylation of the model substrate
3-1a are summarized in Table 3.1. All the metal complexes and potassium
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allyltrifluoroborate were used as received from commercial sources. Out of the
various metal complexes examined initially (Table 3.1, entries 1-5), only [Rh(cod)Cl]2
produced an unexpected hydroallylation product 3-2a as a single syn-isomer in
moderate yield (Table 3.1, entry 3). The anticipated product 3-3a was not obtained at
all under these conditions. Through a more thorough screening of various metal salts,
we were excited to find out that a higher yield of 68% was obtained for 3-2a by using
cobalt bromide (Table 3.1, entry 7), although other cobalt salts such as cobalt acetate
showed no reactivity under similar conditions (Table 3.1, entry 6).Curious about the
source of proton for the formation of 3-2a, we carried out the same reaction as in
entry 7 under strictly moisture-free conditions. This led to a yield of only 9% for 3-2a,
indicating that an external proton source is needed for the catalyst turnover. Based on
this observation, different proton donors were then examined (Table 3.1, entries 8 and
9), out of which ethanol proved to be the most effective choice. Considering the
limited solubility of potassium allyltrifluoroborate in THF, we tested the use of phase
transfer catalysts such as tetrabutylammonium iodide (TBAI)[97], which further
improved the yield of 3-2a to 81% (Table 3.1, entry 10).
Table 3.1 Identification of divergent Co-catalyzed allylation of 3-1a
entry metal additive 3-2a yield[a] 3-3a yield[a]
1 Pd2(dba)3 / <2 <2
2 [Ir(cod)Cl]2 / <2 <2
3 [Rh(cod)Cl]2 / 50 <2
4 CuCl / <2 <2
5 Sc(OTf)3 / <2 <2
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6 Co(OAc)2 / <2 <2
7 CoBr2 / 68(9)[b] <2
8 CoBr2 2 equiv. H2O 38 <2
9 CoBr2 2 equiv. EtOH 72 <2
10[c] CoBr2 2 equiv. EtOH 81 <2
11 CoBr2 20 mol% PPh3 <2 30
12 CoBr2 10 mol% DPPP <2 75
13[d] CoBr2 10 mol% DPPP <2 75
[a] Isolated yields. [b] The number in parenthesis was obtained when the reaction was carried out
under strictly moisture-free conditions. [c] With 10 mol% TBAI. [d] With 2 equiv. EtOH.
The effect of various phosphine ligands was also examined for the allylation
reaction. For the reaction catalyzed by the Rh complex, addition of a bisphosphine
ligand such as 1,3-bis(diphenylphosphino)propane (DPPP) completely shut down the
reaction. When the corresponding Co-catalyzed reaction was carried out in the
presence of PPh3 or DPPP, however, an intriguing complete shift of the reaction
outcome was observed: alcohol 3a was produced exclusively as a single diastereomer
(Table 3.1, entries 11-12). By the use of DPPP, a good yield of 75% could be obtained
for 3-3a. In contrast to the formation of 3-2a, this ring opening reaction turned out to
be insensitive to moisture. Addition of other proton donors such as ethanol also
showed no effect on the reaction outcome (Table 3.1, entry 13).
As the hydroallylation product 3-2a represents a rare example of its kind and is
potentially highly useful in organic synthesis, the scope of this reaction was explored
(Scheme 3.10). Under the optimal conditions using catalytic CoBr2 and TBAI, a wide
range of benzo-fused, oxabicyclic alkenes underwent efficient hydroallylation to
produce 3-2a - 3-2l in good to high yields. While it is well established that the less
strained azabicyclic alkenes as well as non-benzo-fused oxabicylic alkenes are much
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less reactive substrates, we were delighted to find that the hydroallylation of these
compounds proceeded smoothly to deliver 3-2m - 3-2o in good to excellent yields.
Only for the much less strained 3-2p, a moderate yield of 40% was obtained even
with a higher catalyst loading. It is also noteworthy that various functionalities
including ethers, esters, sulfonamide and carbamate in the substrates were
well-tolerated.[98]
Scheme 3.10 Scope of Co-catalyzed hydroallylation[a]
[a] Reaction conditions: THF (0.5ml), 3-1 (0.1mmol, 1 equiv.), potassium trifluoro allylboronate
(0.15mmol, 1.5 equiv.), CoBr2 (10 mol%), TBAI (10 mol%), EtOH (2 equiv.), 70oC, N2. [b] 30
mol% CoBr2
Notably, all the hydroallylation products were obtained as a single
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syn-diastereomer, implying that the heteroatom in the substrate structure may interact
with the cobalt catalyst and direct the allyl addition on the same side in the key
carbocobaltation step. Consistent with this hypothesis, when benzonorbornadiene
(analog of 3-1a with a methylene bridge) was tested as the substrate, no product was
obtained at all. Overall, this simple Co-catalyzed procedure produced a wide range of
novel hydroallylation products in good to excellent efficiency. The development of an
enantioselective variant is underway.
As the use of cobalt-bisphosphine complex induced complete divergent reactivity
to yield the ring opening product 3-3a, a wide range of chiral bisphosphine ligands
were tested in order to realize an enantioselective synthesis of 3-3a. The
representative data of ligand screening is summarized in Table 3.2. In combination
with cobalt bromide, Josiphos and BDPP proved to be the optimal choices of ligands
(Table 3.2, entries 5 and 8); a good yield of 70% and excellent enantioselectivities
were realized in both cases. At this point, different cobalt salts were tested with BDPP,
and the use of CoCl2 led to a slight increase in the chemical yield (Table 3.2, entry 11).
Finally, a more thorough solvent screening was carried out. The mixed solvents of
THF and DCE (1:1) proved to be optimal to deliver 3-3a in 81% yield with nearly
perfect >99:1 er (Table 3.2, entry 12).
Table 3.2 Optimization of enantioselective allylative ring opening
entry metal ligand 3-3a yield[a] er[b]
1 CoBr2 (R)-Segphos 68 50:50
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2 CoBr2 (R)-DTBM-Segphos 83 80:20
3 CoBr2 (S,S)-Me-BPE <2 /
4 CoBr2 (S,S)-Me-DuPhos <2 /
5 CoBr2 (R)-(S)-Josiphos 70 97/3
6 CoBr2 (R)-QuinoxP <2 /
7 CoBr2 (S,S)-Chiraphos 40 96:4
8 CoBr2 (S,S)-BDPP 70 98:2
9 CoI2 (S,S)-BDPP 30 82:18
10 CoF2 (S,S)-BDPP <2 /
11 CoCl2 (S,S)-BDPP 75 98:2
12[c] CoCl2 (S,S)-BDPP 81 >99/1
[a] Isolated yields. [b] Determined by HPLC analysis using a chiral stationary phase. [c] A mixture
solvent (1:1 THF: DCE) was used.
With the optimal conditions in hand, the scope of the enantioselective ring
opening allylation was examined (Scheme 3.11). Various allylation products 3-3a -
3-3h bearing electron-neutral, electron-withdrawing and electron-donating
substituents on the aryl structure were produced in uniformly high yield and excellent
enantioselectivity through desymmetrization of the meso-substrates. However, this
transformation can not access product 3-3i, 3-3j. Possibly, the 1,2-methoxy mioety
may serve as a ligand to precoodinate to cobalt center of cobalt phosphine complex so
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that the oxabycyclic alkenes can not be activated. The extension to the less reactive
non-benzo-fused substrates proved to be partially successful. Highly functionalized
cyclohexadiene 3-3k was obtained in 74% yield with again excellent er of 99:1.
Although 3-3l could be accessed in high er, the efficiency for this reaction requires
further optimization. The relative and absolute configuration of 3-3b was
unambiguously assigned by single crystal x-ray analysis. The configurations of the
other products were assigned by analogy.
Scheme 3.11 Scope of enantioselective allylative ring opening
[a] The same reaction was carried out on a scale of 2 mmol 3-1a, which produced 3-3a in 85%
yield with > 99:1 er. [b] 20 mol% CoCl2 was used.
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Scheme 3.12 Regiodivergent allylative ring opening reaction.
In addition to the desymmetrization of meso-alkenes, the enantioselective
allylation was also successfully extended to regiodivergent ring opening of racemic
3-4 (Scheme 3.12)[99]. Two isomeric products 3-3m and 3-3n were produced in good
yields (sum of 75%) and with excellent enantioselectivity (>99:1 er).
Both series of allylation products are synthetically versatile and representative
derivatizations of them are shown in Scheme 3.13. Hydroboration of the terminal
alkene in 3-2a followed by oxidation yielded alcohol 3-5 in 82% overall yield. In the
case of 3-2i bearing para-dimethoxy substituents, oxidation using CAN produced the
corresponding quinone 3-6 in reasonable yield. For the ring opening products, the
hydroxyl group and the allyl unit can be manipulated in different ways. Allylation of
the alcohol using allyl bromide followed by ring close metathesis yielded tricyclic 3-7
in a high yield of 82% without any erosion of enantioselectivity. Alternatively, a
bromoetherification of 3-3e was realized to yield 3-8 in good combined yield with a
good d.r of 83:17 favoring the diastereomer as shown in Scheme 3.13.
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Scheme 3.13 Derivatization of allylation products
To shed some light on the mechanism of this reaction, we tested the reactions
with substituted allylating reagents (Scheme3.14a). When potassium-methyl
allyltrifluoroborate 3-9 or potassium crotyltrifluoroborate 3-10 were tested under the
standard hydroallylation conditions, the same product 3-2q (as a mixture of E/Z
isomers) was produced. These results strongly support the intermediate of cobalt-allyl
species. The reactivity of 3-10 was much lower than that of 3-9. The use of higher
loading of cobalt catalyst for the reaction using 3-10, however, could improve the
yield of 3-2q to a moderate level. In addition, various substituted reagents such as
ethylallyltrifluoroborate and dimethylallyl trifluoroborate also proved to be successful
in the hydroallylation to deliver 3-2r ans 3-2s in reasonable yields (Scheme 3.14b).
In our reactions the readily available cobalt (II) salts were used as the catalyst.
The addition of radical scavenger such as butylated hydroxytoluene (BHT) showed no
significant influence on the reactivity or selectivity (Scheme 3.14c), implying that no
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single electron transfer is involved in this reaction. For the ring opening reaction, the
enantioselectivity of the product was found to be directly proportional to the
enantiopurity of the chiral ligand. Based on these preliminary studies we propose that
the reaction is catalyzed by the cobalt (II)-bisphosphine complex (1:1 ratio).[100]
Scheme 3.14 Use of substituted allyl reagents and redicals scanverger
We propose the reaction pathways shown in Scheme 3.15 as a working
hypothesis. Transmetallation of cobalt salt with allyltrifluoroborate presumably
generates the allylcobalt species A, the two termini of which can equilibrate through
the cobalt-allyl intermediate for the reaction. syn-allylcobaltation of the alkene
substrate by A then produces B as a common intermediate. In the absence of ligand,
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the C-Co bond directly undergoes protonolysis to produce the hydroallylation product
3-2a. When deuterated ethanol was used as the proton source under otherwise
identical conditions, oxabicycle 3-2a' was obtained as a single diastereomer with
>98% deterium labelling, suggesting a stereoretentive protonolysis. In the presence of
phosphine ligand, on the other hand, β-O elimination proceeds instead of protonolysis
to yield C that in turn is tranformed to D leading to product 3-3a. More detailed
mechanistic and computational studies will be carried out to better understand the
origin of this intriguing divergent reactivity.[101]
Scheme 3.15 Proposed catalytic pathways
3.3 Conclusion
In conclusion, we have developed an unprecedented allylation of heterobicyclic
alkenes catalyzed by cobalt. Divergent reactivities were realized by using either cobalt
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salt or Co-bisphosphine complex as the catalyst. The procedure uses commercially
available and inexpensive catalysts and reagents, and delivers highly synthetically
valuable products in high efficiency and stereoselectivity. Current efforts in our
laboratories are focused on the extension of this allylcobaltation reaction to other
types of alkenes as well as other π-systems.
3.4 Experimental section
3.4.1 General information
Chemicals and solvents were purchased from commercial suppliers and used as
received. 1H and 13C NMR spectra were recorded on a Bruker ACF300 (300 MHz) or
AMX500 (500 MHz) spectrometer. Chemical shifts were reported in parts per million
(ppm), and the residual solvent peak was used as an internal reference: proton
(chloroform δ 7.26), carbon (chloroform δ 77.0) or tetramethylsilane (TMS δ 0.00)
was used as a reference. Multiplicity was indicated as follows: s (singlet), d (doublet),
t (triplet), q (quartet), m (multiplet), dd (doublet of doublet), bs (broad singlet).
Coupling constants were reported in Hertz (Hz). Low resolution mass spectra were
obtained on a Finnigan/MAT LCQ spectrometer in ESI mode, and a Finnigan/MAT
95XL-T mass spectrometer in EI mode. All high resolution mass spectra (HRMS)
were obtained on a Finnigan/MAT 95XL-T spectrometer. For thin layer
chromatography (TLC), Merck pre-coated TLC plates (Merck 60 F254) were used,
and compounds were visualized with a UV light at 254 nm. Further visualization was
achieved by staining with iodine, or potassium permanganate solution followed by
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heating using a heat gun. Flash chromatography separations were performed on
Merck 60 (0.040-0.063 mm) mesh silica gel. The enantiomeric ratios (er) of products
were determined by chiral phase HPLC analysis on SHIMAZU HPLC units, including
the following instruments: pump, LC-20AD; detector, SPD-20A; column, Chiralcel
OD-H, Chiralpak AS-H, IC, IF or AD-H. Optical rotations were recorded on an MRC
AP81 automatic polarimeter.
All reactions were carried out under nitrogen atmosphere. All commercially
available reagents listed below were used as received for the reactions without any
purification. THF was dried on alumina columns using a solvent dispensing system.
Potassium crotyltrifluoroborate and potassium α-methyl allyl trifluoroborate were
synthesized according to the literature.[102] Heterobicyclic alkenes were synthesized
according to reported procedure.[103]
3.4.2 General procedure for co-catalyzed allylation of oxabicylic alkenes
1) cobalt-catalyzed hydroallylation of oxabicyclic alkenes
To a dried Schlenk bomb equipped with a dried stir bar was added potassium
allyltrifluoroborate (0.15 mmol). The Schlenk bomb was taken into the glovebox,
where anhydrous THF (0.5 mL), ethaol (0.2 mmol), heterobicyclic alkene (0.10
mmol), cobalt bromide (0.010 mmol) and tetrabutylammonium iodide (0.010 mmol)
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were added. The tube was then tighted and taken outside the glovebox. The reaction
mixture was allowed to stir at 70 oC for 16 h. The crude reaction mixture was
concentrated under reduced pressure. The products 3-2 were directly purified by silica
gel chromatography (ethyl acetate: hexanes = 1:10).
2) cobalt-catalyzed asymmetric allylative ring opening of oxabicyclic alkenes
To a 10 mL vial equipped with a dried stir bar was added cobalt chloride (0.010
mmol), (S,S)-BDPP (0.012 mmol), anhydrous THF (0.5 mL) and dichloroethane (0.5
mL) in the glovebox. The reaction mixture was then allowed to stir for 30 min,
followed by addition of potassium allyltrifluoroborate (0.15 mmol) and oxabicyclic
alkene 3-1 (0.10 mmol). The reaction mixture was taken outside the glovebox and
allowed to stir at 70 oC for 16 h. The crude reaction mixture was concentrated under
reduced pressure. The products 3-3 were directly purified by silica gel
chromatography (ethyl acetate:hexanes = 1:8). The enantiopurity of the purified
products was analyzed by chiral HPLC (Chiralcel OD-H; chralpak AS-H or AD-H).
3.4.3. Analytical data of hydroallylation products
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Colorless oil, 81% yield. 1H NMR (300 MHz, C6D6): δ 7.02 – 6.85 (m, 4H), 5.79 –
5.59 (m, 1H), 5.08 (d, J = 4.8 Hz, 1H), 5.02 – 4.98 (m, 1H), 4.95 (dd, J = 3.7, 2.4 Hz,
2H), 2.30 – 2.18 (m, 1H), 2.17 – 2.04 (m, 1H), 1.53 (dq, J = 11.3, 3.8 Hz, 1H), 1.43 –
1.35 (m, 1H), 1.29 (dd, J = 11.5, 7.9 Hz, 1H). 13C NMR (75 MHz, C6D6): δ 146.48,
146.07, 136.88, 126.08, 126.06, 118.50, 118.44, 115.49, 82.17, 79.00, 39.69, 38.98,
34.31.HRMS (ESI) m/z Calcd. for [C13H15O, M+H]+ : 187.1123; Found: 187.1124.
Colorless oil, 70% yield. 1H NMR (500 MHz, C6D6): δ 6.86 (s, 1H), 6.82 (s, 1H),
5.84 (dd, J = 17.1, 10.3 Hz, 1H), 5.24 (d, J = 4.8 Hz, 1H), 5.14 (dd, J = 3.5, 1.6 Hz,
1H), 5.12 – 5.10 (m, 1H), 5.10 – 5.08 (m, 1H), 2.40 (dt, J = 14.5, 7.4 Hz, 1H), 2.26 (dt,
J = 14.1, 7.2 Hz, 1H), 2.13 (s, 6H), 1.72 (qd, J = 7.6, 3.7 Hz, 1H), 1.58 – 1.51 (m, 1H),
1.48 (dd, J = 11.4, 7.9 Hz, 1H). 13C NMR (75 MHz, C6D6): δ 144.41, 144.00, 137.10,
133.59, 119.98, 119.93, 115.43, 82.12, 78.98, 40.20, 39.14, 34.88, 19.39.HRMS (ESI)
m/z Calcd. for [C15H19O, M+H]+ : 215.1436; Found: 215.1435.
Colorless oil, 91% yield. 1H NMR (500 MHz, CDCl3): δ 7.52 (s, 1H), 7.50 (s, 1H),
5.84 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 5.34 (d, J = 4.6 Hz, 1H), 5.14 - 5.10 (m, 2H),
5.05 – 4.99 (s, 1H), 2.36 (dd, J = 14.4, 7.2 Hz, 1H), 2.28 (dt, J = 13.6, 6.8 Hz, 1H),
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1.81 (ddd, J = 11.5, 7.6, 4.0 Hz, 1H), 1.69 – 1.57 (m, 2H). 13C NMR (125MHz,
CDCl3): δ 147.13, 146.77, 136.44, 124.33, 122.27, 116.52, 81.91, 78.97, 39.50, 38.81,
34.02. HRMS (ESI) m/z Calcd. for [C13H13Br2O, M+H]+ : 342.9333; Found:
342.9319.
Colorless oil, 78% yield. 1H NMR (300 MHz, CDCl3): δ 7.08 (td, J = 7.9, 5.0 Hz,
2H), 5.86 (ddt, J = 17.1, 10.2, 6.7 Hz, 1H), 5.37 (d, J = 4.4 Hz, 1H), 5.23 – 4.99 (m,
3H), 2.47 – 2.21 (m, 2H), 1.80 (ddd, J = 15.2, 7.6, 4.0 Hz, 1H), 1.72 – 1.55 (m, 2H).
13C NMR (75 MHz, CDCl3): δ 150.60 (d, J C-F = 14.7 Hz, 1F), 147.32 (d, J C-F = 15.0
Hz, 1F), 136.46, 116.30, 108.91, 108.64, 82.09, 79.13, 39.61, 38.77, 34.16. 19F NMR
(282 MHz, CDCl3) δ = -140.22, -140.24, -140.24, -140.26, -140.27, -140.29. HRMS
(ESI) m/z Calcd. for [C13H13F2O, M+H]+: 223.0934; Found: 223.0921.
Colorless oil, 73% yield. 1H NMR (300 MHz, CDCl3): δ 7.07 (s, 1H), 7.05 (s, 1H),
5.90 (ddt, J = 17.1, 10.2, 6.7 Hz, 1H), 5.35 (d, J = 3.3 Hz, 1H), 5.25 – 5.04 (m, 3H),
2.53 – 2.36 (m, 2H), 2.29 (s, 6H), 1.82 (ddd, J = 14.8, 7.4, 4.9 Hz, 1H), 1.72 – 1.59
(m, 2H). 13C NMR (75 MHz, CDCl3): δ 143.85, 143.52, 137.04, 134.27, 120.16,
115.85, 82.34, 79.29, 40.01, 39.10, 34.72, 19.85. HRMS (ESI) m/z Calcd. for
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[C15H18NaO3, M+Na]+: 269.1148; Found: 269.1143.
Colorless oil, 90% yield. 1H NMR (300 MHz, CDCl3): δ 6.90 (s, 1H), 6.88 (s, 1H),
6.10 (ddtd, J = 17.1, 10.5, 5.3, 1.2 Hz, 2H), 5.94 – 5.78 (m, 1H), 5.43 (ddd, J = 17.3,
2.8, 1.5 Hz, 2H), 5.37 – 5.26 (m, 3H), 5.18 – 5.06 (m, 2H), 5.03 (s, 1H), 4.66 – 4.53
(m, 4H), 2.39 (dt, J = 14.7, 7.4 Hz, 1H), 2.32 – 2.19 (m, 1H), 1.78 (qd, J = 7.5, 4.4 Hz,
1H), 1.62 (dd, J = 7.7, 3.5 Hz, 2H). 13C NMR (75 MHz, CDCl3): δ 147.33, 138.88,
138.56, 136.97, 133.56, 117.36, 115.91, 107.06, 106.99, 82.58, 79.54, 70.58, 40.02,
39.04, 34.71. HRMS (ESI) m/z Calcd. for [C19H22NaO3, M+Na]+: 321.1461; Found:
321.1467.
Colorless oil, 84% yield. 1H NMR (300 MHz, CDCl3) δ 7.69 (s, 1H), 7.67 (s, 1H),
5.92 – 5.74 (m, 1H), 5.52 (d, J = 4.8, 1H), 5.23 (s, 1H), 5.18 (dd, J = 3.4, 1.7, 1H),
5.13 (s, 1H), 2.48 – 2.27 (m, 2H), 1.82 (ddd, J = 14.6, 8.1, 3.9, 2H), 1.71 – 1.62 (m,
1H). 13C NMR (75 MHz, CDCl3) δ 151.50, 151.13, 135.67, 123.75, 123.69, 117.10,
115.55, 115.53, 114.74, 114.69, 81.79, 78.92, 38.59, 38.41, 32.89. HRMS (ESI) m/z
Calcd. for [C15H12N2O, M-H]- : 235.0877; Found: 235.0875
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Colorless oil, 83% yield. 1H NMR (300 MHz, CDCl3): δ 6.78 (s, 1H), 6.77 (s, 1H),
5.98 (d, J = 1.3 Hz, 1H), 5.94 (d, J = 1.3 Hz, 1H), 5.93 – 5.79 (m, 1H), 5.32 (t, J = 4.8
Hz, 1H), 5.19 – 5.05 (m, 2H), 5.02 (d, J = 6.3 Hz, 1H), 2.47 – 2.18 (m, 2H), 1.77 (qd,
J = 7.4, 4.3 Hz, 1H), 1.67 – 1.53 (m, 2H). 13C NMR (75 MHz, CDCl3): δ 146.00,
139.62, 139.29, 136.90, 115.93, 101.23, 101.19, 100.96, 82.49, 79.45, 77.36, 76.94,
76.52, 39.87, 38.96, 34.54. HRMS (ESI) m/z Calcd. for [C14H15O3, M+H]+: 231.1021;
Found: 231.1010.
Colorless oil, 75% yield. 1H NMR (300 MHz, CDCl3): δ 6.67 (s, 2H), 5.90 (ddt, J =
17.0, 10.2, 6.6 Hz, 1H), 5.63 – 5.52 (m, 1H), 5.29 (s, 1H), 1H NMR (300 MHz,
CDCl3) δ 5.90 (ddt, J = 17.0, 10.2, 6.6 Hz, 1H), 5.60 – 5.54 (m, 1H), 5.29 (s, 1H),
5.17 (dd, J = 3.5, 1.6 Hz, 0.5H), 5.11 (t, J = 1.4 Hz, 1H), 5.08 (dd, J = 2.0, 1.1 Hz,
0.5H), 3.82 (s, 3H), 3.81 (s, 3H), 2.44 (dt, J = 14.4, 7.2 Hz, 1H), 2.29 (ddd, J = 14.4,
7.6, 6.4 Hz, 1H), 1.86 (ddd, J = 13.0, 7.4, 5.9 Hz, 1H), 1.71 – 1.64 (m, 2H). 13C NMR
(75 MHz, CDCl3): δ 146.62, 146.57, 136.92, 135.19, 134.50, 115.89, 111.27, 111.11,
80.60, 56.22, 56.15, 39.14, 39.01, 33.88. HRMS (ESI) m/z Calcd. for [C15H18NaO3,
M+Na]+: 269.1148; Found: 269.1144.
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Pale yellow oil, 85% yield. 1H NMR (500 MHz, CDCl3): δ 7.47 – 7.39 (m, 8H), 7.36
(t, J = 6.7 Hz, 2H), 6.76 – 6.62 (m, 2H), 5.89 (ddt, J = 17.0, 10.3, 6.7 Hz, 1H), 5.60 (d,
J = 1.8 Hz, 1H), 5.33 (d, J = 4.7 Hz, 1H), 5.15 (dd, J = 17.3, 1.5 Hz, 1H), 5.12 – 5.06
(m, 5H), 2.41 (dt, J = 14.5, 7.3 Hz, 1H), 2.32 – 2.24 (m, 1H), 1.87 – 1.79 (m, 1H),
1.70 – 1.59 (m, 2H). 13C NMR (125 MHz, CDCl3): δ 146.02, 145.89, 137.43, 137.34,
136.95, 135.86, 135.68, 128.57, 128.54, 127.95, 127.88, 127.39, 127.24, 115.92,
113.48, 113.11, 80.70, 71.25, 71.17, 39.17, 38.90, 33.91. HRMS (ESI) m/z Calcd. for
[C27H27O3, M+H]+: 399.1955; Found: 399.1961.
Colorless oil, 89% yield. 1H NMR (500 MHz, CDCl3): δ 6.64 (s, 2H), 6.06 (ddd, J =
22.4, 10.5, 5.2 Hz, 2H), 5.89 (ddt, J = 17.0, 10.3, 6.6 Hz, 1H), 5.58 (d, J = 4.3 Hz,
1H), 5.42 (ddd, J = 17.3, 3.4, 1.5 Hz, 2H), 5.29 (d, J = 10.2 Hz, 2H), 5.19 – 5.03 (m,
2H), 4.54 (dd, J = 6.4, 3.2 Hz, 4H), 2.42 (dt, J = 14.6, 7.3 Hz, 1H), 2.33 – 2.22 (m,
1H), 1.87 (qd, J = 7.5, 4.4 Hz, 1H), 1.72 – 1.64 (m, 2H). 13C NMR (125MHz, CDCl3):
δ 145.74, 145.70, 136.93, 135.67, 135.40, 133.70, 133.67, 117.36, 117.10, 115.88,
113.06, 112.82, 80.61, 69.95, 39.13, 38.93, 33.96. HRMS (ESI) m/z Calcd. for
[C19H22NaO3, M+Na]+: 321.1461; Found: 321.1466.
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Colorless oil, 50% yield. 1H NMR (500 MHz, CDCl3): δ 8.77 (dd, J = 5.8, 3.6 Hz,
2H), 8.01 – 7.88 (m, 2H), 7.80 – 7.62 (m, 4H), 6.01 (d, J = 4.5 Hz, 1H), 6.00 – 5.86
(m, 1H), 5.73 (s, 1H), 5.31 – 5.11 (m, 2H), 2.61 – 2.50 (m, 1H), 2.44 (dd, J = 14.2, 6.4
Hz, 1H), 1.90 – 1.81 (m, 2H), 1.69 (dd, J = 11.5, 8.1 Hz, 1H). 13C NMR (125 MHz,
CDCl3): δ 140.86, 140.50, 137.13, 130.06, 126.90, 126.86, 126.09, 126.05, 125.90,
124.11, 124.06, 123.59, 116.13, 81.87, 78.94, 39.96, 39.05, 34.59. HRMS (ESI) m/z
Calcd. for [C21H18NaO, M+Na]+: 309.1250; Found: 309.1250.
Colorless oil, 75% yield. 1H NMR (300 MHz, CDCl3): δ 8.86 (d, J = 8.6 Hz, 1H),
8.08 (dd, J = 7.4, 1.2 Hz, 1H), 7.79 (dd, J = 17.7, 8.1 Hz, 2H), 7.65 (ddd, J = 8.6, 6.9,
1.4 Hz, 1H), 7.54 (ddd, J = 8.0, 6.9, 1.1 Hz, 1H), 7.33 (dd, J = 15.0, 6.8 Hz, 1H), 6.64
(d, J = 1.6 Hz, 4H), 5.91 – 5.71 (m, 1H), 5.14 (d, J = 4.4 Hz, 1H), 5.12 – 4.90 (m, 2H),
4.81 (s, 1H), 2.56 – 2.27 (m, 2H), 1.95 – 1.78 (m, 1H), 1.76 – 1.65 (m, 1H), 1.52 (dd,
J = 11.3, 8.1 Hz, 1H). 13C NMR (75 MHz, CDCl3): δ 143.07, 136.15, 133.97, 130.22,
128.98, 128.47, 127.51, 126.35, 125.83, 125.37, 123.86, 119.14, 116.55, 67.10, 63.97,
40.75, 38.59, 35.22. HRMS (ESI) m/z Calcd. for [C23H22NO2S, M+H]+: 376.1366;
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Found: 376.1369.
Colorless oil, 99% yield. 1H NMR (300 MHz, CDCl3): δ 7.29 – 7.22 (m, 2H), 7.20 –
7.10 (m, 2H), 5.87 (ddt, J = 17.0, 10.2, 6.8 Hz, 1H), 5.21 – 5.05 (m, 3H), 4.91 (s, 1H),
2.38 (s, 1H), 2.27 (dt, J = 14.1, 6.9 Hz, 1H), 1.79 – 1.68 (m, 2H), 1.57 (dd, J = 11.5,
8.0 Hz, 1H), 1.42 (s, 9H). 13C NMR (75 MHz, CDCl3): δ 145.53, 136.67, 126.18,
126.15, 119.65, 119.37, 119.30, 116.08, 79.76, 64.46, 38.87, 34.50, 28.18. HRMS
(ESI) m/z Calcd. for [C18H23NNaO2, M+Na]+: 308.1621; Found: 308.1624.
Colorless oil, 85% yield. 1H NMR (300 MHz, CDCl3): δ 5.86 (ddt, J = 17.0, 10.2, 6.5
Hz, 1H), 5.23 (d, J = 4.7 Hz, 1H), 5.19 – 5.04 (m, 2H), 4.97 (s, 1H), 4.29 (qd, J = 7.1,
2.1 Hz, 4H), 2.42 – 2.20 (m, 2H), 1.97 (ddd, J = 15.2, 7.7, 3.6 Hz, 1H), 1.77 (dd, J =
11.8, 7.9 Hz, 1H), 1.65 – 1.53 (m, 1H), 1.35 (td, J = 7.1, 1.3 Hz, 6H). 13C NMR (75
MHz, CDCl3): δ = 150.70, 150.51, 147.41, 147.22, 136.46, 116.30, 108.91, 108.64,
82.09, 79.13, 39.61, 38.77, 34.16.HRMS (ESI) m/z Calcd. for [C15H20NaO5, M+Na]+:
303.1203; Found: 303.1209.
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Colorless oil, 40% yield. 1H NMR (500 MHz, CDCl3): δ 8.08 (dd, J = 7.7, 2.0 Hz,
4H), 7.59 (t, J = 7.2 Hz, 2H), 7.48 (t, J = 7.7 Hz, 4H), 5.79 (ddt, J = 17.0, 10.3, 6.7 Hz,
1H), 5.07 (dd, J = 20.0, 4.8 Hz, 2H), 4.58 (d, J = 5.2 Hz, 1H), 4.54 – 4.43 (m, 2H),
4.36 (dd, J = 6.2, 4.4 Hz, 2H), 4.34 – 4.30 (m, 1H), 2.49 – 2.38 (m, 2H), 2.22 (dt, J =
14.6, 7.4 Hz, 1H), 2.11 – 2.01 (m, 1H), 1.94 (qd, J = 7.8, 4.3 Hz, 1H), 1.79 (dd, J =
12.2, 8.3 Hz, 1H), 1.45 (dt, J = 12.2, 4.7 Hz, 1H). 13C NMR (125 MHz, CDCl3): δ
166.36, 166.34, 136.60, 133.07, 130.09, 129.62, 128.45, 116.08, 82.47, 79.33, 63.55,
63.49, 45.15, 45.03, 41.86, 39.30, 36.75. HRMS (ESI) m/z Calcd. for [C25H27O5,
M+H]+: 407.1853; Found: 407.1860.
Colorless oil, 85% yield. 1H NMR (500 MHz, CDCl3): δ 7.28 – 7.20 (m, 2H), 7.16 (dt,
J = 4.2, 3.7 Hz, 2H), 5.61 – 5.53 (m, 1H), 5.48 (ddd, J = 15.0, 6.8, 1.1 Hz, 1H), 5.38
(d, J = 4.3 Hz, 1H), 5.08 (s, 1H), 2.38 – 2.27 (m, 1H), 2.25 – 2.17 (m, 1H), 1.80 –
1.69 (m, 4H), 1.66 – 1.59 (m, 3H). 13C NMR (125 MHz, CDCl3): δ 146.12, 145.81,
129.48, 126.60, 126.41, 126.36, 118.83, 118.79, 82.51, 79.46, 40.28, 38.00, 34.42,
18.04.HRMS (ESI) m/z Calcd. for [C14H17O, M+H]+: 201.1274; Found: 201.1278.
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Colorless oil, 51% yield. 1H NMR (500 MHz, CDCl3) δ 7.24 (ddd, J = 10.7, 8.0, 4.0,
2H), 7.19 – 7.11 (m, 2H), 5.64 – 5.54 (m, 1H), 5.51 – 5.41 (m, 1H), 5.37 (t, J = 4.5,
1H), 5.07 (d, J = 4.6, 1H), 2.33 (dt, J = 14.2, 7.2, 1H), 2.26 – 2.16 (m, 1H), 2.13 –
2.00 (m, 2H), 1.82 – 1.70 (m, 1H), 1.70 – 1.63 (m, 2H), 1.01 (dd, J = 9.9, 5.0, 3H).
13C NMR (125 MHz, CDCl3): δ 146.12, 145.84, 133.89, 127.18, 126.37, 126.32,
118.77, 118.75, 82.52, 79.45, 40.34, 37.90, 34.40, 25.66, 13.96. HRMS (EI) m/z
Calcd. for [C15H18O, M]: 214.1358; Found: 214.1360
O
Colorless oil, 66% yield. 1H NMR (500 MHz, CDCl3) δ 7.26 - 7.18 (m, 2H), 7.17 -
7.09 (m, 2H), 5.36 (d, J = 3.6, 1H), 5.18 (dd, J = 10.3, 4.0, 1H), 5.02 (s, 1H), 2.37 -
2.25 (m, 1H), 2.17 (dt, J = 14.2, 6.9, 1H), 1.74 (s, 3H), 1.73 - 1.69 (m, 1H), 1.68 (d, J
= 8.2, 3H), 1.64 – 1.60 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 146.11, 145.86,
132.93, 126.35, 126.30, 122.77, 118.82, 118.72, 82.58, 79.44, 40.85, 34.50, 33.47,
25.80, 17.97. HRMS (EI) m/z Calcd. for [C14H18O, M]: 214.1358; Found: 214.1359
3.4.4. Analytical data of allylative ring opening products
139
Colorless oil, 81% yield. 1H NMR (300 MHz, CDCl3): δ 7.32 (m, 3H), 7.17 (d, J =
6.9 Hz, 1H), 6.60 (dd, J = 9.6, 1.9 Hz, 1H), 6.14 – 5.93 (m, 1H), 5.88 (d, J = 8.4 Hz,
1H), 5.20 (dd, J = 18.2, 13.7 Hz, 2H), 4.64 (s, 1H), 2.62 (t, J = 7.5 Hz, 2H), 2.49 –
2.30 (m, 1H). 13C NMR (75 MHz, CDCl3): δ 136.56, 132.55, 130.19, 128.51, 127.60,
127.51, 126.93, 126.49, 116.78, 70.17, 40.22, 33.52. HRMS (ESI) m/z Calcd. for
[C13H14NaO, M+Na]+: 209.0942; Found: 209.0945. Optical Rotation: [α]22D =
+94.11 (c = 0.3, CH2Cl2). The absolute configuration was assigned by analog to that
of 3.3b. >99:1 er. HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 95:5,
flow rate = 0.5ml/min, wavelength = 254nm, tR = 15.953 min for minor isomer, tR =
17.156 min for major isomer.
Pale yellow solid, 78% yield. 1H NMR (300 MHz, CDCl3): δ 7.15 (s, 1H), 6.96 (s,
1H), 6.55 (dd, J = 9.6, 2.2 Hz, 1H), 5.99 (ddt, J = 17.1, 10.1, 6.8 Hz, 1H), 5.79 (d, J =
9.6 Hz, 1H), 5.30 – 5.12 (m, 2H), 4.57 (s, 1H), 2.67 – 2.54 (m, 2H), 2.47 – 2.36 (m,
1H), 2.31 (s, 3H), 2.29 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 136.69, 135.95, 134.11,
130.18, 129.08, 129.00, 127.86, 126.76, 116.64, 69.96, 40.46, 33.73, 19.48, 19.39.
HRMS (ESI) m/z Calcd. for [C15H18NaO, M+Na]+: 237.1250; Found: 237.1250.
Optical Rotation: [α]22D = +33.17 (c = 0.2, CH2Cl2). The absolute configuration was
assigned by single crystal x-ray analysis. >99:1er. HPLC condition: Chiralcel OD-H
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column, n-hexane/i-PrOH = 95:5, flow rate = 0.5ml/min, wavelength = 254nm, tR =
14.737 min for minor isomer, tR= 16.252 min for major isomer.
Colorless oil, 68% yield. 1H NMR (500 MHz, CDCl3): δ 7.63 (s, 1H), 7.39 (s, 1H),
6.47 (dd, J = 9.6, 1.6 Hz, 1H), 5.98 (dd, J = 9.6, 2.8 Hz, 1H), 5.95 – 5.86 (m, 1H),
5.24 – 5.12 (m, 2H), 4.65 (s, 1H), 2.62 – 2.49 (m, 2H), 2.37 – 2.27 (m, 1H). 13C NMR
(125 MHz, CDCl3): δ 137.21, 136.13, 133.34, 132.45, 132.24, 131.10, 125.24, 124.32,
122.97, 117.25, 69.40, 39.98, 33.02. HRMS (ESI) m/z Calcd. for [C13H12Br2NaO,
M+Na]+ : 364.9153; Found: 364.9160. Optical Rotation: [α]22D = +75.17 (c = 0.25
CH2Cl2). The absolute configuration was assigned by analog to that of 3.3b. >99:1 er.
HPLC condition: Chiralpak AS-H column, n-hexane/i-PrOH = 95:5, flow rate
=0.5ml/min, wavelength = 254nm, tR = 14.852 min for major isomer, tR = 17.033 min
for minor isomer.
Colorless oil, 85% yield. 1H NMR (500 MHz, CDCl3): δ 7.20 (dd, J = 10.3, 7.9 Hz,
1H), 6.95 (dd, J = 10.6, 7.8 Hz, 1H), 6.47 (dd, J = 9.6, 1.8 Hz, 1H), 5.93 (ddd, J =
14.1, 9.0, 2.8 Hz, 2H), 5.23 – 5.10 (m, 2H), 4.62 (d, J = 6.5 Hz, 1H), 2.64 – 2.49 (m,
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2H), 2.39 – 2.28 (m, 1H). 13C NMR (125 MHz, CDCl3): δ 136.24, 131.03, 125.41,
117.17, 115.21, 115.07, 69.47, 39.89, 33.18. 19F NMR (282 MHz, CDCl3) δ = -138.55
– -138.69 (m, 1F), -138.90 – -139.04 (m, 1F). HRMS (ESI) m/z Calcd. for
[C13H12F2NaO, M+Na]+: 245.0754; Found: 245.0758. Optical Rotation: [α]22D =
+59.67 (c = 0.3, CH2Cl2). The absolute configuration was assigned by analog to that
of 3.3b. >99:1 er. HPLC condition: Chiralpak AS-H column, n-hexane/i-PrOH = 95:5,
flow rate = 0.5ml/min, wavelength = 254nm, tR = 12.529 min for major isomer, tR =
14.019 min for minor isomer.
Pale yellow solid, 66% yield. 1H NMR (300 MHz, CDCl3) δ 7.89 (s, 1H), 7.51 (s,
1H), 6.59 (dd, J = 9.7, 1.4, 1H), 6.31 (dd, J = 9.7, 4.4, 1H), 5.86 (ddt, J = 17.1, 10.1,
7.1, 1H), 5.22 – 5.07 (m, 2H), 4.95 (s, 1H), 2.79 – 2.66 (m, 1H), 2.52 (dt, J = 13.8, 6.9,
1H), 2.31 – 2.14 (m, 1H). 13C NMR (75 MHz, CDCl3) δ141.98, 137.65, 137.39,
135.30, 131.20, 130.20, 124.55, 117.65, 115.61, 115.35, 115.32, 113.89, 69.29, 39.47,
32.02. HRMS (ESI) m/z Calcd. for [C15H12N2O-H]-: 235.0877; Found: 235.0876
Optical Rotation: [α]22D = +45.17 (c = 0.2, CH2Cl2). The absolute configuration was
assigned by analog to that of 3.3b. 97:3 er. HPLC condition: Chiralpak IF column,
n-hexane/i-PrOH = 95:5, flow rate = 0.9 ml/min, wavelength = 254nm, tR = 41.611
min for minor isomer, tR= 52.008 min for major isomer.
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Pale yellow solid, 90% yield. 1H NMR (500 MHz, CDCl3): δ 6.94 (dd, J = 9.8, 2.7 Hz,
1H), 6.80 (q, J = 9.0 Hz, 2H), 6.01 (ddt, J = 16.9, 10.1, 6.9 Hz, 1H), 5.84 (d, J = 9.8
Hz, 1H), 5.24 (d, J = 17.1 Hz, 1H), 5.17 (d, J = 10.1 Hz, 1H), 5.02 (d, J = 2.5 Hz, 1H),
3.86 (s, 3H), 3.83 (s, 3H), 2.71 – 2.58 (m, 1H), 2.54 – 2.43 (m, 2H). 13C NMR
(125MHz, CDCl3): δ 150.56, 149.60, 136.80, 129.61, 125.55, 122.77, 120.96, 116.78,
111.24, 110.53, 62.63, 56.21, 56.07, 39.72, 34.10. HRMS (ESI) m/z Calcd. for
[C15H18NaO3, M+Na]+: 269.1148; Found: 269.1144. Optical Rotation: [α]22D =
+24.83 (c = 0.4, CH2Cl2). The absolute configuration was assigned by analog to that
of 3.3b. 99:1 er. HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 95:5,
flow rate = 0.5ml/min, wavelength = 254nm, tR = 39.373 min for minor isomer, tR =
52.471 min for major isomer.
Pale yellow solid, 85% yield. 1H NMR (400 MHz, CDCl3): δ 7.42 – 7.15 (m, 10H),
6.92 (dd, J = 9.8, 2.8 Hz, 1H), 6.77 – 6.66 (m, 2H), 5.90 (ddd, J = 17.1, 10.2, 7.1 Hz,
1H), 5.76 (dt, J = 9.8, 1.5 Hz, 1H), 5.17 – 5.09 (m, 1H), 5.09 – 5.02 (m, 2H), 4.99 (s,
2H), 4.95 (d, J = 4.6 Hz, 2H), 2.60 – 2.47 (m, 1H), 2.43 – 2.30 (m, 2H). 13C NMR
(100 MHz, CDCl3): δ 149.87, 149.05, 137.32, 137.30, 136.78, 129.67, 128.59, 128.54,
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127.90, 127.86, 127.34, 127.29, 126.54, 123.40, 121.12, 116.75, 113.06, 112.92,
71.31, 71.08, 63.00, 39.66, 34.04. HRMS (ESI) m/z Calcd. for [C27H26NaO3, M+Na]+:
421.1774; Found: 421.1776. Optical Rotation: [α]22D = +18.83 (c = 0.4, CH2Cl2).
The absolute configuration was assigned by analog to that of 3.3b. 99:1 er. HPLC
condition: Chiralcel OD-H column, n-hexane/i-PrOH = 80:20, flow rate = 1ml/min,
wavelength = 254nm, tR = 18.930 min for minor isomer, tR = 31.679 min for major
isomer.
Colorless oil, 78% yield. 1H NMR (500 MHz, CDCl3): δ 6.99 (dd, J = 9.8, 2.7 Hz,
1H), 6.78 (q, J = 8.9 Hz, 2H), 6.19 – 5.95 (m, 3H), 5.86 (d, J = 9.8 Hz, 1H), 5.48 –
5.40 (m, 2H), 5.33 – 5.22 (m, 3H), 5.17 (d, J = 10.2 Hz, 1H), 5.07 (s, 1H), 4.62 (ddt, J
= 13.2, 5.0, 1.6 Hz, 1H), 4.58 – 4.50 (m, 4H), 2.65 (dd, J = 12.4, 6.1 Hz, 1H), 2.53 –
2.44 (m, 2H). 13C NMR (125 MHz, CDCl3): δ 149.72, 148.77, 136.79, 133.63, 133.60,
129.60, 126.21, 123.30, 121.07, 117.31, 117.18, 116.74, 113.01, 112.39, 70.00, 69.93,
62.86, 39.65, 34.07. HRMS (ESI) m/z Calcd. for [C19H22NaO3, M+Na]+: 321.1461;
Found: 321.1476. Optical Rotation:[α]22D = +14.83 (c = 0.3, CH2Cl2). The absolute
configuration was assigned by analog to that of 3.3b. 99:1 er. HPLC condition:
Chiralcel OD-H column, n-hexane/i-PrOH = 95:5, flow rate = 0.5ml/min, wavelength
= 254nm, tR = 23.241 min for minor isomer, tR = 30.632 min for major isomer.
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Colorless oil, 74% yield. 1H NMR (300 MHz, CDCl3): δ 6.24 (dd, J = 9.6, 2.6 Hz,
1H), 6.13 (dd, J = 9.6, 1.2 Hz, 1H), 6.02 – 5.80 (m, 1H), 5.32 – 5.10 (m, 2H), 4.55 (s,
1H), 4.31 (qd, J = 7.1, 3.8 Hz, 4H), 2.67 – 2.53 (m, 2H), 2.42 (dt, J = 19.0, 8.9 Hz,
1H), 1.39 – 1.27 (m, 6H). 13C NMR (75 MHz, CDCl3): δ 167.52, 166.66, 136.51,
135.75, 128.78, 121.78, 117.41, 64.97, 61.47, 61.35, 39.93, 32.44, 13.96, 13.89.
HRMS (ESI) m/z Calcd. for [C19H22NaO3, M+Na]+: 303.1203; Found: 303.1210.
Optical Rotation: [α]22D = +45.32 (c = 0.3, CH2Cl2). The absolute configuration was
assigned by analog to that of 3.3b. 99:1 er. HPLC condition: Chiralcel OD-H column,
n-hexane/i-PrOH = 95:5, flow rate = 1ml/min, wavelength = 254nm, tR = 10.726 min
for major isomer, tR = 12.690 min for minor isomer.
Wax, 20% yield. 1H NMR (500 MHz, CDCl3): δ 8.14 – 8.01 (m, 4H), 7.57 (dd, J =
15.6, 7.7 Hz, 2H), 7.52 – 7.39 (m, 4H), 5.91 (ddt, J = 10.4, 7.0, 5.4 Hz, 2H), 5.66 –
5.54 (m, 1H), 5.15 (dd, J = 28.3, 13.6 Hz, 2H), 4.88 – 4.80 (m, 1H), 4.73 (dd, J = 11.1,
6.2 Hz, 1H), 4.58 (ddd, J = 29.6, 11.1, 6.7 Hz, 2H), 4.10 (s, 1H), 2.92 (dd, J = 6.1, 4.2
Hz, 1H), 2.46 (q, J = 7.1 Hz, 1H), 2.42 – 2.31 (m, 2H), 2.29 – 2.17 (m, 1H), 2.13 –
1.98 (m, 1H). 13C NMR (125 MHz, CDCl3): δ 166.75, 166.35, 136.45, 133.03, 132.95,
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130.20, 130.09, 129.62, 129.54, 128.94, 128.42, 128.39, 126.97, 116.90, 66.92, 65.80,
64.69, 40.73, 35.67, 35.58. HRMS (ESI) m/z Calcd. for [C25H26NaO5, M+Na]+:
429.1672; Found: 429.1685. Optical Rotation: [α]22D = +24.38 (c = 0.2, CH2Cl2).
The absolute configuration was assigned by analog to that of 3.3b. 98:2 er. HPLC
condition: Chiralpak AS-H column, n-hexane/i-PrOH = 95:5, flow rate = 0.5ml/min,
wavelength = 254nm, tR = 21.639 min for minor isomer, tR = 25.266 min for major
isomer.
Colorless oil, 35% yield. 1H NMR (300 MHz, CDCl3): δ 7.30 (dd, J = 5.7, 2.6 Hz,
1H), 6.84 (dd, J = 14.7, 7.9 Hz, 2H), 6.58 (dd, J = 9.6, 2.8 Hz, 1H), 6.03 (ddt, J = 13.7,
10.1, 6.9 Hz, 1H), 5.87 (dd, J = 9.5, 1.5 Hz, 1H), 5.34 – 5.15 (m, 2H), 5.09 (s, 1H),
3.91 (s, 3H), 2.75 – 2.64 (m, 1H), 2.60 – 2.42 (m, 2H). 13C NMR (75 MHz, CDCl3): δ
156.37, 136.71, 133.74, 130.41, 129.19, 126.80, 124.00, 119.40, 116.74, 110.13,
62.23, 55.52, 39.97, 34.05. HRMS (ESI) m/z Calcd. for [C14H16NaO2, M+Na]+:
239.1043; Found: 239.1041. Optical Rotation: [α]22D = +24.66 (c = 0.2, CH2Cl2).
The absolute configuration was assigned by analog to that of 3.3b. >99:1 er. HPLC
condition: Chiralpak AS-H column, n-hexane/i-PrOH = 98:2, flow rate = 0.6 ml/min,
wavelength = 254nm, tR = 37.074 min for major isomer, tR = 53.039 min for minor
isomer.
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Colorless oil, 40% yield. 1H NMR (300 MHz, CDCl3): δ 7.28 – 7.19 (m, 1H), 7.06 –
6.92 (m, 2H), 6.89 (dd, J = 8.3, 0.8 Hz, 1H), 6.09 – 5.90 (m, 1H), 5.85 (ddd, J = 9.8,
2.4, 1.1 Hz, 1H), 5.26 – 5.12 (m, 2H), 4.59 (s, 1H), 3.89 (s, 3H), 2.66 – 2.53 (m, 2H),
2.45 – 2.33 (m, 1H). 13C NMR (75 MHz, CDCl3): δ 154.89, 137.88, 136.61, 129.01,
128.32, 121.68, 120.90, 119.89, 116.67, 110.75, 70.28, 55.56, 39.96, 33.51. HRMS
(ESI) m/z Calcd. for [C14H16NaO2, M+Na]+: 239.1043; Found: 239.1040. Optical
Rotation: [α]22D = +48.33 (c = 0.2, CH2Cl2). The absolute configuration was assigned
by analog to that of 3.3b. >99:1 er. HPLC condition: Chiralpak AS-H column,
n-hexane/i-PrOH = 98:2, flow rate = 0.6 ml/min, wavelength = 254nm, tR = 37.284
min for major isomer, tR = 54.740 min for minor isomer.
3.4.5 Procedures for derivatization of allylation products
OO
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2) 5 mol % Grubbs I




To the solution of 3-2a (0.2 mmol) in 3 mL dry THF was added 9-BBN (0.3
mmol). The reaction mixture was allowed to stir at 24 oC for 3 h, at which time
NaBO3 (0.3 mmol) and 1 mL water were added to the reaction mixture. After stirring
for 1 h, the reaction mixture was quenched by saturated NaHCO3 and extracted by
ethyl acetate (3 x 10 mL). The combined organic layer was dried over Na2SO4,
filtered and concentrated. The crude mixture was purified by chromatography (ethyl
acetate: hexane 1:2) to yield 3.5 in a pure form. Colorless oil, 82% yield. 1H NMR
(300 MHz, CDCl3): δ 7.37 – 7.11 (m, 4H), 5.40 (d, J = 3.9 Hz, 1H), 5.08 (s, 1H), 3.70
(t, J = 6.3 Hz, 2H), 1.90 – 1.54 (m, 9H). 13C NMR (75 MHz, CDCl3): δ 145.78,
145.67, 126.38, 126.34, 118.77, 118.68, 82.98, 79.30, 62.74, 40.25, 34.57, 31.16,
31.05.HRMS (ESI) m/z Calcd. for [C13H17O, M+H]+: 205.1229; Found: 205.1233,
(b) Oxidation to quinone:
To the solution of 3-2i (0.2 mmol) in MeCN (2 mL) and water (1 mL) was added
CAN (0.6 mmol) at 0 oC. The reaction mixture was allowed to stir at 24 oC for 12 h.
The reaction mixture was quenched by saturated NaHCO3 and extracted by ethyl
acetate (3 x 10 mL). The combined organic layer was dried over Na2SO4, filtered and
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concentrated. The crude mixture was purified by chromatography (ethyl acetate:
hexane 1:10) to yield 3.6 in a pure form. Pale yellow solid, 60% yield. 1H NMR (500
MHz, CDCl3): δ 6.65 (s, 2H), 5.84 (ddt, J = 17.0, 10.5, 6.7 Hz, 1H), 5.44 (d, J = 4.7
Hz, 1H), 5.20 – 5.06 (m, 3H), 2.45 – 2.37 (m, 1H), 2.29 (dt, J = 18.8, 9.7 Hz, 1H),
1.83 (dd, J = 7.6, 3.8 Hz, 1H), 1.66 (ddd, J = 19.9, 10.1, 5.7 Hz, 2H). 13C NMR (125
MHz, CDCl3) δ 183.03, 182.97, 150.97, 150.65, 136.15, 135.88, 116.71, 80.47, 77.37,
38.29, 37.61, 31.78. HRMS (ESI) m/z Calcd. for [C13H17O, M+H]+: 217.0865; Found:
217.0860.
(c) Allylation-ring closing metathesis:
To a stirred suspension of sodium hydride (0.15 mmol, 60% in mineral oil) in
THF (1.0 mL) at 0 oC was carefully added 3-3f (0.1 mmol) in 0.5 mL THF. After
stirring at this temperature for 1 h, allyl bromide (0.12 mmol) was added in one
portion. The reaction mixture was allowed to warm to room temperature and stirred
for 12 h. After quenching with a saturated aqueous solution of NH4Cl at 0 ºC, the
mixture was extracted with ether. The combined organic layers were washed with
brine, dried over anhydrous NaSO4 and then concentrated. The crude product was
dissolved in 2 mL toluene. Grubbs I catalyst (5 mol%) was then added to this solution.
The reaction was allowed to stir for 12 h under refluxing. The reaction was quenched
149
by the addition of saturated NaHCO3. The crude mixture was extracted with ethyl
acetate (3 x 10mL). The combined organic layers were washed with brine, dried over
anhydrous NaSO4, filtered and concentrated. Purification by chromatography (ethyl
acetate: hexane 1:10) then yielded 3.7 in a pure form. Colorless oil, 82% yield. 1H
NMR (500 MHz, CDCl3): δ 6.87 (dd, J = 9.9, 3.1 Hz, 1H), 6.81 (q, J = 8.9 Hz, 2H),
5.89 – 5.83 (m, 1H), 5.82 – 5.76 (m, 1H), 5.64 – 5.57 (m, 1H), 5.09 (d, J = 7.7 Hz,
1H), 4.39 – 4.24 (m, 2H), 4.00 – 3.95 (m, 1H), 3.86 (d, J = 8.7 Hz, 3H), 3.81 (d, J =
6.0 Hz, 3H), 2.86 (tdd, J = 10.0, 5.0, 2.7 Hz, 1H), 2.71 – 2.57 (m, 2H). 13C NMR (125
MHz, CDCl3): δ 151.71, 149.22, 131.47, 129.93, 127.66, 123.72, 122.70, 119.54,
111.35, 110.20, 69.50, 69.40, 56.34, 56.16, 39.04, 29.33. HRMS (ESI) m/z Calcd. for
[C16H18NaO3, M+Na]+: 281.1148; Found: 281.1157. Optical Rotation: [α]22D = +52
(c = 0.24, CH2Cl2). 99:1 er. HPLC condition: Chiralcel OD-H column,
n-hexane/i-PrOH = 95:5, flow rate = 0.5ml/min, wavelength = 254nm, tR = 11.550
min for minor isomer, tR= 15.322 min for major isomer.
(d) Bromoetherification:
To the solution of 3-3f (0.2 mmol) in 3 ml dry toluene at 0 oC was added NBS (0.3
mmol). The reaction mixture was allowed to stir at 24 oC for 12 h and quenched by
saturated NaHCO3. The crude mixture was extracted by ethyl acetate (3 x 10 ml),
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washed with brine, dried over anhydrous NaSO4, filtered and concentrated.
Purification by chromatography (ethyl acetate : hexane 1:10) then yielded 3-8 as a
mixture of diastereomers. Colorless oil, 64% yield. 1H NMR (500 MHz, CDCl3): δ
6.82 (dd, J = 19.8, 8.9 Hz, 2H), 5.77 – 5.73 (m, 1H), 5.41 (d, J = 6.2 Hz, 1H), 4.18 –
4.11 (m, 1H), 3.87 (s, 3H), 3.82 (s, 3H), 3.61 (dd, J = 9.8, 4.0 Hz, 1H), 3.45 (dd, J =
9.7, 7.9 Hz, 1H), 3.19 (t, J = 6.7 Hz, 1H), 2.44 (dd, J = 12.3, 5.7 Hz, 1H), 2.29 (ddd, J
= 12.3, 9.6, 7.4 Hz, 1H). 13C NMR (125 MHz, CDCl3): δ 152.06, 149.77, 129.13,
122.57, 120.98, 120.82, 112.10, 111.18, 71.20, 56.61, 56.31, 39.06, 38.76, 35.93.
HRMS (ESI) m/z Calcd. for [C15H17BrNaO3, M+Na]+: 347.0253; Found: 347.0259.
Optical Rotation: [α]22D = +47.5 (c = 0.27, CH2Cl2). >99:1 er. HPLC condition:
Chiralcel OD-H column, n-hexane/i-PrOH = 95:5, flow rate = 0.5ml/min, wavelength
= 254nm, tR =16.808 min for major isomer, tR = 29.084 min for minor isomer.
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Figure 3.1 X-ray analysis of 3-3b







Space group P 2(1)
Unit cell dimensions a = 14.1080(5) α = 90°
b = 5.0112(2) β = 94.2616(16)°
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c = 17.5339(7) ɤ = 90°
Volume 1236.18(8) Å3
Z 2
Density (calculated) 1.157 Mg/m3
Absorption coefficient 0.539 mm-1
F(000) 468
Crystal size 0.309 x 0.089 x 0.067 mm3
Theta range for data collection 2.527 to 74.614°
Index ranges -17<=h<=17, -6<=k<=6, -21<=l<=21
Reflections collected 28571
Independent reflections 5059 [R(int) = 0.0391]
Completeness to theta = 67.679° 100.0 %
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 5059 / 6 / 295
Goodness-of-fit on F2 1.049
Final R indices [I>2sigma(I)] R1 = 0.0439, wR2 = 0.1154
R indices (all data) R1 = 0.0483, wR2 = 0.1218
Absolute structure parameter -0.01(8) *
Largest diff. peak and hole 0.294 and -0.285 e.Å-3
* Bernardinelli, G.; Flack, H. D. Acta Crystallogr., Sect. A 1985, 41, 500-511.
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3.5 Misellaneous
Asymmetric alkynlation reaction has been realized by the use of
cobalt-bisphophine catalyst system. Alkynyl potassium trifluoroboronates 3-11 can be
employed as a nucleophile to engage in enantioselective alkynlative ring openging
reaction of oxabicyclic alkenes 3-1a (Scheme 3.16). After systematic ligand screening,
and solvents screening, the combination of chiral bisphospine DIOP and CoCl2 in
chlorobenzene turned out to be the most effective catalyst system in term of
enantioselectivity and reactivity. The product 3-4a - 3-4d bearing different
substituents on the phenyl ring were well tolerated. The alkynlation with Alkyl
substituents on the alkynl position can be proceeded smoothly and obtained the
products 3-4e - 3-4g in good yield and enantioselectivtiy.
Scheme 3.16 Enantioselective alkynlation of oxabicyclic alkenes
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Vinyl epoxide was also identified to be a suitable substrate for alkyne addition
reaction. The use of alkynyl potassium trifluroboronates and butadiene monnooxide
3-12 can effectively synthesized 1,4-enyne intermediates in the presence of 10mol%
NiCl2(PPh3)2 (Scheme 3.17). The development of an asymmetric version is underway.
Scheme 3.17 Ni catalyzed alkynylation of vinyl epoxide
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The transition metal-catalyzed organic transformations has been extensively
investigated in the past two decades.[104] Traditionally most of the successful
transformations are carried out with precious metals such as Pd, Pt, Rh, Ru, Ir and
Au[105] which are generally toxic, expensive, and less abundant. There has been a
strong push for using the abundant and less expensive transition metals such as Co, Fe,
Ni instead of noble metals as an effort to promote more economical and sustainable
chemical synthesis[85]. Among the less expensive metal catalysts, Cobalt-based
catalysts have been actively explored in a variety of chemical transformations such as
cross-coupling,[89a] C-H activation,[106] alkene functionalization[86][87][88]and many
others[89b]. Therefore, in our study, we mainly focused on exploring new cobalt
catalyzed transformations.[107]
As reviewed in chapter 1, the asymmetric vinylation has been extensively studied
by many research groups. For example, in the field of asymmetric vinylation of
alkenes (Scheme 4.1a), the Hoveyda and Carreira groups have made great
contributions in developing asymmetric allylic substitution reactions. For the
alternative asymmetric vinylation of carbonyls and imines, various moisture and
air-sensitive vinyl organometallic reagents have been explored (Scheme 4.1b).
Typical examples have been reported by Oppolzer, Walsh, Mikami, Shibasaki, Schaus,
Lin, Lam and others.
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Scheme 4.1Asymmetric vinylation of alkenes, carbonyls and imines
Whereas the great potential of these methods for asymmetric vinylation has been
demonstrated, the use of air sensitive vinyl metallic reagents and noble metal catalysts
in most reactions as well as the necessity of multiple step synthesis of the chiral
ligands remain the key bottlenecks that largely limit the practical utility of these
methods. The development of catalytic methods using the more economical and
aboundant base metals will be highly desired, which has served as a key impetus for
the promotion of sustainable chemical synthesis. Herein, we have developed the first
cobalt-catalyzed highly efficient asymmetric vinylation of a wide range of
electrophiles. The catalytic system is widely applicable for activated alkenes,
carbonyls and imines by using commercially available chiral phosphine ligands and
the easy-to-handle vinylboronic acids as the vinylating reagent (Scheme 4.2). The
efficiency, selectivity and operational simplicity of the transformations and the wide
range of electrophiles are expected to render this method important for future progress
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in the synthesis of chiral allylic alcohols and amines which could be used in chemistry,
biology and medicine.
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4.2 Results and discussion
The representative optimization studies for the vinylation of the model substrate
4.1a are summarized in Table 4.1. More recently, our group has developed the
allylation of oxabicyclic alkenes 4.1a by the use of non-precious metal catalysis.[107]
Out of the various non precious metal complexes such as Ni, Fe, Cu, Co were
examined initially (Table 4.1, entries 1-4), the vinylated product was obtained only
with cobalt choride and bis phosphine complex in excellent yield in dioxane as
solvent (Table 4.1, entry 4). The desired product 4.2a was not obtained at all in the
absence of K2CO3 (Table 4.1, entry 5), suggesting the base is required to facilitate
vinyl boronic acid transmetalation step with cobalt chloride. Through a thorough
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screening of various chiral phosphine ligands, it is found that the reaction was
strongly affected by the identity of chiral phosphine ligands. SDP and Me-duphos
ligands shut down the vinylation reaction (Table 4.1, entry 6, 11) completely. While
excellent reactivity was obtained by using DIPAMP, almost racemic product 4.2a was
obtained (Table 4.1, entry 9). The reaction could be catalyzed by using BDPP and
Duanphos in good yield but the enantioselectivity was still far from satisfactory
(Table 4.1, entry 8, 12). To our delight, we were excited to find out that higher
enantioselectivity of 94:6 and 96.5:3.5 was obtained for 4.2a by using
(R)-(S)-Josiphos and (S,S′,R,R′)-TangPhos (Table 4.1, entry 10,13). Other cobalt salts
were also screened, however,they showed no reactivity under the same reaction
conditions (Table 4.1, entry 14).
Table 4.1 Identification of Co-catalyzed asymmetric vinylation
Entry Metal salt Ligand 4.2a Yield (%)[a] e.r.[%][b]
1 NiBr2 DPPP <2 /
2 FeBr2 DPPP <2 /
3 CuCl DPPP <2 /
4 CoCl2 DPPP 80 /
5[c] CoCl2 DPPP <2 /
6 CoCl2 (S)-SDP <2 /
7 CoCl2 (R)-Prophos 56 65:35
8 CoCl2 (S,S)-BDPP 70 85:15
9 CoCl2 (-)-DIPAMP 85 54:46
10 CoCl2 (R)-(S)-Josiphos 70 94:6
11 CoCl2 (S,S)-Me-DuPhos <2 /
12 CoCl2 (R,R',S,S')-DuanPhos 78 80:20
13 CoCl2 (S,S′,R,R′)-TangPhos 90 96.5:3.5
14 Co(OAc)2 (S,S′,R,R′)-TangPhos <2 /
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[a] Isolated yields. [b] Determined by HPLC analysis.[c] Without K2CO3.
With the optimal condition in hand, the scope of the enantioselective ring opening
vinylation was examined (Scheme 4.3). Various vinylation products 4.2a - 4.2d
bearing electron-neutral, electron-withdrawing and electron-donating substituents on
the aryl structure of oxabicycles were produced in excellent yield and
enantioselectivity. Similar reaction efficiency and enantioselectivity were also
obtained for different vinyl boronic acid (Scheme 4.2, 4.2e - 4.2h). It is particularly
noteworthy that alkyl- substituted vinyl reagent could undergo the reaction in high
selectivity as well. (Scheme 4.2, 4.2i).
Scheme 4.3 Scope of enantioselective vinylation of oxabicyclic alkenes[a]
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[a] Reaction conditions: dioxane (0.5 ml), 4-1 (0.1 mmol, 1 equiv.), boronic acid (0.2 mmol, 2
equiv.), CoCl2 (10 mol%), (S,S′,R,R′)-Tangphos (10 mol%), K2CO3 (2 equiv.), 70 oC, N2.
With this highly efficient and robust transformation in hand, we moved on to test
this cobalt catalysis system for the asymmetric vinylation of carbonyls, since the
chiral allylic alcohols products are common structural motifs in various biologically
active molecules and natural products. To our knowledge, only a few examples have
been reported in this research field using precious metal catalysts[14][15][16] and there is
still plenty of room for improvement. We initiated our studies by examining the
catalytic activity of cobalt catalyst system for addition of various vinylboronic acids
to α-ketoesters, the product of which is highly synthetically useful but was not
previously available using vinyl organometallic reagents. After optimization of the
reaction condition, it was identified that the combination of 10 mol% (S,S)-BDPP and
10 mol% CoBr2 at THF under refluxing condition was the most efficient protocol for
the vinylation of simple methyl substituted α-ketoesters in term of reactivity and
enantioselectivity (Scheme 4.4). To evaluate the scope of the reaction, vinylation
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products 4.4a-4.4c bearing electon-neutral, electron-withdrawing, and
electron-donating substituents on the aryl structure were obtained in good yield and
excellent enantioselectity. 2-methyl-vinyl boronic acid can react with α-ketoester
smoothly and obtained the desired product 4.4d in 48% yield and 94.5:5.5 er. The
extension of this catalystic system to other α-ketoesters is underway.
Scheme 4.4 Scope of enantioselective vinylation of ketone esters[a]
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[a] Unless specific statement, reaction conditions: THF (0.5 ml), 4.3 (0.1 mmol, 1 equiv.), vinyl
boronic acid (0.2 mmol, 2 equiv.), CoI2 (10 mol%), (S,S)-BDPP (10 mol%), K2CO3 (2 equiv.), 70
oC, N2, 18h.
The catalytic system could also be applied to the α,β-unsaturated ketoester, The
use of (R,R',S,S')-DuanPhos with CoI2 proved to be the optimal choice. This reaction
turned out to be highly regioselective, and no 1,4-conjugate vinylation product was
obtained. A wide range of α,β-unsaturated ketoester were tested and the results were
summarized in Scheme 4.5. Various vinylation products 4.4e-4.4j bearing
electon-neutral, electron-withdraw, and electron-donating substituents on the aryl
group of ketone ester part were obtained in good yield and excellent enantioselectity.
More importantly, synthetically useful bromo functionalized product 4.4f, 4.4p can be
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accessed in good yield and enantioselectivity. Moreover, the product 4.4k, 4.4m
bearing either heterocycles or diene moiety on the ketoesters were well tolerated. In
addition, various vinyl boronic acids can be used in this reaction to produce product
4.4n, 4.4o, 4.4q in high efficiency under the optimal reaction condition. It is
noteworthy that alkyl substituted vinyl boronic acid led to the desired product 4.4q
with the same level of enantioselectivity and reactivity.
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[a] Unless specific statement, reaction conditions: THF (0.5 ml), 4.3 (0.1 mmol, 1 equiv.),
vinylboronic acid (0.2 mmol, 2 equiv.), CoI2 (10 mol%), (S,S′,R,R′)-Duanphos (10 mol%), K2CO3
(2 equiv.), 70 oC, N2, 18h.
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To our delight, this simple catalyst system could be applied to aldehyde
vinylation (Scheme 4.6). Typical aldehyde substrates were examined, it was found
that aromatic aldehyde showed a lower level of selectivity (87:13 er) but the good
reactivity. For synthetically valuable aliphatic aldehyde, the vinylation products(such
as 4.5b) could be obtained in high yield with good er. The reaction also worked for
alkenyl aldehyde to yield 4.5c in 90% yield and 93:7 er.
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[a] Reaction conditions: THF (0.5ml), 4-5 (0.1mmol, 1 equiv.), 2-phenyl vinylboronic acid
(0.2mmol, 2 equiv.), CoI2 (10 mol%), (S,S)-BDPP (10 mol%), K2CO3 (2 equiv.), 45oC, N2, 48h.
Owing to the ubiquitous existence of the chiral allylic amine moiety in
biologically and pharmacologically active molecules, we examined our cobalt
catalytic system to the asymmetric imines vinylation as well. As the different
protecting groups on amines are known to lead to unique reactivity of imines, we
initiated our studies by the synthesis and examination of various imines with a range
of protecting group. The results are summarized in Table 4.2.
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Table 4.2 Examining reactivity of imines with a variety of protecting group[a]
[a] Unless specific statement, reaction conditions: THF (0.5 ml), 4.3 (0.1 mmol, 1 equiv.),
2-phenyl-vinylboronic acid (0.2 mmol, 2 equiv.), CoI2 (10 mol%), ligand (10 mol%), K2CO3 (2
equiv.), 70 oC, N2, 18h. [b] Isolated yields. [c] Determined by HPLC analysis using a chiral
stationary phase.[d] 10mol% CoBr2 was used. [e] Reaction time is 24h.
Entry imines ligand products yield(%)[b] e.r.[%][c]
1 4.7a DPPP 4.8a <2 /
2 4.7b DPPP 4.8b <2 /
3 4.7c DPPP 4.8c <2 /
4 4.7d DPPP 4.8d <2 /
5 4.7e DPPP 4.8e <2 /
6 4.7f DPPP 4.8f <2 /
7 4.7g DPPP 4.8g <2 /
8 4.7h DPPP 4.8h 60 /
9 4.7h (R)-(S)-Josiphos 4.8h 18 68:32
10 4.7h (R,R',S,S')-DuanPhos 4.8h 25 72.5:27.5
11 4.7h (S,S)-BDPP 4.8h 60 86:14
12 4.7i DPPP 4.8i <2 /
13 4.7j DPPP 4.8j <2 /
14 4.7k DPPP 4.8k 78 /
15 4.7k (S,S)-BDPP 4.8K 60 85:15
16 4.7k (R,R',S,S')-DuanPhos 4.8K 68 96.5:3.5
17[d] 4.7k (R,R',S,S')-DuanPhos 4.8K 68 99.7:0.3
18[e] 4.7K (R,R',S,S')-DuanPhos 4.8K 75 99.7:0.3
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This study started with the vinylation of acyclic imines 4.7(a-h) with 2
equivalent of 2-phenyl-vinylboronic acid at 70 oC in THF for 18h in the presence of
10 mol% CoI2 and 10 mol% achiral bisphosphine ligand DPPP. Given that imines
4.7(a-g) are highly effective substrates for enantioselective Rh, Pd-catalyzed additions
of arylboronic reagents and chiral bisphosphine ligand have provided excellent results
in these types of reactions[108]. However, we were surprised to find that cobalt
bisphosphine catalytic system failed to promote vinylation of imines completely.
What’s more, the particular imines 4.7a, 4.7d, 4.7g underwent significant
decomposition. While appreciable alkenylation was observed with 2-phenolic imine
4.7h in the presence of DPPP, the enantioselectivity of the corresponding product was
only moderate after screening different types of chiral phosphine ligands. The best
result (60% yield, 86:14 er) was obtained by the use of (S,S)-BDPP, however, it was
far from satisfactory.
As shown in Table 4-2, entries 1–11 clearly highlight the difficulties of these
vinylation reaction. The no conversion or low conversion into the desired products
might be explained by the fact that alkenylcobalt species are less stable or less
nucleophilic, which renders the decompostion pathway of alkenylcobalt species
highly competitive with imine addition. On the other hand, it is difficult to improve
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enantioselectivity by using 4.7h. It was possible that E/Z isomerization of the imine at
high temperature, has a negative influence on stereoselectivity in the alkenylation
reaction.[29] In order to verify our assumption, the vinylation of cyclic imine 4.7i, 4.7j,
4.7k that can not undergo E/Z isomerization were examined. The cyclic hydrozones
and N-oxide imine failed to react. Surprisingly, we were delighted to observe that
under conditions identical to those employed for imines 4.7 (a-h), the use of imine
4.7k led to desired product 4.8k in 78% yield. After optimization of reaction
conditions, the enantioriched vinylation product in 68% yield was obtained in the
presence of 10 mol% CoI2 and 10 mol% (R, R', S, S')-DuanPhos. Results showed
different cobalt salts led to different levels of enantioselectivity. When CoBr2 was
used, the enantiomeric ratio was increased to 99.7:0.3. The longer reaction time had a
positive effect on the chemical yield.
With the optimal reaction condition in hand, a variety of highly substituted
benzoxathiazine-2,2-dioxides were examined (Scheme 4.7). Imines containing a
range of arene substituents (including chloro, bromo, methyl and methoxy) at various
positions performed very smoothly, providing vinylation products 4.10(b-e)
in good yield(52-78%) and uniformly excellent enantioselectivity(≥99:1er).
Benzoxathiazine-2,2-dioxide smoothly reacted with various vinylboronic acids
containing alkyl or aryl substituents at the β-carbon to provide vinylation products in
good yields and excellent enantioselectivities (≥ 99:1 er). After evaluation of effect of
electronic property of the aryl substituents at the β-carbon, it was found that there was
a reasonable trend that electron donating group on the phenyl ring at the carbon of
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vinyl boronic acid had a positive effect on the chemical yield, but enantioselectivity
remained the same level (4.10h, 4.10i vs 4.10k).
Scheme 4.7 Scopes of asymmetric vinylation of cyclic imines[a]
[a] Unless specific statement, reaction conditions: THF (0.5 ml), 4.3 (0.1 mmol, 1 equiv.),
vinylboronic acid (0.2 mmol, 2 equiv.), CoI2 (10 mol%), (R,R',S,S')-DuanPhos (10 mol%), K2CO3
(2 equiv.), 70 oC, N2, 24h.
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The proposed catalytic cycles of cobalt-catalyzed vinylation reactions shown in
scheme 4.8. Transmetalation of cobalt salt with vinylboronic acid presumably
generates the vinylcobalt species 4.11, syn-vinylcobaltation of the alkene substrate
4.12 by 4.11 then produces 4.13 as an intermediate. In the presence of chiral
bisphosphine ligand, β-O elimination proceeds to yield 4.14 that in turn is
transformed to 4.15 leading to product 4.2.
Carbonyls and imines vinylation proceeds in a 1.2-addition fashion and the
proposed catalytic cycle is shown in Scheme 4.8b.
Scheme 4.8 Proposed catalytic cycles
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4.3 Conclusion
We have demonstrated, for the first time, a practical and simple cobalt-based
catalytic system that is applicable for highly enantioselective vinylation of wide range
of substrates such as oxabicyclic alkenes, carbonyls (including ketones and aldehydes)
and imines by the use of commercially available cobalt(II) salts, chiral phosphine
ligands and vinylboronic acids. The efficiency, selectivity and operational simplicity
of the transformations, and together with the wide range of electrophiles, are expected
to render this method important for future progress in syntheses of chiral homoallylic
and allylic alcohols and amines, which are useful in chemistry, biology and medicine.
4.4 Experimental section
4.4.1. General information
Chemicals and solvents were purchased from commercial suppliers and used as
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received. 1H and 13C NMR spectra were recorded on a Bruker ACF300 (300 MHz) or
AMX500 (500 MHz) spectrometer. Chemical shifts were reported in parts per million
(ppm), and the residual solvent peak was used as an internal reference: proton
(chloroform δ 7.26), carbon (chloroform δ 77.0) or tetramethylsilane (TMS δ 0.00)
was used as a reference. Multiplicity was indicated as follows: s (singlet), d (doublet),
t (triplet), q (quartet), m (multiplet), dd (doublet of doublet), bs (broad singlet).
Coupling constants were reported in Hertz (Hz). Low resolution mass spectra were
obtained on a Finnigan/MAT LCQ spectrometer in ESI mode, and a Finnigan/MAT
95XL-T mass spectrometer in EI mode. All high resolution mass spectra (HRMS)
were obtained on a Finnigan/MAT 95XL-T spectrometer. For thin layer
chromatography (TLC), Merck pre-coated TLC plates (Merck 60 F254) were used,
and compounds were visualized with a UV light at 254 nm. Further visualization was
achieved by staining with iodine, or potassium permanganate solution followed by
heating using a heat gun. Flash chromatography separations were performed on
Merck 60 (0.040-0.063 mm) mesh silica gel. The enantiomeric ratios (er) of products
were determined by chiral phase HPLC analysis on SHIMAZU HPLC units, including
the following instruments: pump, LC-20AD; detector, SPD-20A; column, Chiralcel
OD-H, Chiralpark AS-H, IC, IE or AD-H. Optical rotations were recorded on an
MRC AP81 automatic polarimeter.
All reactions were carried out under nitrogen atmosphere. All commercially
available reagents listed below were used as received for the reactions without any
purification. THF was dried on alumina columns using a solvent dispensing system.
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Cyclic imines were synthesized according to the literature.[102] Heterobicyclic alkenes
were synthesized according to reported procedure.[103] α,β-unsaturated α-ketoesters
were synthesized according to the reported procedure.[111]
4.4.2. General procedure for cobalt-catalyzed enantioselective vinylation.
4.4.2.1 Cobalt-catalyzed enantioselective vinylationof oxabicyclic alkenes
To a 10 mL vial equipped with a dried stir bar was added cobalt chloride (0.010
mmol), (S,S’,R,R’)-Tangphos (0.010 mmol), anhydrous dioxane (1 mL) in the
glovebox. The reaction mixture was then allowed to stir for 30 min, followed by
addition of vinylboronic acid (0.2 mmol) and oxabicyclic alkene 4.1 (0.10 mmol). The
reaction mixture was taken outside the glovebox and allowed to stir at 70 oC for 16 h.
The crude reaction mixture was concentrated under reduced pressure. The products
4.2 were directly purified by silica gel chromatography (ethyl acetate: hexanes = 1:8).
The enantiopurity of the purified products was analyzed by chiral HPLC (Chiralcel
OD-H).
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White solid, 90% yield. 1H NMR (300 MHz, CDCl3) δ 7.54 – 7.44 (m, 1H), 7.43 –
7.25 (m, 7H), 7.21 – 7.09 (m, 1H), 6.76 – 6.58 (m, 2H), 6.24 – 6.14 (m, 1H), 6.06 (dd,
J = 9.5, 4.7, 1H), 4.97 (d, J = 5.7, 1H), 3.39 (dtd, J = 5.8, 4.7, 1.1, 1H). 13C NMR (75
MHz, CDCl3) δ 136.88, 136.72, 134.19, 132.46, 128.87, 128.47, 127.99, 127.92,
127.62, 127.58, 126.32, 125.86, 70.65, 45.20. HRMS (ESI) m/z Calcd. for
[C18H16NaO, M+Na]+: 271.1093; Found: 271.1086. Optical Rotation: [α]22D = +39 (c
= 0.25, CH2Cl2). The absolute configuration was assigned by reported literature[109].
97.5:2.5er. HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 96:4, flow
rate = 1 ml/min, wavelength = 254nm, tR = 6.146 min for major isomer, tR = 7.563 min
for minor isomer.
White solid, 90% yield. 1H NMR (300 MHz, CDCl3) δ 7.44 – 7.20 (m, 6H), 6.97 (s,
1H), 6.69 (d, J = 15.9, 1H), 6.58 (dd, J = 9.5, 1.1, 1H), 6.25 (dd, J = 15.9, 8.8, 1H),
5.97 (dd, J = 9.5, 4.5, 1H), 4.89 (s, 1H), 3.42 – 3.30 (m, 1H), 2.32 (d, J = 3.3, 6H).13C
NMR (75 MHz, CDCl3) δ 136.84, 136.27, 136.10, 134.27, 133.82, 130.07, 128.45,
127.80, 127.76, 127.45, 126.50, 126.30, 70.58, 45.36, 19.62, 19.38. HRMS (ESI) m/z
Calcd. for [C20H20NaO, M+Na]+: 299.1406; Found: 299.1412. Optical Rotation:
[α]22D = +11.00 (c = 0.45, CH2Cl2). The absolute configuration was assigned by the
analogue 4.1a. 96:4 er. HPLC condition: Chiralpark OD-H column, n-hexane/i-PrOH
= 95:5, flow rate = 1 ml/min, wavelength = 254nm, tR = 16.557 min for minor isomer,
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tR= 23.957 min for major isomer.
White solid, 90% yield. 1H NMR (300 MHz, CDCl3) δ 7.53 – 7.22 (m, 6H), 6.97 (dd,
J = 10.5, 7.6, 1H), 6.68 (d, J = 15.9, 1H), 6.49 (d, J = 9.5, 1H), 6.19 – 6.00 (m, 2H),
5.04 – 4.89 (m, 1H), 3.45 – 3.28 (m, 1H).13C NMR (75 MHz, CDCl3) δ 151.47 (d, J =
30.0 Hz, 1F), 149.73 (d, J = 17.1 Hz, 1F), 136.34, 135.14, 129.62, 129.59, 128.60,
128.53, 127.84, 126.32, 125.95, 125.90, 124.31, 115.34, 115.09, 114.85, 114.01,
69.75, 44.61. HRMS (ESI) m/z Calcd. for [C18H13F2O, M-H]: 283.0940; Found:
283.0935. Optical Rotation: [α]22D = +93.67 (c = 0.30, CH2Cl2). The absolute
configuration was assigned by the analogue 4.1a. 96:4 er. HPLC condition: Chiralcel
OD-H column, n-hexane/i-PrOH = 95:5, flow rate = 1 ml/min, wavelength = 254nm,
tR= 26.216 min for minor isomer, tR= 16.417 min for major isomer.
Colorless oil, 91% yield. 1H NMR (300 MHz, CDCl3) δ 7.56 – 7.45 (m, 2H), 7.43 –
7.25 (m, 3H), 7.10 (dd, J = 9.8, 3.0, 1H), 6.83 (d, J = 2.2, 2H), 6.71 (d, J = 6.8, 1H),
6.18 – 5.96 (m, 3H), 5.52 – 5.40 (m, 2H), 5.31 (ddd, J = 6.0, 2.8, 1.4, 2H), 5.20 (d, J =
3.9, 1H), 4.65 – 4.49 (m, 4H), 3.37 (ddd, J = 7.0, 5.1, 2.8, 1H). 13C NMR (75 MHz,
CDCl3) δ 149.70, 148.76, 137.25, 133.47, 133.42, 132.08, 128.78, 128.46, 128.40,
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127.26, 126.25, 125.59, 122.84, 121.48, 117.46, 117.20, 113.04, 112.49, 69.91, 63.94,
44.11. HRMS (ESI) m/z Calcd. For [C24H24NaO, M+Na]: 383.1725; Found:
383.1726. Optical Rotation: [α]22D = +57.50 (c = 0.45, CH2Cl2). The absolute
configuration was assigned by the analogue 4.1a..97:3 er. HPLC condition: Chiralcel
OD-H column, n-hexane/i-PrOH = 98:2, flow rate = 1ml/min, wavelength = 254nm,
tR = 65.379 min for minor isomer, tR = 71.298 min for major isomer.
White solidl, 88% yield. 1H NMR (500 MHz, CDCl3) δ 7.53 – 7.45 (m, 1H), 7.37 –
7.23 (m, 4H), 7.15 (dd, J = 5.6, 3.1, 1H), 6.85 (dd, J = 6.6, 4.9, 2H), 6.62 (d, J = 15.9
Hz, 1H), 6.59 (d, J = 9.7 Hz, 1H), 6.04 (dd, J = 6.1, 3.4 Hz, 1H), 6.01 (dd, J = 12.5,
5.5 Hz, 1H). 4.94 (dd, J = 8.5, 6.0, 1H), 3.82 (s, 3H), 3.37 – 3.27 (m, 1H). 13C NMR
(75 MHz, CDCl3) δ 159.18, 136.97, 133.76, 129.10, 127.90, 127.85, 127.49, 127.46,
126.26, 125.79, 123.25, 113.86, 70.59, 55.22, 45.20. HRMS (ESI) m/z Calcd. for
[C19H18NaO2, M+Na]: 301.1199; Found: 301.1200. Optical Rotation: [α]22D = +97 (c
= 0.30, CH2Cl2). The absolute configuration was assigned by the analogue4.1a.
97.5:2.5 er. HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 95:5, flow
rate = 1 ml/min, wavelength = 254 nm, tR = 21.588 min for minor isomer, tR = 22.838
min for major isomer.
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Pale yellow solid, 95% yield. 1H NMR (500 MHz, CDCl3) δ 7.42 (d, J = 1.6 Hz, 1H),
7.39 (d, J = 0.8 Hz, 2H), 7.37 – 7.27 (m, 3H), 7.26 (s, 2H). 6.65 (d, J = 15.9, 1H), 6.60
(d, J = 9.7, 1H), 6.11 (dd, J = 15.8, 8.9, 1H), 6.04 (dd, J = 9.5, 4.7, 1H), 4.94 (d, J =
5.6, 1H), 3.36 (dt, J = 9.4, 5.3, 1H), 2.35 (s, 3H). 13C NMR (75 MHz, CDCl3) δ
137.44, 136.94, 134.19, 132.49, 129.15, 129.00, 127.93, 127.87, 127.52, 126.28,
126.21, 125.82, 124.59, 70.61, 45.20, 21.11. HRMS (ESI) m/z Calcd. for
[C19H18NaO, M+Na]: 285.1250; Found: 285.1255. Optical Rotation: [α]22D = +32.44
(c = 0.30, CH2Cl2). The absolute configuration was assigned by the analogue 4.1a.
97.5:2.5 er. HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 95:5, flow
rate = 1 ml/min, wavelength = 254nm, tR = 17.826 min for minor isomer, tR = 15.001
min for major isomer.
White solid, 90% yield. 1H NMR (500 MHz, CDCl3) δ 7.47 (dd, J = 8.1, 4.8, 1H),
7.37 – 7.26 (m, 4H), 7.19 – 7.10 (m, 1H), 7.04 – 6.94 (m, 2H), 6.63 (d, J = 27.4, 1H),
6.62 (s,1H), 6.11 (dd, J = 15.9, 8.9, 1H), 6.02 (dd, J = 9.5, 4.8, 1H), 4.94 (s, 1H), 3.40
– 3.28 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 162.33 (d, J = 247.2 Hz)., 136.89,
132.93, 132.49, 128.83, 128.12, 128.02, 127.92, 127.86, 127.73, 126.44, 125.94,
125.76, 115.51, 115.34, 70.75, 45.22. HRMS (ESI) m/z Calcd. for [C18H14FO, M-H]:
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265.1034; Found: 265.1036. Optical Rotation: [α]22D = +31.88 (c = 0.30, CH2Cl2).
The absolute configuration was assigned by the analogue 4.1a. 97.5:2.5er. HPLC
condition: Chiralcel OD-H column, n-hexane/i-PrOH = 95:5, flow rate = 0.5ml/min,
wavelength = 254nm, tR = 13.745 min for minor isomer, tR = 14.780 min for major
isomer.
White solid, 85% yield 1H NMR (500 MHz, CDCl3) δ 7.49 – 7.42 (m, 1H), 7.34 –
7.24 (m, 6H), 7.18 – 7.09 (m, 1H), 6.67 – 6.56 (m, 2H), 6.19 (dd, J = 15.9, 8.9, 1H),
6.01 (dd, J = 9.5, 4.6, 1H), 4.94 (d, J = 5.3, 1H), 3.42 – 3.27 (m, 1H). 13C NMR (125
MHz, CDCl3) δ 136.82, 135.35, 133.22, 132.82, 132.46, 128.68, 128.17, 128.06,
127.81, 127.59, 126.89, 126.48, 125.97, 70.76, 45.24. HRMS (ESI) m/z Calcd. for
[C18H14ClO, M-H]: 281.0739; Found: 281.0738. Optical Rotation: [α]22D = +69.67 (c
= 0.25, CH2Cl2). The absolute configuration was assigned by the analogue 4.1a.
97:3er. HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 97:3, flow rate
= 1ml/min, wavelength = 254nm, tR = 15.953 min for minor isomer, tR = 17.156 min
for major isomer.
Colorless oil, 90% yield. 1H NMR (300 MHz, CDCl3) δ 7.48 (dt, J = 7.6, 3.7, 1H),
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7.37 – 7.22 (m, 2H), 7.12 (dd, J = 5.1, 3.6, 1H), 6.54 (d, J = 9.6, 1H), 5.98 (dd, J = 9.6,
4.8, 1H), 5.74 (dd, J = 15.5, 6.9, 1H), 5.34 (ddd, J =15.5, 8.8, 1.0, 1H), 4.84 (d, J =
5.8, 1H), 3.20 – 2.98 (m, 1H), 1.73 (d, J = 9.5, 4H), 1.30 (t, J = 11.7, 3H), 1.20 – 1.04
(m, 3H). 13C NMR (75 MHz, CDCl3) δ 142.33, 137.05, 132.53, 129.66, 127.77,
127.69, 127.06, 126.12, 125.88, 122.86, 70.13, 44.70, 40.81, 33.09, 32.95, 25.99,
25.88. HRMS (ESI) m/z Calcd. for [C18H22NaO, M+Na]+: 277.1563; Found:
277.1557. Optical Rotation: [α]22D = +18.55 (c = 0.30, CH2Cl2). The absolute
configuration was assigned by the analogue 4.1a. 97:3 er. HPLC condition: Chiralcel
OD-H column, n-hexane/i-PrOH = 95:5, flow rate = 1 ml/min, wavelength = 254nm,
tR= 6.288 min for minor isomer, tR =7.077 min for major isomer.
4.4.2.2 Cobalt-catalyzed enantioselective vinylation of α-ketoesters
To a 10 mL vial equipped with a dried stir bar was added cobalt iodide (0.010
mmol), (1S, 1’S, 2R, 2’R)-duanphos (0.010 mmol) or S,S’-BDPP, anhydrous THF (0.5
mL) in the glovebox. The reaction mixture was then allowed to stir for 30 min,
followed by addition of vinylboronic acid (0.2 mmol) and ketone 4.3, (0.10 mmol).
The reaction mixture was taken outside the glovebox and allowed to stir at 70 oC for
24h. The crude reaction mixture was concentrated under reduced pressure. The
products 4.4 were directly purified by silica gel chromatography (ethyl
acetate:hexanes = 1:10). The enantiopurity of the purified products was analyzed by
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chiral HPLC (Chiralcel OD-H; AS-H, AD-H).
Colorless liquid, yield: 60%. 1H NMR (500 MHz, CDCl3) δ 7.38 (dd, J = 8.6, 5.5 Hz, 2H),
7.03 (t, J = 8.7 Hz, 2H), 6.79 (d, J = 15.9 Hz, 1H), 6.28 (d, J = 15.9 Hz, 1H), 4.40 – 4.18 (m,
2H), 3.51 (s, 1H), 1.60 (s, 3H), 1.35 (t, J = 7.1 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ δ
175.54, 162.46 (d, JFC = 247.2 Hz), 132.55 (d, JFCCCC= 3.4 Hz), 130.62 (d, JFCCCCC = 2.2 Hz),
128.29, 128.23 (d, JFCCC = 8.0 Hz), 115.48 (d, JFCC= 21.6 Hz), 74.42, 62.40, 26.36, 14.15.
HRMS(ESI): m/z Calcd. for [C13H15FNaO3, M+Na]+: 261.0903; Found: 261.0895. Optical
Rotation: [α]22D = -17.0 (c = 0.21, MeOH). The absolute configuration was assigned
by analog to that of 4.3b. 95.5:4.5 er. HPLC condition: Chiralpak OJ-H column,
n-hexane/i-PrOH = 95:5, flow rate = 1ml/min, wavelength = 254nm, tR = 10.065 min
for minorisomer, tR = 12.880 min for major isomer.
Colorless oil, yield: 75%. 1H NMR (500 MHz, CDCl3) δ 7.35 (d, J = 8.7 Hz, 2H),
6.88 (d, J = 8.6 Hz, 2H), 6.76 (d, J = 15.9 Hz, 1H), 6.22 (d, J = 15.8 Hz, 1H), 4.41 –
4.16 (m, 2H), 3.83 (s, 3H), 3.47 (s, 1H), 1.60 (s, 3H), 1.34 (t, J = 7.1 Hz, 3H). 13C
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NMR (125 MHz, CDCl3) δ 175.73, 159.43, 129.14, 128.84, 128.74, 127.89, 114.02,
74.48, 62.28, 55.30, 26.29, 14.15. HRMS(ESI): m/z Calcd. for [C14H18NaO4,
M+Na]+: 273.1103; Found: 273.1095. Optical Rotation: [α]22D = -26.7 (c = 0.21,
MeOH). The absolute configuration was assigned by analog to that of 4.3b. 95: 5 er.
HPLC condition: Chiralpak OJ-H column, n-hexane/i-PrOH = 95:5, flow rate =
1ml/min, wavelength = 254nm, tR = 24.337 min for minorisomer, tR = 26.529 min for
major isomer.
Colorless oil, yield: 60%. 1H NMR (300 MHz, CDCl3) δ 7.46 – 7.25 (m, 5H), 6.85 (d,
J = 15.9 Hz, 1H), 6.38 (d, J = 15.9 Hz, 1H), 4.45 – 4.18 (m, 2H), 3.52 (s, 1H), 1.63 (s,
3H), 1.36 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 175.52, 136.27, 130.78,
129.32, 128.50, 127.74, 126.62, 74.41, 62.31, 26.23, 14.08. HRMS(ESI): m/z Calcd.
for [C13H16NaO3, M+Na]+: 243.0997; Found: 243.0988. Optical Rotation: [α]22D =
-56.83 (c = 0.17, MeOH). The absolute configuration was assigned by x-ray
crystallography of its hydrolyzed form. 95:5 er. HPLC condition: Chiralpak OJ-H
column, n-hexane/i-PrOH = 96:4, flow rate = 1ml/min, wavelength = 254nm, tR
=18.443min for minor isomer, tR= 21.197min for major isomer.
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Colorless oil, yield: 48%. 1H NMR (500 MHz, CDCl3) δ 7.44 – 7.34 (m, 5H), 5.88
(dq, J = 15.3, 6.6 Hz, 1H), 5.65 (dq, J = 15.3, 1.6 Hz, 1H), 5.26 (d, J = 12.3 Hz, 1H),
5.20 (d, J = 12.3 Hz, 1H), 3.25 (s, 1H), 1.72 (dd, J = 6.6, 1.6 Hz, 3H), 1.52 (s, 3H).
13C NMR (125 MHz, CDCl3) δ 175.75, 135.36, 132.54, 128.62, 128.43, 127.97,
125.98, 74.30, 67.55, 25.82, 17.49. HRMS(ESI): m/z Calcd. for [C13H16NaO3,
M+Na]+: 243.0997; Found: 243.0991. Optical Rotation: [α]22D = -11.0 (c = 0.14,
MeOH). The absolute configuration was assigned by analog to that of 4.4e. 95:5 er.
HPLC condition: Chiralpak OJ-H column, n-hexane/i-PrOH = 94.5:5.5, flow rate =
1ml/min, wavelength = 227nm, tR =19.720min for minorisomer, tR = 21.617min for
major isomer.
Colorless oil, 66% yield. 1H NMR (300 MHz, CDCl3) δ 7.49 – 7.43 (m, 2H), 7.43 –
7.26 (m, 5H), 6.96 - 6.84 (m, 4H), 6.50 (d, J = 15.8, 1H), 6.36 (d, J = 15.8, 1H), 3.90
(s, 3H), 3.87 – 3.83 (m, 3H), 3.79 (s, 1H). 13C NMR (75 MHz, CDCl3) δ 174.46,
159.45, 136.19, 129.94, 129.59, 128.87, 128.55, 128.51, 127.96, 127.87, 126.72,
126.36, 126.14, 113.93, 55.22, 53.52. HRMS(ESI) m/z Calcd. for [C20H20NaO4,
M+Na]+: 347.1254; Found: 347.1267. Optical Rotation: (S, S’)-BDPP: [α]22D = -6.15
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(c = 0.1, CH2Cl2). (1S, 1’S, 2R, 2’R)-duanphos: [α]22D = +16.5 (c = 0.3, CH2Cl2). The
absolute configuration was assigned by analog to that of 4.4e. 95.6:4.3 er. (1S, 1’S, 2R,
2’R)-duanphos: HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 99:1,
flow rate = 1ml/min, wavelength = 254nm, tR = 22.322 min for major isomer, tR =
35.907 min for minor isomer.
Colorless oil, 50% yield. 1H NMR (300 MHz, CDCl3) δ 7.53 – 7.42 (m, 2H), 7.41 –
7.24 (m, 7H), δ 6.89 (d, J = 34.3 Hz, 1H).6.88 (d, J = 2.6 Hz, 1H), 6.48 (d, J = 1.8 Hz,
1H), 6.44 (d, J = 1.7 Hz, 1H), 3.91 (s, 3H), 3.82 (s, 1H). 13C NMR (75 MHz, CDCl3)
δ 174.15, 136.02, 134.65, 130.17, 128.96, 128.86, 128.69, 128.55, 128.13, 128.00,
127.95, 126.74, 53.65. HRMS (ESI) m/z Calcd. for [C19H16ClO3, M-H]-: 327.0793;
Found: 327.0784. Optical Rotation: [α]22D = +11.5 (c = 0.15, CH2Cl2). The absolute
configuration was assigned by analog to that of 4.4e. 95.6:4.3 er. HPLC condition:
Chiralcel OD-H column, n-hexane/i-PrOH = 99:1, flow rate = 1ml/min, wavelength =
254nm, tR= 22.322 min for major isomer, tR = 35.907 min for minor isomer.
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Pale yellow solid, 60% yield.1H NMR (500 MHz, CDCl3) δ 7.45 (dt, J = 23.6, 8.8,
4H), 7.38 – 7.23 (m, 5H), 6.92 (d, J = 15.9 Hz, 1H), 6.86 (d, J = 15.9 Hz, 1H), 6.49 (s,
1H), 6.46 (d, J = 7.0 Hz, 1H). 3.90 (s,3H). 13C NMR (125 MHz, CDCl3) δ 174.19,
136.11, 135.20, 131.73, 130.29, 129.20, 129.02, 128.63, 128.35, 128.20, 128.09,
126.83, 121.83, 53.73. HRMS (ESI) m/z Calcd. for [C19H16BrO3, M-H]-: 371.0288;
Found: 371.0290. Optical Rotation: [α]22D = -4.5 (c = 0.2, CH2Cl2). The absolute
configuration was assigned by by analog to that of 4.4e. 95.5:4.5 er. HPLC condition:
Chiralcel OD-H column, n-hexane/i-PrOH = 99:1, flow rate = 1ml/min, wavelength =
254nm, tR =29.640 min for minor isomer, tR = 38.409 min for major isomer.
Colorless oil, 62% yield. 1H NMR (300 MHz, CDCl3) δ 7.52 – 7.26 (m, 8H), 7.12 –
7.00 (m, 2H), 6.93 (d, J = 9.7 Hz, 1H), 6.88 (d, J = 9.6 Hz, 1H)., 6.44 (d, J = 5.0 Hz,
1H), 6.43 (d, J = 36.6 Hz, 1H), 3.91 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 174.25,
136.06, 132.31, 130.10, 128.93, 128.53, 128.35, 128.25, 128.07, 127.97, 126.73,
115.60, 115.31, 53.61. HRMS (ESI) m/z Calcd. for [C19H16FO3, M-H]-:311.1089;
Found: 311.1086. Optical Rotation: [α]22D = -7.3 (c = 0.25 CH2Cl2). The absolute
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configuration was assigned by analog to that of 4.4e. 97:3 er. HPLC condition:
Chiralcel OD-H column, n-hexane/i-PrOH = 99:1, flow rate = 1ml/min, wavelength =
254nm, tR= 25.508 min for minor isomer, tR =32.382 min for major isomer.
Colorless oil, 52% yield. 1H NMR (500 MHz, CDCl3) δ 7.45 (d, J = 7.5, 2H), 7.38 –
7.33 (m, 4H), 7.32 – 7.24 (m, 1H), 7.16 (d, J = 7.9, 2H), 6.91 (s, 1H), 6.90 (d, J = 32.4
Hz, 1H), 6.49 (d, J = 15.8 Hz, 1H), 6.43 (d, J = 15.8 Hz, 1H), 3.89 (d, J = 3.8, 3H),
3.78 (s, 1H), 2.37 (s, 3H). 13C NMR (125MHz, CDCl3) δ 174.49, 137.91, 136.28,
133.44, 130.11, 129.32, 128.61, 127.98, 127.45, 126.82, 126.73, 53.61, 21.24. HRMS
(ESI) m/z Calcd. for [C20H20NaO3, M+Na]+:331.1305; Found:331.1312. Optical
Rotation: [α]22D = -12.6 (c = 0.16, CH2Cl2). The absolute configuration was assigned
by analog to that of 4.4e. 96:4 er. HPLC condition: Chiralcel OD-H column,
n-hexane/i-PrOH = 99:1, flow rate = 1ml/min, wavelength = 254nm, tR = 23.341 min
for minor isomer, tR = 25.713 min for major isomer.
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Pale yellow solid, 58% yield. 1H NMR (500 MHz, CDCl3) δ 7.49 – 7.41 (m, 3H),
7.36 (m, 2H), 7.32 – 7.21 (m, 4H), 6.91 (d, J = 15.8 Hz, 1H), 6.86 (s, 1H), 6.50 (d, J =
15.8 Hz, 1H), 6.46 (d, J = 15.9 Hz, 2H). 3.90 (s, 3H). 13C NMR (125 MHz, CDCl3) δ
174.18, 138.14, 136.09, 134.57, 130.35, 129.92, 129.83, 128.83, 128.63, 128.15,
128.09, 127.92, 126.83, 126.57, 125.22, 53.75. HRMS (ESI) m/z Calcd. for
[C19H16ClO3, M-H]-: 327.0793; Found: 327.0784 Optical Rotation: [α]22D = -3.7 (c =
0.2, CH2Cl2). The absolute configuration was assigned by analog to that of 4.4e.
96.5:3.5 er. HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 99:1, flow
rate = 1ml/min, wavelength = 254nm, tR = 32.055 min for minor isomer, tR = 34.134
min for major isomer.
Colorless oil, 66% yield. 1H NMR (300 MHz, CDCl3) δ 7.46 – 7.44 (m, 2H), 7.41 –
7.24 (m, 7H), δ 6.89 (d, J = 34.3 Hz, 1H).6.88 (d, J = 2.6 Hz, 1H), 6.48 (d, J = 1.8 Hz,
1H), 6.45 (d, J = 1.7 Hz, 1H), 3.91 (s, 3H), 3.82 (s, 1H). 13C NMR (75 MHz, CDCl3)
δ 174.15, 145.12, 136.02, 134.65, 133.57, 130.17, 128.95, 128.86, 128.69, 128.54,
128.13, 127.99, 127.95, 126.73, 53.65. HRMS (ESI) m/z Calcd. For [C19H16ClO3,
M-H]-: 327.0793; Found: 327.0791. Optical Rotation: [α]22D = -7.67 (c = 0.12,
CH2Cl2). The absolute configuration was assigned by x-ray crystallography. 96.5:3.5
er. HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 99:1, flow rate =
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1ml/min, wavelength = 254nm, tR = 27.238 min for minor isomer, tR = 34.185 min for
major isomer.
Pale yellow solid, 56% yield. 1H NMR (500 MHz, CDCl3) δ 7.55 (d, J =7.6, 1H),
7.52 – 7.43 (m, 3H), 7.41 – 7.27 (m, 4H), 7.22 (t, J = 7.5, 1H), 6.93 (d, J = 15.8 Hz,
1H), 6.87 (s, 1H), 6.74 (d, J = 15.6 Hz, 1H), 6.48 (d, J = 15.8 Hz, 1H). 3.92 (s, 3H),
3.84 (s, 1H). 13C NMR (125 MHz, CDCl3) δ 174.14, 153.86, 136.13, 130.37, 130.06,
128.62, 128.07, 126.84, 124.82, 122.88, 121.07, 118.55, 110.92, 106.00, 53.82.
HRMS (ESI) m/z Calcd. for [C21H18NaO4, M+Na]+: 357.1097; Found: 357.1111.
Optical Rotation: [α]22D = -13.45(c = 0.3, CH2Cl2). The absolute configuration was
assigned by analog to that of 4-4e. 96:4 er. HPLC condition: Chiralcel OD-H column,
n-hexane/i-PrOH = 99:1, flow rate = 1ml/min, wavelength = 254nm, tR = 19.580 min
for minor isomer, tR= 21.822 min for major isomer.
Pale yellow solid, 40% yield. 1H NMR (500 MHz, CDCl3) δ 7.43 (m, 4H), 7.35 (m,
H), 7.27 (m, 2H), 6.90 (d, J = 15.8 Hz, 1H), 6.84 (dd, J = 15.6, 10.6 Hz, 1H), 6.71 (dd,
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J = 15.0, 10.7 Hz, 1H), 6.64 (d, J = 15.6 Hz, 1H), 6.43 (d, J = 15.8 Hz, 1H), 6.09 (d, J
= 15.0 Hz, 1H). 4.39 – 4.28 (m, 2H), 3.76 (s, 1H), 1.37 (t, J = 7.2, 3H). 13C NMR
(125 MHz, CDCl3) δ 173.86, 137.06, 133.95, 132.35, 130.55, 129.99, 128.63, 128.59,
127.93, 127.75, 127.71, 126.80, 126.48, 62.94, 14.18. HRMS (ESI) m/z Calcd. for
[C21H20NaO3, M+Na]+: 343.1305; Found: 343.1314. Optical Rotation: [α]22D = -5.6
(c = 0.5, CH2Cl2). The absolute configuration was assigned by analog to that of 4.4e.
92:8 er. HPLC condition: Chiralpak AS-H column, n-hexane/i-PrOH = 99:1, flow rate
= 1ml/min, wavelength = 254nm, tR = 25.005 min for minor isomer, tR = 31.829 min
for major isomer.
Colorless oil, 60% yield. 1H NMR (500 MHz, CDCl3) δ 7.48 (s, 1H), 7.46 (s, 1H),
7.40 (m, 2H), 7.31 (s, 1H), 7.29 (d, J = 2.6 Hz, 1H), 6.88 (d, J = 8.9 Hz, 1H), 6.84 (d,
J = 8.9 Hz, 1H), 6.46 (d, J = 15.8 Hz, 1H), 6.37 (d, J = 15.8 Hz, 1H). 3.90 (s, 3H). 13C
NMR (125 MHz, CDCl3) δ 174.11, 163.59, 161.62, 135.15, 132.31, 131.73, 129.13,
129.04, 128.42, 128.35, 128.33, 127.93, 121.87, 115.64, 115.47, 53.72. HRMS (ESI)
m/z Calcd. for [C19H15BrFO3, M-H]-: 389.0194; Found: 389.0190. Optical Rotation:
[α]22D = -14.83 (c = 0.3, CH2Cl2). The absolute configuration was assigned by analog
to that of 4.4e. 96:4 er. HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH =
99:1, flow rate = 1ml/min, wavelength = 254nm, tR = 36.688 min for minor isomer, tR
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=39.461 min for major isomer.
Colorless oil, 65% yield. 1H NMR (300 MHz, CDCl3) δ 7.49 – 7.39 (m, 2H), 7.39 –
7.24 (m, 3H), 6.87 (d, J= 15.9, 1H), 6.42 (d, J = 15.9, 1H), 6.07 – 5.93 (m, 1H), 5.78
(dq, J = 15.3, 1.5, 1H), 3.87 (s, 3H), 3.83 (s, 1H), 1.79 (dd, J = 6.5, 1.6, 3H). 13C
NMR (75 MHz, CDCl3) δ 174.64, 136.26, 130.34, 129.61, 128.76, 128.48, 128.37,
127.77, 126.94, 126.67, 126.35, 53.33, 17.58. HRMS (ESI) m/z Calcd. for
[C14H16NaO3, M+Na]+: 255.0992; Found: 255.0987. Optical Rotation: [α]22D =
+24.38 (c = 0.2, CH2Cl2). The absolute configuration was assigned by analog to that
of 4-4e. 95.5: 4.5 er. HPLC condition: Chiralpak AS-H column, n-hexane/i-PrOH =
99:1, flow rate = 1ml/min, wavelength = 254nm, tR = 16.817 min for minor isomer, tR
= 20.036 min for major isomer.
Colorless oil, 55% yield. 1H NMR (500 MHz, CDCl3) δ 7.60 (d, J = 8.2, 2H), 7.54 (d,
J = 8.2, 2H), 7.45 (d, J = 7.7, 2H), 7.36 (t, J = 7.6, 2H), 7.30 (dd, J = 7.3, 1H), 6.93 (d,
J = 5 Hz, 1H), 6.92 (d, J = 5 Hz, 1H), 6.58 (d, J = 15.8, 1H), 6.47 (d, J = 15.8, 1H),
3.91 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 174.06, 139.76, 136.05, 131.06, 130.46,
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128.81, 128.64, 128.14, 128.04, 126.98, 126.83, 125.57, 125.54, 53.76. 9F NMR (282
MHz, CDCl3) δ -62.52. HRMS (ESI) m/z Calcd. for [C20H16F3O3,
M-H]-:361.1057;Found: 361.1063. Optical Rotation: [α]22D = -24.66 (c = 0.2,
CH2Cl2). The absolute configuration was assigned by analog to that of 4.4e. 95.5:4.5
er. HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 99:1, flow rate = 1
ml/min, wavelength = 254nm, tR = 25.121 min for minor isomer, tR = 29.647 min for
major isomer.
4.4.2.3 Cobalt-catalyzed enantioselective vinylation of aldehydes
To a 10 mL vial equipped with a dried stir bar was added cobalt iodide (0.010
mmol), (S,S)-BDPP (0.010 mmol), anhydrous THF (0.5 mL) in the glovebox. The
reaction mixture was then allowed to stir for 30 min, followed by addition of
vinylboronic acid (0.2 mmol) and imine 4.7, (0.10 mmol). The reaction mixture was
taken outside the glovebox and allowed to stir at 70 oC for 24h. The crude reaction
mixture was concentrated under reduced pressure. The products 4.8 were directly
purified by silica gel chromatography(ethyl acetate:hexanes = 1:10).The enantiopurity
of the purified products was analyzed by chiral HPLC (Chiralcel OD-H).
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Colorless oil, 75% yield. 1H NMR (400 MHz, CDCl3): δ 7.23-7.43 (m, 10H), 6.68 (d,
J = 15.6 Hz, 1H), 6.37 (dd, J = 6.4, 16.0 Hz, 1H), 5.37 (d, J = 6.8 Hz, 1H), 2.12 (br, s,
1H); 13C NMR (100 MHz, CDCl3): δ 143.0, 136.8, 131.8, 130.8, 128.9, 128.8, 128.0,
126.9, 126.6, 75.4. Optical Rotation: [α]22D = +12.66 (c = 0.4, CHCl3). The absolute
configuration was assigned by reported literature[110]. 87:13 er. HPLC condition:
Chiralcel OD-H column, n-hexane/i-PrOH = 90:10, flow rate = 0.9 ml/min,
wavelength = 254nm, tR = 16.418 min for minor isomer, tR = 21.374 min for major
isomer.
Colorless oil, 78% yield. 1H NMR (500 MHz, CDCl3) δ 7.57 – 7.26 (m, 10H), 6.73 (d,
J = 16.0 Hz, 1H), 6.22 (dd, J = 15.9, 6.2 Hz, 1H), 4.78 – 4.61 (m, 2H), 4.61 – 4.49 (m,
1H), 3.65 (dd, J = 9.6, 3.3 Hz, 1H), 3.59 – 3.47 (m, 1H). 13C NMR (125 MHz, CDCl3)
δ 137.83, 136.62, 131.77, 128.56, 128.52, 127.89, 127.85, 127.76, 126.53, 74.18,
73.46, 71.40. Optical Rotation: [α]22D = +8.54 (c = 0.4, CHCl3). The absolute
configuration was assigned by the analogue 4.6a. 91:9 er. HPLC condition: Chiralcel
OD-H column, n-hexane/i-PrOH = 90:10, flow rate = 0.9 ml/min, wavelength =
254nm, tR= 27.532 min for minor isomer, tR = 37.651 min for major isomer.
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Colorless oil, 88% yield. 1H NMR (500 MHz, CDCl3) δ 7.67 (d, J = 7.5 Hz, 2H), 7.52
– 7.28 (m, 8H), 6.82 (d, J = 15.9 Hz, 1H), 6.38 (dd, J = 15.9, 6.0 Hz, 1H), 5.05 (d, J =
5.5 Hz, 1H), 2.38 (s, 1H). 13C NMR (125 MHz, CDCl3) δ 136.26, 134.99, 132.69,
129.16, 128.66, 128.56, 128.49, 128.31, 128.20, 128.12, 126.76, 77.99. Optical
Rotation: [α]22D = +10.46 (c = 0.3, CHCl3). The absolute configuration was assigned
by the analogue 4.6a. 93:7 er. HPLC condition: Chiralcel OD-H column,
n-hexane/i-PrOH = 92:8, flow rate = 1 ml/min, wavelength = 254nm, tR = 22.996 min
for minor isomer, tR = 39.678 min for major isomer.
4.4.2.4 Cobalt-catalyzed enantioselective vinylation of ketone esters
To a 10 mL vial equipped with a dried stir bar was added cobalt bromide (0.010
mmol), (1S, 1’S, 2R, 2’R)-duanphos (0.010 mmol), anhydrous THF (0.5 mL) in the
glovebox. The reaction mixture was then allowed to stir for 30 min, followed by
addition of vinylboronic acid (0.2 mmol) and imine 4.7, (0.10 mmol). The reaction
mixture was taken outside the glovebox and allowed to stir at 70 oC for 24h. The
crude reaction mixture was concentrated under reduced pressure. The products 4.8
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were directly purified by silica gel chromatography(ethyl acetate:hexanes = 1:10).The
enantiopurity of the purified products was analyzed by chiral HPLC (Chiralcel OD-H;
Chiralpak AS-H, AD-H, IE).
Colorless solid, 78% Yield. 1H NMR (500 MHz, CDCl3) δ 7.53 – 7.33 (m, 6H), 7.31
– 7.17 (m, 2H), 7.05 (d, J = 8.3 Hz, 1H), 6.88 (d, J = 15.7 Hz, 1H), 6.32 (dd, J = 15.7,
8.6 Hz, 1H), 5.47 (t, J = 7.4 Hz, 1H), 4.93 (s, 1H). 13C NMR (125MHz, CDCl3) δ
151.00, 136.76, 135.26, 129.85, 128.91, 128.84, 127.84, 126.96, 125.37, 124.16,
121.30, 118.88, 60.03. HRMS (ESI) m/z Calcd. for [C15H12NO3S, M-H]-: 286.0543;
Found: 286.0542. Optical Rotation: [α]22D = -3.70 (c = 0.4, CH2Cl2). The absolute
configuration was assigned according the analogue 4.10g. 99.8:0.2 er. HPLC
condition: Chiralcel OD-H column, n-hexane/i-PrOH = 80:20, flow rate = 0.8 ml/min,
wavelength = 254nm, tR = 23.294 min for major isomer, tR = 29.770 min for minor
isomer.
Colorless solid, 65% Yield. 1H NMR (500 MHz, CDCl3) δ 7.61-7.35 (m, 8H), 6.97 (d,
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J = 8.8 Hz, 1H), 6.91 (d, J = 15.6 Hz, 1H). 6.29 (dd, J = 15.6, 8.6 Hz, 1H), 5.46 (t, J =
8.4 Hz, 1H), 4.86 (d, J = 8.2 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 150.08, 137.66,
134.90, 132.95, 130.58, 129.18, 128.90, 127.05, 123.32, 123.14, 120.66, 118.11,
59.80. HRMS (ESI) m/z Calcd. For [C15H11BrNO3S, M-H]-: 363.9649; Found:
363.9650. Optical Rotation: [α]22D = -6.60 (c = 0.5, CH2Cl2). The absolute
configuration was assigned according the analogue 4.10g.. 99.6: 0.4 er. HPLC
condition: Chiralcel OD-H column, n-hexane/i-PrOH = 80:20, flow rate = 0.8 ml/min,
wavelength = 254nm, tR = 20.739 min for major isomer, tR = 27.963 min for minor
isomer.
Colorless solid, 70% Yield. 1H NMR (300 MHz, CDCl3) δ 7.61-7.33 (m, 6H), 7.15
(dd, J = 2.4, 1.0 Hz, 1H), 6.93 (d, J = 15.6 Hz, 1H), 6.28 (dd, J = 15.6, 8.7 Hz, 1H),
5.54 -5.41 (m, 1H), 5.09 (d, J = 8.3 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 145.74,
137.99, 134.74, 130.38, 130.34, 129.29, 128.92, 127.06, 126.09, 124.88, 124.32,
122.68, 60.07. HRMS (ESI) m/z Calcd. for [C15H10Cl2NO3S, M-H]-: 353.9764;
Found: 353.9767. Optical Rotation: [α]22D = -5.50 (c = 0.4, CH2Cl2). The absolute
configuration was assigned according the analogue 4.10g. 99.1:0.9 er. HPLC
condition: Chiralpark IE column, n-hexane/i-PrOH = 90:10, flow rate = 0.9 ml/min,
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wavelength = 254nm, tR = 8.958 min for major isomer, tR = 11.770 min for minor
isomer.
Colorless solid, 78% Yield. 1H NMR (500 MHz, CDCl3) δ 7.46 (m, 2H), 7.38 (m,
3H), 7.11 (d, J = 7.9 Hz, 1H), 7.02 (d, J = 7.9 Hz, 1H), 6.89 (s, 1H), 6.87 (s, 1H), 6.30
(dd, J = 15.7, 8.5 Hz, 1H), 5.44 (t, J = 8.3 Hz, 1H), 4.78 (d, J = 8.1 Hz, 1H), 2.38 (s,
3H). 13C NMR (125 MHz, CDCl3) δ 150.81, 140.47, 136.53, 135.30, 128.85, 128.81,
127.52, 126.92, 126.24, 124.40, 119.12, 118.17, 59.87, 20.96. HRMS (ESI) m/z
Calcd. For [C16H15NNaO3S, M+Na]+: 324.0665; Found: 324.0663. Optical Rotation:
[α]22D = -8.80 (c = 0.4, CH2Cl2). The absolute configuration was assigned according
the analogue 4.10g. 99.6: 0.4 er. HPLC condition: Chiralcel OD-H column,
n-hexane/i-PrOH = 80:20, flow rate = 0.8 ml/min, wavelength = 254nm, tR = 22.787
min for major isomer, tR =28.820 min for minor isomer.
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Colorless solid, 73% yield. 1H NMR (500 MHz, CDCl3) δ 7.46 (d, J = 7.2 Hz, 2H),
7.42 – 7.32 (m, 2H), 7.01 (d, J = 9.1 Hz, 1H), 6.93 – 6.81 (m, 2H), 6.73 (d, J = 2.9 Hz,
1H), 6.31 (dd, J = 15.7, 8.6 Hz, 1H), 5.43 (t, J = 8.3 Hz, 1H), 4.82 (d, J = 8.1 Hz, 1H),
3.78 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 156.76, 144.74, 136.83, 135.22, 128.92,
128.83, 126.96, 124.12, 122.16, 119.80, 115.13, 112.69, 60.12, 55.79. HRMS (ESI)
m/z Calcd. For [C16H15NNaO4S, M+Na]+: 340.0614; Found: 340.0614. Optical
Rotation: [α]22D = -15.67 (c = 0.5, CH2Cl2). The absolute configuration was assigned
according the analogue 4.10g. 99.8: 0.2 er. HPLC condition: Chiralcel OD-H column,
n-hexane/i-PrOH = 80:20, flow rate = 0.8 ml/min, wavelength = 254nm, tR = 30.949
min for major isomer, tR = 39.189 min for minor isomer.
Colorless solid, 77% yield. 1H NMR (300 MHz, CDCl3) δ 7.47 – 7.32 (m, 5H), 7.23
(dd, J = 3.2, 2.5 Hz, 2H), 7.07 (d, J = 8.1 Hz, 1H), 6.84 (d, J = 15.7 Hz, 1H), 6.33 (dd,
J = 15.7, 8.5 Hz, 1H), 5.48 (t, J = 8.3 Hz, 1H), 5.01 (d, J = 8.2 Hz, 1H). 13C NMR (75
MHz, CDCl3) δ 150.83, 135.30, 134.59, 133.62, 129.87, 128.95, 128.08, 127.70,
125.37, 124.73, 120.89, 118.87, 59.83. HRMS (ESI) m/z Calcd. For [C15H11FNO3S,
M-H]-: 320.0154; Found: 320.0159 Optical Rotation: [α]22D = -40.23 (c = 0.4,
CH2Cl2). The absolute configuration was assigned according the analogue 4.10g. 99.8:
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0.2 er. HPLC condition: Chiralcel OD-H column, n-hexane/i-PrOH = 80:20, flow rate
= 0.8 ml/min, wavelength = 254nm, tR = 15.154 min for major isomer, tR = 20.669 min
for minor isomer.
Colorless solid, 85% yield. 1H NMR (300 MHz, CDCl3 δ 7.46 – 7.32 (m, 3H), 7.26 –
7.16 (m, 4H), 7.07 (dd, J = 8.2, 0.9 Hz, 1H), 6.87 (d, J = 15.7 Hz, 1H), 6.26 (dd, J =
15.7, 8.6 Hz, 1H), 5.47 (t, J = 8.4 Hz, 1H), 4.90 (d, J = 8.3 Hz, 1H), 2.40 (s, 3H). 13C
NMR (75 MHz, CDCl3) δ 150.86, 138.96, 136.73, 132.31, 129.74, 129.46, 127.81,
126.80, 125.28, 122.86, 121.29, 118.76, 60.07, 21.22. HRMS (ESI) m/z Calcd. For
[C16H15NNaO3S, M+Na]+: 324.0664; Found: 324.0664. Optical Rotation: [α]22D =
-12.4 (c = 0.4, CH2Cl2). The absolute configuration was assigned according the
analogue 4.10g. 99.6:0.4 er. HPLC condition: Chiralcel OD-H column,
n-hexane/i-PrOH = 80:20, flow rate = 0.8 ml/min, wavelength = 254nm, tR = 14.591
min for major isomer, tR =25.394 min for minor isomer.
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Pale yellow solid, 86 % yield. 1H NMR (500 MHz, CDCl3) δ 7.45 – 7.32 (m, 3H),
7.22 (m, 2H), 7.06 (d, J = 8.2 Hz, 1H), 6.92 (d, J = 8.7 Hz, 2H), 6.83 (d, J = 15.6 Hz,
1H), 6.15 (dd, J = 15.6, 8.6 Hz, 1H), 5.45 (t, J = 8.5 Hz, 1H), 4.85 (d, J = 8.2 Hz, 1H),
3.85 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 160.23, 150.97, 136.44, 129.80, 128.29,
127.90, 125.34, 121.75, 121.53, 118.84, 114.26, 60.22, 55.38. HRMS (ESI) m/z
Calcd. For [C16H15NNaO4S, M+Na]+: 340.0614; Found: 340.0620 Optical Rotation:
[α]22D = -3.80 (c = 0.5, CHCl3). The absolute configuration was assigned according
the analogue 4.10g. 99.6: 0.4 er. HPLC condition: Chiralcel OD-H column,
n-hexane/i-PrOH = 80:20, flow rate = 0.8 ml/min, wavelength = 254nm, tR = 20.035
min for major isomer, tR =26.855 min for minor isomer.
Colorless solid, 68% yield. 1H NMR (300 MHz, CDCl3) δ 7.41 – 7.32 (m, 1H), 7.21
(dd, J = 3.4, 2.2 Hz, 2H), 7.04 (d, J = 8.1 Hz, 1H), 6.14 – 5.98 (m, 1H), 5.73 – 5.55 (m,
1H), 5.29 (t, J = 8.5 Hz, 1H), 4.67 (d, J = 8.3 Hz, 1H), 1.88 (dd, J = 6.6, 1.6 Hz, 3H).
13C NMR (75 MHz, CDCl3) δ 150.84, 134.07, 129.58, 127.68, 126.51, 125.13, 121.51,
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118.65, 59.82, 17.74. HRMS (EI) m/z Calcd. for C10H10NO3S [M-H]-: 224.0387,
found: 224.0381. Optical Rotation: [α]22D = -24.60 (c = 0.4, CH2Cl2). The absolute
configuration was assigned by x-ray crystallography. 99.8: 0.2 er. HPLC condition:
Chiralcel OD-H column, n-hexane/i-PrOH = 95/5, flow rate = 1.0 ml/min, wavelength
= 254nm, tR =15.761 min for minor isomer, tR =21.047 min for major isomer.
Colorless solid, 65% yield. 1H NMR (300 MHz, CDCl3) δ 7.14 – 6.93 (m, 2H), 6.86
(s, 1H), 6.13 – 5.95 (m, 1H), 5.59 (ddt, J = 15.1, 8.4, 1.4 Hz, 1H), 5.25 (t, J = 8.4 Hz,
1H), 4.60 (d, J = 8.4 Hz, 1H), 2.38 (s, 3H), 2.22 – 2.10 (m, 2H), 1.49 (m, 2H), 0.99 (t,
J = 7.4 Hz,3H). 13C NMR (75 MHz, CDCl3) δ 150.66, 140.12, 138.88, 127.35, 126.02,
125.58, 118.87, 118.45, 59.71, 34.14, 21.87, 20.88, 13.57. HRMS (ESI) m/z Calcd.
For [C13H17NNaO3S, M+Na]+: 290.0821; Found: 290.0826. Optical Rotation: [α]22D
= -14.56 (c = 0.3, CH2Cl2). The absolute configuration was assigned according the
analogue 4.10g. 99.6: 0.4 er. HPLC condition: Chiralcel OD-H column,
n-hexane/i-PrOH = 95:5, flow rate = 1 ml/min, wavelength = 254nm, tR = 11.458 min
for minor isomer, tR = 15.033 min for major isomer.
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Colorless solid, 58% yield. 1H NMR (300 MHz, CDCl3) δ 7.62 – 7.34 (m, 3H), 7.30
– 7.18 (m, 2H), 7.18 – 7.02 (m, 3H), 6.86 (d, J = 15.7 Hz, 1H), 6.26 (dd, J = 15.7, 8.5
Hz, 1H), 5.48 (t, J = 8.4 Hz, 1H), 4.96 (d, J = 8.2 Hz, 1H).
13C NMR (75 MHz, CDCl3) δ 164.61, 161.31, 150.84, 135.45, 131.33, 129.84,
128.60, 128.50, 127.72, 125.34, 123.84, 121.04, 118.84, 115.92, 115.63, 59.90.
19F NMR (282 MHz, CDCl3) δ -112.09 (ddd, J = 12.4, 8.1, 4.3 Hz, 1F).
HRMS (ESI) m/z Calcd. For [C15H11FNO3S, M-H]-: 304.0449; Found: 304.0451
Optical Rotation: [α]22D = -23.43 (c = 0.30, CH2Cl2). The absolute configuration was
assigned according the analogue 4.10g.
Pale yellow solid, 75% yield. 1H NMR (300 MHz, CDCl3) δ 7.54 – 7.34 (m, 4H),
7.02 – 6.91 (m, 3H), 6.86 (d, J = 15.6 Hz, 1H), 6.12 (dd, J = 15.6, 8.7 Hz, 1H), 5.43 (t,








160.45, 150.05, 137.22, 132.84, 130.64, 128.41, 127.62, 123.62, 120.78, 120.58,
118.04, 114.33, 59.97, 55.39. HRMS (ESI) m/z Calcd. For [C16H13BrNO4S, M-H]-:
393.9754; Found: 393.9752 Optical Rotation: [α]22D = -9.03 (c = 0.4, CH2Cl2). The
absolute configuration was assigned according the analogue 4.10g. 99.6: 0.4 er. HPLC
condition: Chiralcel OD-H column, n-hexane/i-PrOH = 80/20, flow rate = 0.8 ml/min,
wavelength = 254nm, tR = 20.739 min for major isomer, tR = 27.963 min for minor
isomer.
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Figure 4.1 X-ray analysis of hydrolysis of 4.4c
e.r 98:2
Molecule’s view






Space group P 2(1) 2(1) 2(1)
Unit cell dimensions a = 5.8398(2) Å α = 90°
b = 21.5974(8) Å β = 90°




Density (calculated) 1.309 Mg/m3
Absorption coefficient 0.783 mm-1
F(000) 1224
Crystal size 0.361 x 0.133 x 0.090 mm3
Theta range for data collection 2.796 to 72.458°
Index ranges -7<=h<=6, -18<=k<=26, -28<=l<=24
Reflections collected 14205
Independent reflections 5676 [R(int) = 0.0354]
Completeness to theta = 67.679° 99.6 %
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 5676 / 0 / 385
Goodness-of-fit on F2 1.054
Final R indices [I>2sigma(I)] R1 = 0.0377, wR2 = 0.0929
R indices (all data) R1 = 0.0428, wR2 = 0.0962
Absolute structure parameter 0.00(8)*
Largest diff. peak and hole 0.260 and -0.224 e.Å-3
*Flack x determined using 2042 quotients [(I+)-(I-)]/[(I+)+(I-)]
(Parsons, Flack and Wagner, Acta Cryst. B69 (2013) 249-259)
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Figure 4.2 X-ray analysis of hydrolysis of 4.4e
Molecule’s view:




Formula weight 328.77 g/mol
Temperature 100(2) K
Wavelength 1.54178 Å
Crystal size 0.117 x 0.157 x 0.208 mm
Crystal system monoclinic
Space group P 1 2(1) 1
Unit cell dimensions a = 5.9854(7) Å α = 90°
b = 7.5004(8) Å β = 97.565(4)°
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c = 18.085(2) Å γ = 90°
Volume 804.82(16) Å3
Z 2
Density (calculated) 1.357 g/cm3
Absorption coefficient 2.205 mm-1
F(000) 344
Table S2. Data collection and structure refinement for g061.
___________________________________________________________________________________________
Theta range for data collection 4.93 to 68.19°
Index ranges -7<=h<=7, -9<=k<=9, -21<=l<=21
Reflections collected 10346
Independent reflections 2871 [R(int) = 0.0289]
Coverage of independent reflections 99.9%
Absorption correction multi-scan
Max. and min. transmission 0.7820 and 0.6570
Refinement method Full-matrix least-squares on F2
Refinement program SHELXL-2014/7 (Sheldrick, 2014)
Function minimized Σ w(Fo2 - Fc2)2
Data / restraints / parameters 2871 / 1 / 210
Goodness-of-fit on F2 1.031
Final R indices 2798 data; I>2σ(I) R1 = 0.0233, wR2 = 0.0580




Absolute structure parameter 0.057(5)*
205
Largest diff. peak and hole 0.251 and -0.195 eÅ-3
R.M.S. deviation from mean 0.037 eÅ-3
*Flack x determined using 1213 quotients [(I+)-(I-)]/[(I+)+(I-)]
(Parsons, Flack andWagner,Acta Cryst. B69 (2013) 249-259).
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Figure 4.3 X-ray analysis of hydrolysis of 4.10g
Table 1. Crystal data and structure refinement for G114.
Identification code G114







Unit cell dimensionsa = 9.1983(10) ? A = 90?
b = 16.7173(18) ? b= 90.549(2)?
c = 13.7123(15) ? g = 90?
Volume 2108.5(4) ?3
Z 8
Density (calculated) 1.419 Mg/m3
Absorption coefficient 0.293 mm-1
F(000) 944
Crystal size 0.580 x 0.360 x 0.260 mm3
Theta range for data collection 1.921 to 28.275?
Index ranges -12<=h<=12, -22<=k<=22, -18<=l<=18
Reflections collected 24981
Independent reflections 10429 [R(int) = 0.0246]
Completeness to theta = 25.242? 99.9 %
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.7457 and 0.6473
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 10429 / 1 / 561
Goodness-of-fit on F2 1.028
Final R indices [I>2sigma(I)] R1 = 0.0285, wR2 = 0.0741
R indices (all data) R1 = 0.0292, wR2 = 0.0746
Absolute structure parameter 0.031(14)
Extinction coefficient n/a
Largest diff. peak and hole 0.398 and -0.277 e.-3
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (2x 103)
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